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General introduction
Background
Animals are being used in fundamental and applied research, to advance health and 
safety for both humans and animals. The use of animals in research has always been 
controversial, this is why the Universities Federation for Animal Welfare in the UK initiated 
a study in 1954 for more humane techniques in laboratory animal experimentation. This 
study led to the 3R-principles (replacement, reduction and refinement), which were 
first introduced by William Russell and Rex Burch in their publication The Principles 
of Humane Experimental Technique in the late-1950s [1]. Russell and Burch argue 
that good science and animal welfare are intricately intertwined, for example chronic 
stress in research animals can result in inaccurate and misleading experimental data. 
The 3Rs are defined as: Replacement; avoid or replace the use of animals wherever 
possible, Reduction; employ strategies that will result in fewer animals being used 
and which are consistent with sound experimental design and Refinement; modify 
husbandry or experimental procedures to minimize pain and distress. Later this 
definition was expanded to also encompass the improvement of welfare (e.g. by 
providing enrichment). Laboratory animal science is the scientific field focussing on 
improving scientific quality and animal welfare. The 3Rs have become the central 
theme to implement this concept. Over the last decades the 3R principles have become 
incorporated in many animal research policies and legislations worldwide, as well as 
funding programs and education. However, despite all efforts, practice has shown that 
successful implementations of the 3Rs and thereby improving scientific quality and 
animal welfare is not as straight forward as it might seem [2].
The aim of this thesis is to contribute to responsible use of animals in research by 
providing strategies to improve scientific quality and animal welfare in animal-based 
research. First the state of affairs on implementation of the 3Rs in the Netherlands was 
studied. This evaluation was used to generate new ideas on how to improve quality 
of animal- based research. This initiated further investigation of a new upcoming 
methodology in animal based research namely systematic reviews of animal studies. 
Therefore this thesis consists of two parts: part one focuses on the 3Rs and part two 
on systematic reviews.
Thesis outline part 1
In order to get insights into the current situation in the Netherlands, the Netherlands 
Organisation for Health Research and Development (ZonMW) [3] funded the project: 
“3Rs search and implementation – a national survey”.  The results of this study are 
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presented in the first part of this thesis. The aim of the national survey was to gain 
insights into the professional view on the 3R principles from researchers, animal welfare 
officers and animal ethics committee members. Chapter 2 of this thesis presents the 
survey outcomes of the first group: the researcher, which is a very important group as 
they are primary responsible for the implementation of 3R methods in their research. 
Chapter 3 describes the survey outcomes of the animal welfare officers and animal 
ethics committee members. These two groups are primary responsible for the ethical 
evaluation of animal based research including adequate implementation of 3R methods. 
Chapter 4 presents the outcomes of the follow-up 3Rs workshop after the surveys. 
Respondents from all 3 groups were asked to participate in this one-day workshop 
to discuss how 3Rs search and implementation in the Netherlands can be improved. 
Shift in research focus
Over the course of the research for this thesis we have found that improving quality 
and welfare in animal-based research requires more than ‘just’ stimulating better 
implementation of the 3Rs. 
Issues discussed in Chapter 4 such as poor experimental design and unpublished 
negative or neutral research results  are not unique for pre-clinical research. Similar 
issues have existed - or still exist -  in medical research. In medical research, systematic 
reviews of clinical trials have contributed significantly to raising awareness for these 
issues and have stimulated improvement as the need for guidelines on design 
and reporting of trials became apparent. The systematic review methodology is a 
systematic, thorough and transparent way of collecting, appraising and analysing all 
available studies and is a method to summarize and synthesise evidence in a most 
objective and reproducible way.
A systematic review aims to be a transparent summary of all available evidence on a 
certain topic. The methodology specifically aims to produce a complete overview and 
reduce possible bias in the review process to a minimum. An overview of available 
evidence is useful in the reduction of unnecessary duplication of animal studies 
and provide evidence-based input for the design of new animal studies (including 
refinement methods) and clinical trials. Another pivotal step in a systematic review 
is providing transparency on the validity of the available evidence, by assessing the 
methodological quality of the included studies. Therefore, the conduct of systematic 
reviews of animal studies, seems a logical and natural road to follow when aiming to 
promote responsible animal use in research. 
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Thesis outline part 2
The second part of this thesis focuses on the methodology that is currently used for 
systematic reviews of animal studies, specifically on the steps of searching for studies 
(completeness) and risk of bias assessment (quality). 
First Chapter 5 is an example of a systematic review of animal studies. This review aims 
to appraise and summarize all available evidence of animal studies on the protective 
effect of meniscus allograft transplantation on articular cartilage. Chapter 6 aims to 
evaluate the use of a risk of bias assessment in systematic reviews of animal studies, 
including an evaluation of what type of items are being scored and what the actual 
quality of these items was in the included primary studies. Chapter 7 aims to provide 
empirical evidence on how choices in the search strategy (database selection and 
language restriction) might affect the outcome of a systematic review or meta-analysis. 
The last chapter (Chapter 8) provides an overview of the main findings of the previous 
chapters, and their implications in the domain of animal based research. The final 
chapter also provides recommendations for further applications of the systematic 
review methodology in animal-based research, in order to promote responsible use 
of animals. 
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Abstract
A local survey conducted among scientists into the current practice of searching 
for Replacement, Reduction and Refinement has highlighted the gap between the 
statutory requirement to apply 3R methods and the lack of criteria for a 3R search. 
To verify these findings on a national level, we conducted a survey among scientists 
throughout the Netherlands. 
Due to the low response rate the results give an impression of opinions rather than 
being representative for the Netherlands. The findings of both surveys complement 
each other and indicate that there is room for improvement. Scientists perceive 
searching for 3R information in literature as a difficult task, and specific 3R search skills 
and knowledge of 3R databases are limited. Rather than using a literature search, 
researchers obtain 3R information through personal communication, so that published 
3R possibilities often remain unfound and unused. 
A solution may be to move beyond the search for the 3Rs and choose another approach. 
A method that seems most appropriate is systematic reviews (SR). It provides insight 
into the necessity of new animal studies, as well as optimal implementation of available 
data and the prevention of unnecessary animal use in the future.
Introduction
Dutch legislation requires that available Replacement, Reduction and Refinement 
[1, 2] (Three Rs) alternatives must be used. Before starting a new animal study, 
researchers are obliged to obtain approval from an Animal Ethics Committee (AEC). 
In the AEC application, researchers need to state whether Three Rs alternatives exist 
for this particular study, what evidence they have found for this, and whether these 3R 
alternatives will be applied. There are currently no criteria determining how this evidence 
should be presented, nor strict guidelines for how this evidence should be searched for 
and evaluated. It is therefore not known how scientists conduct their searches for Three 
Rs alternatives, what type of information sources they use, whether the search leads 
to useful information and whether Three Rs alternatives are successfully implemented 
in the study design.
In 2009, Leenaars et al. published a survey among scientists of the Radboud University 
Medical Centre. The results show that there is room for improvement in searching more 
effectively for the Three Rs. For instance, searching for the Three Rs is not a structural 
part of a research process and search skills for Three Rs alternatives are limited, as is 
knowledge of specialised Three Rs databases. Respondents indicated dissatisfaction 
with the availability and accessibility of information regarding the Three Rs. No budget 
for a Three Rs search is allocated and time spent on a Three Rs search is rather limited 
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[3]. The current questionnaire was held among scientists in the Netherlands in order 
to examine whether the local results were more generally found on a national level as 
well, and if so, what opportunities the respondents see for improving the search and 
implementation of the Three Rs.
Materials and Methods
A survey was conducted among researchers in the Netherlands (Federation of 
Laboratory Animal Science Associations (FELASA) category C scientists). The survey 
was descriptive in nature and designed to systematically categorise the problems that 
scientists experience when searching for the 3Rs. The questionnaire used in this study 
is an extended version of the local questionnaire by Leenaars et al. [3]. Questions were 
added based on in-depth face-to-face interviews with five researchers, two members of 
the AEC and one Animal Welfare Officer AWO. A closed set of answers to each question 
ensured that respondents were consistent in the way they answered. There was room 
for comments in questions for which the set of answers was not exhaustive. Multiple 
answers were allowed in inventory questions, for example about which resources were 
used. The complete questionnaire can be found in the appendix. The results of the 
survey were separated from the background and contact details of the respondent to 
safeguard the anonymity of the respondents and to exclude possible bias. The results 
were analysed per question. 
Results
This results section is a selection of the full data overview in the Appendix. 
Respondents
Fifty-two scientists from 20 different organisations responded to the questionnaire. 
As it is not known how many scientists in total are currently involved in animal 
experimentation in the Netherlands, nor how many scientists were approached for 
this survey, since the researchers could only be approached indirectly via the AWOs. 
Therefore a percentage of the response cannot be calculated. Most respondents (32 
in total) are employed by 9 different universities and academic medical centres. All 
respondents were familiar with the term 3Rs and were able to provide a description 
of the meaning. 
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Use of information sources
The 3R information sources that scientists (N=52) evaluated as being ‘high’ 
contributors to 3R knowledge in general were: the researcher’s own experience in 
conducting animal experiments (76.9%), the FELASA category C course (71.2%), 
the researcher’s own experience with research applications (57.7%), and personal 
communication with the AWO (61.5%) or with animal caretakers and technicians 
(53.8%). Personal communications with other researchers in animal-based research 
were also evaluated as ‘high’ contributors (48.1%). The majority of respondents (73%) 
indicated that updating oneself with 3R literature scores as a ‘low’ contribution. 
Researchers were asked which information sources they use in order to gain knowledge 
on the 3R possibilities for a specific research topic and how much these sources 
actually contribute to the implementation of 3Rs in their work. The information sources 
considered as ‘high’ contributors were: personal communication with colleague 
researchers (69.2%), information from their own earlier work (61.5%), earlier work done 
by the researcher’s own research group (61.5%), personal communication with the 
AWO (55.8%) or with animal caretakers and technicians (50.0%), and the feedback of 
the AEC (48.1%). Literature searches and outsourcing of literature searches were not 
considered important contributors. 
When the scientists (N=52) were asked which databases they knew, respondents 
answered that they were familiar with PubMed (96.2%), Google (86.5%) and 
Web of Science (59.6%). The sources Embase (21.2%), Agricola (15.4%), Toxnet 
(15.4%) and NCA (15.4%) were known by a relatively small group. Only a handful of 
respondents had heard of NC3Rs (7.7%), Altweb (5.8%), Zebet (3.8%) and Scopus 
(3.8%). The online information sources AWIC, Norina, FRAME and Go3R were 
known to one and the same respondent. UCCAAI, AVAR and Altbib were not known 
to any of the respondents. 
For cases where databases were actually used for the 3R search (N=39), we asked 
how frequently they were used. When searching for possibilities on the 3Rs in Pubmed, 
30 respondents (76.9%) indicated that they used it either frequently or always. For 
cases where Embase was used for the 3R search (N=10), 20% indicated that they 
used it frequently. Frequent use of Web of Science was 21.7% (N=23), for Google 
54.3% (N=35) and Agricola 14.3% (N=7). Online information sources specialised on 
the 3Rs were hardly known and thus barely used. 
Search activities
When respondents were asked if they conducted a literature search specifically on the 
3Rs for their research, 41 respondents (78.8%) answered ‘no’, whereas 11 (21.2%) 
did conduct such a specific literature search. Of those not conducting a specific 3R 
literature search (N=41), 39.0% indicated that it did seem useful to conduct a literature 
search on the 3Rs, the other 61.0% indicated that it did not seem useful.
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When the 41 respondents who did not conduct a 3R literature search were also asked 
why not, they selected one of the following pre-set answers: I do not think this will lead 
to new information (29.3%), I have never thought about this (17.1%), it is not part of my 
project (7.3%), I do not know how this will improve my research (4.9%), I do not know 
how to search for the 3Rs (4.9%), it does not have priority (4.9%), or it will delay my 
research (2.4%). 
The respondents writing AEC applications were asked how many hours they spent 
on a 3R search. This question was answered by 46 out of 52 respondents (88.5). For 
each AEC application, respondents spent an average of 3.3 hours on a search for 3R 
possibilities. The majority (93.5%) did not outsource the 3R search. 
Table 1 presents the results of the question that asked whether scientists perform a 
specific literature study on the 3Rs in relation to each phase of research, and so, how 
much time is then spent on this process. 
Nearly all respondents (98.1%) indicated that they do not include the search for 3R 
possibilities in their budgets. 
Issues with searching 
Researchers were asked how they evaluate their skills in searching databases for the 
3Rs (N=41). Most researchers (56.1%) indicated that they have sufficient skills for 
searching for the 3Rs in these databases, whereas 12.2% rated this as insufficient. 
The other 31.7% answered neutrally.
When evaluating satisfaction with the availability of information on the 3Rs, 26.9% 
(N=52) was dissatisfied, 51.9% was neutral and 21.2% was satisfied. About the same 
results were obtained when respondents were asked about the accessibility of the 3R 
information (30.8% dissatisfied, 48.1% neutral and 21.2% satisfied).
Implementation of 3R knowledge in practice
When asked whether they think 3R possibilities are often missed, scientists indicated that 
information on the 3R possibilities is missed; this was ‘sometimes to regularly’ for 63.5% 
(N=52) of the respondents and ‘often to always’ for to 9.6%. The 3R possibilities that 
are known to the respondents are ‘often to always’ implemented, as indicated by 80.8%. 
Respondents were asked in which phases of research they are involved, and how 
they evaluate the importance of each ‘R’ per phase (N=52). Most researchers were 
involved in writing AEC applications (88.5%), study plans or ‘work protocol’ (92.3%), 
and conducting the animal experiments (82.7%). During AEC applications (N=46), 
52.2% found that Replacement plays a role, with 95.7% indicating Reduction, and 
87.0% Refinement. Those involved in study plans (N=48) indicated that Refinement 
is most relevant (81.3%), followed by Reduction (54.2%) and Replacement (14.6%). 
During the practical execution (N=43), Refinement is considered most important 
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(83.7%), followed by Reduction (46.5%) and Replacement (14.0%). The attention for 
Replacement appears to be low in all phases of research.
Solutions
Scientists were asked to give reasons for not implementing 3R possibilities in their own 
research (N=52). Frequently mentioned answers by respondents were: ‘lack of time, 
budget and knowledge’. 
Scientists were then asked to estimate the degree of implementation of each of the 3Rs 
in own research if given unlimited time and budget. Twenty-eight respondents (53.8%) 
thought that the implementation for Replacement with unlimited resources would be 
‘none to very limited’, followed by 23.1% who thought this would be ‘reasonable’ and 
for 23.1% this would be ‘relatively good to good’. For Reduction the scores are as 
follows: 34.6% ‘none to very limited’, 28.8% ‘reasonable’ and 36.5% ‘relatively good 
to good’. For Refinement: 13.5% ‘none to very limited’, 30.8% ‘reasonable’ and 55.8% 
‘relatively good to good’. 
The answers to the question ‘If you could start a new initiative on how to improve optimal 
use of existing 3R knowledge, what would be your point of focus?’ were pooled. The 
respondents were also asked to give each item a priority score from 1 (most important) 
to 4 (least important). The item ‘more openness between organisations on how animal 
experiments are conducted’ received the highest score, followed by ‘support at the 
level of the research department’ and ‘better (accessibility of) information systems 
and databases on 3R knowledge’. In fourth place came ‘improved facilitation of 3R 
knowledge exchange inside and outside the organisation’, and in fifth place ‘systematic 
reviews of existing literature’. 
Discussion
A broad range of opinions from scientists working in different types of organisations 
has been obtained in this survey. As mentioned above, the results of the questionnaire 
cannot be interpreted as generally representative for all researchers conducting animal 
experiments in the Netherlands, but it does give valuable insight into how researchers 
from different backgrounds experience and evaluate the current 3R information search 
and how it can be improved.
The 3R principles of Replacement, Reduction and Refinement of animal studies are a 
well-known concept. In practice however the 3Rs cannot be seen as three equal matters. 
For instance, Replacement gets the most attention during funding applications and AEC 
applications but less so during the other phases. This is understandable, since Replacement 
usually involves multiple steps (e.g. including international multicentre validation studies) 
and multiple groups/organisations (e.g. involvement of legislative bodies). The choice 
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for animal-based research can be made if Replacement methods are not suitable or 
available. This then explains why Reduction and Refinement get the most attention in the 
other research phases. From this perspective it is therefore useful to treat Replacement 
separately from the other two Rs, since it usually covers a much broader perspective.
Updating oneself with 3R literature is a low contributor to general 3R knowledge and a 
specific literature search on the 3Rs is not usually conducted. Even though updating 
oneself with the latest literature is one of the prerequisites of good science [4], this seems 
not to be common practice for 3R literature. The majority of respondents neither reserves 
budget for a 3R literature nor conducts it. The minority that does search for the 3Rs, 
searches for an average of only 3.3 hours. The low use of literature may also be caused 
by the fact that it is complex and ineffective to do a Pubmed search with a specific focus 
on the 3Rs. Moreover, the specialised 3R databases and websites are hardly known and, 
when used, difficult to search due to differences in content, quality and search profiles 
[3]. This corroborates the outcome of the previous local questionnaire [3] and underlines 
the low priority given to the 3R search throughout a variety of organisations. There is 
clearly not yet sufficient pressure from legal authorities, funding bodies, editorial boards 
or AECs for scientists to perform a proper 3R literature search.
In general, the relevance of the implementation of the 3Rs for laboratory animal welfare 
and the quality of science [5, 6] is supported by the majority of researchers. According 
to the majority of the respondents, known 3R possibilities are implemented most of the 
time, although a smaller majority also thought that information on the 3R possibilities 
is sometimes missed or that known 3R possibilities remain unused. This is worrying 
because the law requires implementation of 3R methods whenever possible. This may 
be related to the fact that the search and implementation of the 3Rs are not seen as 
easy tasks. This corroborates our earlier findings and our own practical experience 
[3]. It is the researcher’s own personal contacts and experience that are especially 
considered high contributors to obtaining 3R knowledge. The situation whereby 
professionals consult other people rather than literature or databases is not specific 
to laboratory animal science however; it is also seen in information-seeking behaviour 
of engineers and public health practitioners, for the simple reason that they are easily 
accessible [7, 8]. People seeking information act in such a way that they minimise the 
effort spent on gaining information, and do not use the quality of information as the 
main criterion (the ‘principle of least effort’ in information science).
If given unlimited time and budget, about half of the respondents thought that 
especially the implementation for Refinement would be improved in their own 
research. Half of the respondents  working at institutes where legally required tests 
are performed feel (very) strongly stimulated by the licence holder to implement the 
3Rs, even though one third state that it is difficult to implement the 3Rs for such tests. 
This is a remarkably high figure, since legal guidelines make it virtually impossible 
to make fast 3R changes and thus to implement the 3Rs. Here there appears to be 
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greater  motivation for implementing the 3Rs, due to the sometimes harsh nature of 
legally required tests.
Respondents were asked what focus points they would wish to have if starting a 
programme for more optimal use of 3R knowledge. The top 3 was as follows: 1) more 
openness between organisations, 2) better access to 3R information and databases 
as well as support at the research department, and 3) better knowledge exchange. 
The range in wishes illustrates the complexity of the subject, and there does not 
appear to be a single solution or a single strategy for improving the use of existing 
3R knowledge. More openness in the exchange of information between institutes is 
considered the most important factor for better use of 3R knowledge. This requires 
that there be a more direct manner for researchers to make contact and communicate 
with one another, e.g. through a central (protected) database. 
While time and money are perceived as obstacles for implementing the 3Rs, they 
score low on the list of stimuli. It seems that money is a problem, but not a solution. 
This makes sense, since money will not provide knowledge and expertise for setting 
up an animal experiment that fully incorporates 3R knowledge, whereas collaboration 
with experts will increase knowledge and expertise. Because current procedures need 
to be adapted, new strategies need to be formulated and put into practice. Here we 
see opportunities for Systematic Reviews, on which we elaborate further below. 
Only a few respondents indicated that a 3R service would be their focus point of choice 
for more optimal use of 3R methods; we therefore suggest another strategy for a more 
successful search and implementation of the 3Rs. Prior to planning and executing new 
research, it is good science to perform a critical review of existing knowledge, in order 
to determine whether the current hypothesis is really novel and to become familiar 
with how previous similar studies were conducted [9]. This knowledge synthesis can 
be reached by following the path of systematic reviews (SR) [6]. It is worthwhile taking 
as an example the medical field, which made this successful change about 20 years 
ago. Evidence-based medicine based on systematic reviews is now considered the 
highest form of scientific evidence. Although SRs are now commonly performed for 
clinical studies, and have been for decades, this is surprisingly not yet the case for 
animal-based research; despite the fact that animal studies are used to predict the 
effect size of new therapies as well as their possible side effects in humans [10]. 
The advantage of introducing SRs into the field of animal-based research is that SR 
requires the involvement of specialists in several scientific disciplines, which allows 
for integrated and critical knowledge synthesis of ‘all’ available data and evidence. 
SRs will improve scientific quality, prevent unnecessary animal use and improve 
translational value [10]. Due to the critical analysis of all available knowledge, this will 
also ‘automatically’ lead to finding and implementing the 3Rs [6, 11, 12].
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Concluding remarks
Various studies describing strategies to improve 3R implementation have been published 
over the last decade [13-20]. This survey shows there is still much room for improvement. 
While huge efforts have been made in developing 3R databases, they are hardly 
known or used and appear to be ineffective, which seems a waste of resources. Local 
3R experts may offer a solution, since the local/personal network (knowledge gained 
via oral communication) is considered the main information source. The possibility 
of increasing the implementation of the 3Rs by facilitating local knowledge exchange 
through personal contacts is an important issue but also an opportunity. 
Because the 3Rs differ so much in nature, it is very difficult to determine common 
strategies for implementing all the 3Rs. Ideal implementation of the 3Rs will only occur 
when the 3Rs are an integral part of scientific practice. It may therefore be more fruitful 
to talk about gaining knowledge for responsible experimental design and animal use, 
instead of gaining 3R knowledge. This brings us back to the roots of the Three Rs: 
humane science, as expressed by Russell and Burch [1]. We believe that introducing 
the SR methodology from the medical field into animal-based research will lead to 
improvements in quality of science, animal welfare and implementation of the 3Rs, 
and enable genuine progress in humane science [4, 12]. This systematic approach will 
help in the identification, selection and analysis of all relevant published studies. An SR 
can tackle the above-mentioned inconsistencies and difficulties in the Three R search 
strategies. It does this by providing guidelines for formulating a search question, how 
and where to search for studies and how to process this literature into a review in 
an interdisciplinary team, naturally triggering personal contacts and networking in the 
process [11]. Systematic reviews have major potential for improving the quality of 
animal studies, compliance with laws and regulations, and most importantly preventing 
unnecessary animal use and improving animal welfare. We therefore propose that we 
move beyond the 3Rs towards systematic reviews as the leading concept. 
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Table 1  In what phase of research do you conduct a literature study specifically on the 3Rs and 
how much time (on average) do you then spend on this activity?  
(N=11, more answers per person possible)
No. of respondents No. of hours spent
Funding application 5 1, 8, 4, 12, 1
AEC application 10 120, 3, 1, 2, 2, 3, 1, 1, 1, 1
Study plan 4 120, 2, 1, 1
Practical conducting the study 2 40, 1
Reporting/publication 3 24, 8, 1
Other: Starting phase of a project 1 20
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Appendix chapter 2:
Translated from Dutch to Englisch
Part 1: Background researchers
1.1 Name organization
Excluded for privacy reasons. 
1.2 Gender
Male Female
23 29
1.3 Year of Birth
Excluded for privacy reasons.  Mean age 37,73
1.4 What type of organization do you work for?
University 32
Industry 4
Knowledge institute 11
Contract Research Organization 5
Other, namely. 0
1.5 What is the main purpose of the animal experiments?
Humane medicine 44
Veterinary medicine 13
Field Biology 1
Environmental research/ecosystem  2
1.6 Did you ever or how often do you execute animal experiments for the following purposes?
Purpose Never Sometimes Regularly Often Always
Development, production, control or calibration of 
reagents, medicine, vaccines and/or diagnostics 25 8 8 3 8
Toxicological research 34 9 1 5 3
Diagnostics 39 10 1 0 2
Education and training 31 18 2 1 0
Fundamental research 4 7 8 12 21
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1.7 How many years of experience in animal experimentation do you have?
Years of experience Respondents
0-2 years 9
3-5 years 15
6-10 years 9
11-15 years 6
> 16 years 13
1.8  Did you participate in the course on laboratory animal science (Required by Dutch law) and 
if so in which year?
LAS course Respondents
No 1
No, I obtained exemption by the ministry in 1986 9
Yes, year: 42 (Years are excluded for privacy reasons)
Part 2: View on the 3R principles
2.1 Are you acquainted with the 3Rs?
Yes No
52 0
2.2 Can you give a description of your perception of the 3Rs?
All respondents gave a more or less similar description of the 3Rs which was in compliance with the definition by Russell 
and Burch.
2.3 To what extend do you (dis)agree with following statements?
 Fully 
disagree Disagree Neutral Agree
Fully
agree
3R implementation is important for animal welfare 0 1 0 9 42
Existing 3R possibilities are optimally applied 1 7 27 16 1
3R implementation is of benefit to the animal, not to the 
researcher 9 32 4 6 1
Optimal implementation of the 3Rs is important in my 
job 1 2 9 29 11
3R implementation will lead to higher appreciation by 
journals 7 11 32 1 1
3R implementation will increase research costs 3 21 14 14 0
3R implementation needs to be rejected because of the 
necessity to compare results with earlier findings 18 19 15 0 0
3R possibilities often remain unused 1 7 15 25 4
The obligation for 3R implementation increases bureau-
cracy 5 16 11 18 2
Chapter 2
32
Better animal welfare leads to better experimental results 0 3 15 15 19
Finding the 3Rs is simple 7 18 14 13 0
3R implementation is easy 6 17 18 10 1
Application of the 3Rs slows down innovation 16 22 11 2 1
Part 3: Information sources
3.1  To what extent did the following information sources contribute to your 3R-knowledge  
in general?
Not 
applicable
Low
1 2 3 4
High
5
Education and training 6 11 7 12 12 4
Laboratory Animal Science course (Felasa cat. C course) 8 3 0 4 23 14
My own experience with conducting animal experiments 0 1 2 9 28 12
The experience with 3R possibilities within my research 
team 2 6 7 16 17 4
My own experience with research application 2 4 4 12 22 8
Conferences/workshops/symposia 8 14 14 9 6 1
Updating oneself with 3R literature 9 16 12 9 5 1
By conducting 3R research 14 14 6 8 7 3
Through the network within my own field of research 3 7 7 19 15 1
By consulting contacts in the laboratory animal science 
network:
- AEC members
6 12 9 10 12 3
- AWO 1 2 5 12 23 9
- Researchers 2 3 5 17 23 2
- Animal care staff and technicians 2 6 6 10 21 7
3.2  In case you are working on a specific research topic: which sources provide you with the 
necessary information on 3R possibilities? Can you please specify for each source to what 
extent is has been helpful in the process of optimal implementation of 3R possibilities in 
your research?
 Not 
applicable
Low
1 2 3 4
High
5
Information from my own previous work 8 4 3 5 25 7
Previous work by my own research group 2 4 1 13 26 6
Consulting:
 ...AEC members
7 9 13 12 9 2
 ...AWOs 2 1 4 16 20 9
 ...other researchers (colleagues) 1 2 5 8 28 8
 ...Animal care staff and technicians 2 6 8 10 18 8
 ...bio statistician 6 9 16 9 9 3
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...Replacement expert 15 13 11 8 4 1
A search in scientific databases, search engines, 3R 
databases or websites
11 10 12 5 11 3
Outsourcing a literature search 37 8 2 1 3 1
Consultation within the own network of professional asso-
ciations (not specified)
41 6 3 2 0 0
Use of online internet forums. (not specified) 39 5 5 3 0 0
Feedback from the AEC 8 7 8 4 19 6
Other. (not specified) 45 5 1 1 0 0
3.2.1  You have indicated that you sometimes outsource a literature search.  
To whom do you outsource? (N=4)
Information specialists 1
A specialized search service 1
Student assistants /students 6
PhD students 3
Other, namely: (I don’t outsource (2)/Do it myself, I misin-
terpreted the question /not applicable) 4
3.3  There are numerous databases, websites and search engines for a 3R search.  
Can you indicate in the list below which ones you know?
Pubmed 50
Google 45
Web of Science 31
Embase 11
Agricola 8
TOXNET 8
NCA 8
NC3R 4
Altweb 3
ZEBET 2
Other, namely. Scopus (2) 2
AWIC 1
Norinia 1
FRAME 1
GO3R 1
UCCAAI 0
AVAR 0
Altbib 0
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3.3.1  In case you use these databases, websites and search engines for your 3R search, 
please indicate for each database the intensity of consultation.
Never
1 2 3 4
Always
5
PubMed 3 2 4 9 21
Embase 2 2 4 2
Web of Science 6 8 4 4 1
Google 5 3 8 13 6
Agricola 5 1 1
AWIC 1
Norina 1
UCCAAI
AVAR
TOXNET 2 3 1 1
Altbib
Altweb 2 1
NCA 3 2 1 1
FRAME 1
GO3R 1
NC3R 3 1
ZEBET 1 1
Other, namely. Scopus 1 1
3.3.2 How do you evaluate your own 3R search skills to search in these databases and websites?
Very insufficient
1 2 3 4
Very sufficient
5
3 2 13 13 10
3.4 Is there within your organization a form of 3R support?
Respondents
No 15
Yes, other, namely (specified below) 15
Yes, a replacement expert 9
Yes, a 3R research department 8
Yes, an information specialist for a literature search 6
Other, namely. “an AWO” 7
Yes, meetings for exchanging 3R knowledge 5
Yes, a service centre for 3R advice 4
Other, namely. “The AEC, Central service for laboratory animals or AEC members” 5
Other, namely. “The laboratory animal science department” 3
Other, namely. “A platform for alternatives within the organization” 1
Other, namely. “an expert within the field” 1
Other, namely. “I don’t know” 1
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3.4.1 Do you, and if yes to what extent, use this support? (N=38)
Never Sometimes Regularly Often Always
13 11 6 5 3
3.5  To what extent does your professional environment stimulate you to implement 3R  
possibilities in your research?
Not
1 2 3 4
Very much
5
1 8 20 15 8
3.5.1 Can you elaborate on your previous answer?
Previous answer Comment
5 3R Research is (part of) my job/interest/experience
Professional context/merges with other interests:
- fewer/better animal studies result in faster/cheaper research
focus of Animal Ethics Committee (AEC)
3Rs are of interest/focus point of the client or organization
4 Optimization of research and reduction of costs
Input on experiments by: AEC, AWO animal care staff and technicians.
(not so much by my supervisor, more interested in the results)
Implementation 3Rs merges with other interests e.g. new research opportunities
Focus of the organization/AEC/animal care staff and technicians
Own interest/experience
3 Dutch magazine for applied laboratory animal science (Biotechniek)
Research question is the main focus
Have to because of the AEC
Its more expected then stimulated, when stimulation is defined as positive motivation
Most of our research are standard procedures and thus already optimized, otherwise consult 
the AWO
In the veterinary context: we need to learn more from our daily practice next to experimental 
situations, needs more attention from editors of veterinary journals
Some research is mainly guided by regulatory agencies. This makes the implementation of 
3Rs not possible and a search thus un-use full.
Focus of the research department/AEC
Own interest/elaboration with colleges
2 No stimulation within our group, it is more seen as a burden
I am the most experienced worker
1 Not part of a group, an thus not directly simulated. However do collaborate and elaborate 
with my supervisor, other groups, the AWO and AEC.
3.6 Evaluation of information sources
 
Very 
dissatisfied Dissatisfied Neutral Satisfied
Very 
satisfied
Are you satisfied with the availability of information 
on replacement, reduction and refinement? 0 14 27 10 1
Are you satisfied with the accessibility of this infor-
mation? 2 14 25 10 1
How satisfied are you with the effort needed seen 
in relation to the output of a 3R search? 3 17 23 8 1
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3.7 Space for additional comments on your experience with accumulating 3R knowledge.
Selection of the most relevant comments:
-  Refinement comes mainly from the Animal Welfare Officer, whereas Replacement and Reduction arise from the own 
research group and own experience
-  This depends on what area of research you are working in
- I do not use information from others in this area
-  Except from feedback from persons, I never use information sources on the 3Rs, and did not know they existed
- It has no priority
-  For my type of studies I cannot use e.g. computer models as Replacement, so here I do not need extra knowledge.  
For Reduction more knowledge would be advisable, but I have too little experience. The Refinement I apply is based on 
experience, and not on information sources on the 3Rs
-  My information comes from AEC members, animal technicians and animal welfare officers and experienced researchers.
-  The culture at my department reflects an attitude that experience in itself suffices. But, as a young researcher I feel partly 
responsible for new 3R developments. So I have tried to do 3R searches, however, it appears to be very complex to find 
specific 3R information. Refinement can always be applied, but Replacement and Reduction is more difficult.
-  It is difficult to find a good 3R method for the purpose of a study, certainly from literature. Mostly this process works 
better through discussions with researchers in another field or AEC members.
-  Within my department the 3R efforts arise from discussions with colleagues on Refinement and Reduction. There is a 
lack in (accessibility to) good 3R sites, and especially a lack on how 3Rs can be applied within a specific field of  
research. The AEC gives good feedback, which leads to discussion on the planned execution of studies.
Part 4: 3R knowledge in practice
4.1  In which phases of research are you involved? And can you specify to which of the Rs you 
contribute in each phase?
 Phase Replacement Reduction Refinement
Funding application 27 17 24 13
AEC application 46 24 44 40
Study protocol 48 7 26 39
Practical execution 43 6 20 36
Writing report /publication 49 6 12 14
Other moment, namely:
-  monitoring of the experimental 
part of the test
- autopsy on dropouts
2 0 0 2
4.2 How much time do you spend on a 3R search for each AEC application?
0 h 4
1 h 27
2 h 7
3 h 2
4 h 2
5 h 1
6 h 1
Other namely. (16 h /72 h) 2
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4.3 Do you outsource the search for 3R possibilities? Please specify.
No 43
Yes, to
- AWO
- knowledge group
- experienced researchers or self
3
4.4 Who reviews your application for 3R possibilities? (open question)
AEC 20 respondents
AWO  19
Colleague                                                                                                                                                                                                                8
Scientific committee/staff/supervisor 8
Nobody 5
Animal-care staff/technician 3
4.5 How do you experience the AEC’s advice on your planned animal experiment?
 Never Rarely Sometimes Often Always
Help to improve quality of research 7 6 22 9 2
Help to improve animal welfare 1 7 15 18 5
Necessary for AEC approval 2 4 8 12 20
Interference 8 17 18 3 0
Necessary bureaucracy 7 6 15 15 3
Unnecessary bureaucracy 13 13 15 5 0
 
4.6 Do you conduct a specific literature search, for 3R possibilities in your research?
Yes No
11 41
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4.6.1 What is the reason for not executing a 3R literature search?
I don’t think this will reveal new information. 12
I have never thought about it. 7
It is not part of my project. 3
I don’t know how it will improve my research. 2
I don’t know how to search for the 3Rs. 2
It has no priority. 2
It will delay my research. 1
Other namely:
- it is not useful (1 respondent), 
- there are no 3R possibilities for the type of studies I am 
doing (1), 
-  I already work on the 3Rs in a different way (5 respon-
dents: a pilot study; 3R study is part of the entire literature 
study; in the project proposal a clear description of which 
part of the 3Rs that is examined is presented; 3Rs are an 
integral part of the research, so all aspects are always 
included; I rely on experience of colleagues that have 
already evaluated the 3R possibilities)
-  We use standardised studies and protocols for which the-
re are no 3R possibilities, or which make a new literature 
study before every study superfluous (3)
-  It is not my own research, I am merely a spectator (1)
-  Required expertise for us is very specific (1)
12
4.6.1.1 Do you think this is useful? Yes (N=16) Comments:
- It could lead to new information, ideas and developments (5 respondents), 
- New information may lead to an improved protocol and/or better animal welfare (3)
- Not tried it before (1)
- In case an animal study is not necessary then you should not do it (1), 
- In case I encounter problems I give feedback and try to indicate alternatives (1), 
- Particularly want to learn more on Reduction (experimental design) (1)
4.6.1.2 Do you think this is useful? No (N=25) Comments:
- It takes too much time
- I don’t think this will lead to new information (4 respondents)
- There are no good alternatives for our type of research
- A pilot study serves this purpose 
- Our group has a large 3R experience already
-  When producing anti sera Reduction is not relevant, Replacement not possible and animal caretakers practice Refinement
- I know the 3R possibilities and get advice from a statistician
- Study design is dictated by legal requirements (2x)
- Some experiments cannot be performed differently (2x)
- Required expertise for our studies is very specific
- Once yearly review of toxicity study setup seems sufficient to me
- In our project proposal it is clearly described which part of the 3Rs is being examined
- I always do a power analysis on the most important outcome
- I already include this in the study design
- I get the information in a different way
- For my research there is no alternative and I already use the minimum nr of animals per group
- The study design is fixed at the moment of the AEC application
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4.6.2  In which research phase do you conduct the 3R literature search? And what is the time 
length of your search?
 Respondents Time (Hours)
Funding application 5 1, 8, 4, 12, 1
AEC application 10 120, 3, 1, 2, 2, 3, 1, 1, 1, 1
Study protocol 4 120, 2, 1, 1
Practical execution 2 40, 1,
Writing report /publication 3 24, 8, 1
Other moment, namely: Starting phase of a project 1 20
4.6.3  As a researcher, what are your practical possibilities (in time, budget, skills, knowledge) 
to find ways to optimize 3R implementation in research?
None Very limited Limited High
Replacement 7 18 15 7
Reduction 1 6 28 8
Refinement 1 7 18 14
4.6.3.1 Space for additional comments:
Reduction with my own data the others from literature
I have no limitations
3R search goes hand in hand with cost/effectiveness research
Essential part of my work. 
I don’t do my own research, however I do elaborate with researchers and animal care staff and technicians                                         
Replacement is in my field of research not an option
Right statistics can reduce the number of animals
Refinement can be difficult because in some situations it requires more animals to reduce the amount of suffering per 
animal. More animals vs. less suffering related to the purpose of the experiment is a difficult balance.                          
We use an animal-PET scanner and thus is replacement not an option.
Refinement and Reduction is discussed during the writing and design process of the study
4.7  What is your estimation of the potential for implementing 3R possibilities in case time and 
budget are unlimited?
None Very low Low High Very high
Replacement 11 17 12 7 5
Reduction 5 13 15 13 6
Refinement 4 3 16 17 12
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4.7.1 Space for additional comments:
You can never be sure if authors from other studies have the same quality or moral standards as you have. How will the 
experiment change if you change something in the set-up? What have the authors of the other studies possibly left out?          
I have done everything possible, more time or money would not have resulted in more 3R implementation                                                                   
It is hard to say how field research can effectively replace experimental animal-based research                                                                                                                               
Replacement and Reduction are not an option in my field of research. Refinement could be an option e.g. 
developing an animal model with reduced suffering                                            
No own research/experience
Implementation of more alternatives needs to by established by modification of legislation not by optimizing 
methodology
Replacement is not an option in my field of research. Reduction can be improved by collaboration with other research  
groups and consulting experienced animal technicians. Refinement search for optimal dose for post operative analgesia
4.8 Does your AEC (also) advice on legally required animal experiments?
Yes No
29 23
4.8.1  To what extent do you think legislative demands (e.g. European Pharmacopoeia) inhibits 
3R implementation in animal experimentation? Legislative requirements make it...
Very difficult
1 2 3 4
Absolutely not difficult
5
4 6 15 1 3
4.8.2  Despite these regulatory demands, to what extent does your license holder stimulate you 
to fully implement 3R possibilities in your animal experiments?
Not at all
1 2 3 4
Very stimulating
5
1 5 9 12 2
4.9 Do you include the 3R search in your research budget?
Yes No
1 
(not specified by respondent)
51
4.10 How often do the following situations occur?
Never Sometimes Regularly Often Always Don’t know
How often do you think that 3R information 
is missed and thus not applied? 5 16 17 4 1 9
Do you apply all the known 3R possibilities 
in your research? 1 2 6 28 14 1
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4.11  When known replacement, reduction or refinement methods were not fully applied, what 
was the cause for this?
This is not an issue/does not happen 17 (respondents)
Practical or Scientific reasons 15
Time/money (resources)          15
Legislation 7
Carelessness/unfamiliarity 5
4.12  In case optimal implementation of the 3Rs in your research has been applied, what has 
made this possible?
Good support and collaboration 15 (respondents)
Own motivation and experience 15
Scientific of practical considerations 8
Time and money 3
4.13 Room for additional comments to the use of 3R knowledge in practice:
Balance between science and practice can be difficult. E.g. the need to reproduce the animal experiment for validation and 
publication, but not receiving the permission of an AEC to duplicate experiments.
This survey is extremely focused on clinical (human) and fundamental research. Hard to translate some questions to the 
agricultural or veterinary setting.                                                                                         
Research can dependent on many factors such as the willingness of the animals to co-operate in training
I believe that the implementation of the 3Rs depends on motivation and creativity of the researcher and his attitude/respect 
towards the lab. animal.                                                               
It is suggested that many 3R possibilities are already available, however in practice this is not the reality. There is a lot of 3R 
research being conducted, the pace however is low. 3R implementations can interfere with the research and thus interfere 
with answering the research question. The theory is good, however in practice not always feasible.
An issue that I am currently struggling with: Previous research has indicated that more post operative analgesia is needed, 
however this introduces variation in the new test groups compared to the previous groups. Still I think and feel the need that 
the extra analgesia should be admitted and that this will result in refinement of the research.
I think that there is much 3R info but that this is hard to reach and thus not used. Additionally legislation is to strict on older 
(non-3R) methods.     
I think that researchers need to be informed where to find information. This makes it easier to evaluate what has been done 
and what is available within a certain field of research. Prior to writing a new application.
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Part 5: Wishes
5.1  Suppose you could start a new project for gaining a more optimal use of existing 3R knowl-
edge, what would be your focus points?
More openness between organizations about animal experimental practices. 26
Better and accessible information systems and databases with 3R literature. 19
Support at a level of a research department (3R research and development). 19
Well facilitated 3R knowledge exchange between individuals within and between organisations. 17
Courses to refresh and update 3R knowledge. 13
Systematic reviews of excising literature 10
External expert on alternatives that can be consulted, just like a bio-statistician. 10
A 3R literature search service for you specific research. 8
More focus on 3Rs in education 7
Funding – Providing budget for conducting a literature search by the researcher. 7
Encourage 3R assessment before funding applications. 6
Other, namely:
(A) funding for 3R research and development    
(B) quicker validation and acceptance of replacing in-vitro methods by regulatory bodies                                  
(C) professional 3V support during planning phase                       
(D) periodically refreshment/update courses
(E) More lenient legislation
5
5.2 Please prioritize the following statements from High priority (4 points) to Low priority (1 point)
                                                                       Priority high low
                                                                            4 3 2 1 Score
More openness between organizations about animal experimental 
practices. 14 4 5 3 81
Support at a level of a research department (3R research and 
development). 8 5 4 2 57
Better and accessible information systems and databases with 
3R literature. 5 6 8 0 54
Well facilitated 3R knowledge exchange between individuals 
within and between organisations. 4 9 2 2 49
Systematic reviews of existing literature. 4 4 2 0 32
Courses to refresh and update 3R knowledge. 0 3 8 2 27
External expert on alternatives that can be consulted just like a 
bio-statistician. 2 4 3 1 27
A 3R literature search service for you specific research. 3 2 1 2 22
More focus on 3Rs in education 0 6 0 1 19
Funding – Providing budget for conducting a literature search by 
the researcher. 3 0 2 2 18
Encourage 3R assessment before funding applications. 2 0 2 2 14
Other, namely: 2
(B/E)
1
(A)
1
(D)
1  
(C)
14
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Part 6: Evaluation of this questionnaire
6.1  Room for additional comments (any comments on this survey or important topics you  
have missed):
Selection of comments for privacy reasons:
- A lot depends on the discussion what information is needed before we can go to human trials. 
- Although I am in favour of openness, the increasing violence of activists leads to the opposite.
-  New multimedia, such as the Journal of Visualised experiments or even YouTube could contribute to the 3Rs to demon-
strate practical (im)possibilities of new research techniques and make this easily accessible to a large audience. 
-  This questionnaire has raised my 3R awareness again. I find it important to increase 3R knowledge and that this deserves 
attention. This research and questionnaire have certainly contributed.
-  It is my experience that there is a focus on the 3Rs in the FELASA category C course and AEC applications. However, 
besides this, there is not a lot of attention for the 3Rs. I have never had questions from a journal on the execution of the 
animal experiments. As long as a local AEC has approved it, then that is ok. I have never heard of funding bodies asking 
about the planned execution of animal experiments. It would be good to inform researchers where to find 3R information, 
also in FELASA category C courses. Publication of 3R experience should be stimulated.
6.2 Would you like to be informed about the outcome of this survey?
Yes No
36 16
6.3 Can we contact you for additional information/comments?
Yes No
32 20
6.4 Would you be willing to participate in the follow-up study? If yes, can we contact you?
Yes No
20 32
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Abstract
Implementation of the 3Rs in animal studies is a legal requirement in many countries. 
In the Netherlands, Animal Welfare Officers (AWOs) are appointed to monitor the 
welfare of laboratory animals. As part of this task, AWOs give advice to researchers 
and can therefore have an influential role in implementing 3Rs methods in research. 
A national survey was conducted to gain more insight into how Dutch AWOs obtain 
and apply 3Rs information in their daily work. Nearly half of the AWO population 
filled out the questionnaire (15/32; a response rate of 46.9%). Two-thirds of the 
respondents pointed out that finding 3Rs information is not an easy task and more 
than half of the respondents believed that information on possibilities to implement 
the 3Rs is regularly being missed. Respondents indicated that most 3Rs information 
is obtained from direct colleagues and other AWOs. Special online 3Rs databases 
are rarely used. All responding AWOs feel that they contribute to Refinement 
(15/15), nearly one-third of the respondents feel they contribute to Reduction (4/15), 
and one AWO feels he/she contributes to Replacement (1/15). According to the 
respondents, a better exchange of knowledge can contribute to a more successful 
3Rs implementation. How this knowledge exchange can best be established and 
facilitated needs further exploration. To that end, the authors make suggestions for a 
3Rs-integrated evidence-based approach. 
Introduction
As in many other countries, Dutch law only permits animal experiments if available 
3Rs methods have been considered and, if feasible, implemented. This means that, 
if possible, experiments have to be performed without animals (Replacement), with 
fewer animals (Reduction) and/or with less pain/distress for the animals (Refinement) 
[1]. Nowadays, also improved welfare, for example through cage enrichment, 
is considered part of refinement. Information about and expert knowledge of the 
3Rs principles are necessary for effectively applying these principles in research. 
To facilitate the retrieval of information regarding the possibilities to implement 
the 3Rs in a specific research field/study , a lot of effort has been put into the 
development of specific 3Rs databases [2, 3] and of guidelines on how to search for 
3Rs information [4-7]. An earlier survey by Leenaars et al. revealed that, despite all 
these developments, there is still much room for improvement in the way scientists 
currently retrieve information about the 3Rs (from databases) [8]. From this survey, 
it was concluded that searching for the 3Rs is not considered an integral part of the 
research process (and thus not funded), knowledge of 3Rs databases is minimal, 
and that search skills in general are limited. 
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Scientists, however, are not the only persons playing a role in implementing the 
3Rs. In the Netherlands, each licence holder (a legal or natural person possessing a 
licence to conduct animal experiments at their institution) has to appoint an Animal 
Welfare Officer (AWO). The task of this officer is to monitor the welfare of laboratory 
animals before, during and after experiments (Dutch Experiments on Animals Act, in 
Dutch; Wet op de Dierproeven, Article 14) [9, 10]. In general, the role of an AWO is 
comparable with the work of a FELASA category D officer [11]. The AWOs have a 
pivotal role in ensuring the proper conduct of animal experiments. They are in direct 
contact with scientists designing animal studies as well as with the animal care staff 
and technicians, who actually handle the animals and carry out the biotechnical 
procedures (such as drug administration or operations). The AWOs are required by 
law to give their advice about laboratory animal science-related topics in all research 
protocols that are assessed by the Animal Ethics Committees, including advice on 
implementation of 3Rs information. The AWOs can therefore play a crucial role in 
influencing the quality of the design and conduct of animal experiments as well as in 
safeguarding the implementation of the 3Rs. 
At present, we do not know how AWOs gain their knowledge on 3Rs possibilities, how 
this knowledge is implemented and whether obstacles and/or possibilities exist for 
improvement of 3Rsimplementation. In order to answer these questions, a survey was 
designed and sent out to all AWOs in the Netherlands. Similar surveys were sent out 
to scientists who are involved in animal-based research [12] and members of Animal 
Ethics Committees (unpublished observations).
Materials and methods
From April to June 2009, a national survey was conducted among AWOs in 
the Netherlands, in order to study their views on the use and implementation of 
3Rs knowledge. An online questionnaire was developed and distributed among all 
Dutch AWOs.
Questionnaire design 
The outline of the questionnaire was developed by the second author (YC) and was 
based on: 1) a previously conducted survey among researchers involved in animal-
based research at the Radboud University Nijmegen Medical Centre [8] and 2) in-
depth semi-structured interviews with five researchers, two Animal Ethics Committee 
(AEC) members and one AWO. The survey was descriptive in nature and included 
both qualitative and quantitative questions. Three AWOs, a communication expert and 
a knowledge management specialist assisted in optimising the questionnaire. The 
questionnaire was tested by three AWOs and adjusted according to their feedback. 
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The use of closed-ended questions ensured that respondents were consistent in 
their answers. There was room to give additional comments to questions, in case a 
respondent would not consider the provided set of answers exhaustive. Some questions 
allowed for multiple answers, e.g. on information sources. The language of the original 
questionnaire was Dutch; an English translation of the complete questionnaire can be 
requested from the authors.
Questionnaire distribution
A link to the online questionnaire was distributed among all AWOs in the Netherlands, 
with the help of the AWO-group of the Dutch organisation for Laboratory Animal Science 
(Nederlandse Vereniging voor Proefdierkunde; NVP). The Dutch inspectorate sent out 
a letter to all licence holders in the Netherlands, asking them to stimulate participation 
in this survey within their institutes. 
Data analyses
All answers given by the respondents were in Dutch. Despite the efforts of the authors, 
some misinterpretations and/or small translation errors cannot be ruled out. To 
safeguard anonymity and to exclude potential bias, the survey data were disconnected 
from the respondents’ background and contact details. The results were analysed per 
question. The closed-ended multiple answer questions, the yes/no questions and the 
questions with scaled answers were analysed through counting frequencies in Excel. 
The answers to open questions were listed and categorised by inductive analysis. The 
data were analysed by the first (JvL) and second author (YC).
Results
Response
At the time of the survey, the Dutch professional association of AWOs consisted of 42 
members, of whom 32 were actually appointed as an AWO by a licence holder. Fifteen 
AWOs filled out the questionnaire (response rate 15/32 = 46.9%). The affiliations of the 
responding AWOs were as follows: universities (6/15), knowledge institutes (3/15), industry 
(3/15), Contract Research Organisations (CRO) (2/15) and the government (1/15). 
Views on the 3Rs principles
Question 2.1, table 1. A large majority of the respondents agreed with the statements 
‘3Rs implementation is important for animal welfare’, ‘Optimal implementation of the 
3Rs is important in my job’ and ‘Better animal welfare leads to better experimental 
data’. A vast majority disagreed with the statements that ‘the 3Rs benefit animal 
welfare, but not the researchers’, ‘3Rs implementation needs to be rejected because 
3R suRvey among aWos
49
of the necessity to compare results with earlier findings’ and that ‘application of the 3Rs 
will slow down innovation’. Neutral responses or a wider diversity of opinion were found 
with respect to the other statements: ‘Existing 3Rs possibilities are optimally applied’, 
‘3Rs implementation will lead to higher appreciation by journals’, ‘3Rs implementation 
will increase research costs’, ‘3Rs possibilities often remain unused’, ‘The obligation of 
3Rs implementation increases bureaucracy’, ‘Finding information on 3Rs methods is 
simple’ and ‘Implementation of 3Rs methods is easy’.
General 3R information sources 
Question 3.1, table 2. The information sources considered to contribute the most to 
general 3Rsknowledge are ‘own experience as an AWO’, ‘consulting other AWOs’, ‘the 
postgraduate training to become an AWO’, ‘conferences, workshops and symposia’ 
and ‘consulting animal care staff and technicians’. Large differences of opinion are 
seen among AWOs concerning the contribution of their ‘academic education’, of 
‘consulting AEC members’ and of ‘conducting 3Rs Research’. Information sources 
evaluated as low contributors are: ‘consulting researchers’ and ‘updating oneself with 
literature on the 3Rs’.
Information sources for 3Rs information requests 
Question 3.2, table 3. ‘Own knowledge and experience’, ‘Other AWOs’, ‘Consulting other 
members of the Dutch AWO organisation’ and ‘Animal care staff and technicians’ are the 
most frequently consulted information sources when AWOs are requested to provide 3Rs 
information to scientists. ‘Searching in scientific and/or 3Rs databases’, ‘AEC members’, 
‘Outsourcing a literature search’ and ‘Consulting within an organisation or online forum’ 
are the least consulted information sources or are considered not relevant (chosen 
answer: ‘not applicable’) according to the majority of the respondents. The vast majority 
of the respondents answered ’indifferent’ to the option: ‘Consulting researchers’.
Acquaintance with and use of databases for 3Rs search
Question 3.3.Participants were asked which databases, websites and search engines 
for finding information on 3Rs methods they were familiar with. The best known 
databases, websites or search engines were: PubMed [13] by 15/15, Google [14] by 
14/15, NCA [15] by 12/15, NC3Rs [16] by 10/15, Agricola [17] and FRAME [18] by 
8/15, Altweb [19] by 7/15 and ZEBET [20] by 5/15. Web of Science [21], AWIC [22] 
and Norina [23] were known by 4 of the 15 respondents and 3 of the 15 respondents 
were familiar with Embase [24] and Toxnet [25]. Two respondents were familiar with 
GO3R [26] and one respondent knew the website Altbib [27]. None of the respondents 
indicated to be familiar with UCCAAI [28] or AVAR [29]. Three respondents used the 
option to add extra online 3Rs information sources. The sources they added were: 
CompMed [30], Laboratory Animals [31] and FELASA [32]. 
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Question 3.4. When respondents were asked which databases, websites and search 
engines they most frequently used to find relevant 3Rs literature (score 4 or 5, where 5 
is ‘very often’), the majority answered: PubMed (12/15) and Google (10/15).
Question 3.5. Nearly half (7/15) of the respondents considered their own skills to 
search for information on 3Rs methods in online databases, websites and search 
engines to be insufficient. Another group of 7 respondents answered ‘indifferent’ to the 
question about the sufficiency of their search skills. Only one respondent believed to 
have sufficient search skills for retrieving information on relevant 3Rs methods. 
Evaluation of online 3Rs information sources
Question 3.8, 3.9 and 3.10. Forty percent (6/15) of the AWOs were dissatisfied (score 
4 ‘much’ or 5 ’very much‘) with the availability of 3Rs information and another 6/15 
answered ‘neutral’ (score 3). A small majority (8/15) was dissatisfied (score ‘much’ or 
‘very much’) with the accessibility of information and 5/15 answered ‘neutral’ (score 3). 
Nearly half (7/15) of the respondents were dissatisfied (score 4 or 5) with the balance 
between search effort required and retrieved 3Rsinformation.
Experience with 3Rs advice 
Question 4.1. As the answers presented in table 4 show, responding AWOs mainly 
advise researchers on Refinement methods:  8/15 always give advice on humane 
endpoints and 7/15 always give advice on anaesthesia/analgesia. Least advice is 
given on Replacement methods:  9/15 never have advised on the use of computer 
simulations and only 7/15 sometimes advise on the use of human biomaterial.
Preferences and possibilities regarding giving advice to the AEC 
Question 4.4, table 5. For most given topics, the scores for whether AWOs would like 
to give more advice to the AEC on that particular topic and for whether this is already 
possible in the current practice  were largely similar. However, there was one exception: 
‘The advice to the AEC on the assessment of the effort put into searching, finding 
and implementing 3Rs as demonstrated by researchers’. Of the respondents, 12/15 
claimed that they would like to advise the AEC more on this topic, while 4/15 of the 
respondents indicate this is currently already possible. 
AWOs’ influence on the 3Rs
Question 4.10, figure 1. All 15 respondents consider their influence on the 
implementation of Refinement to be ‘high’. The influence on the implementation of 
Reduction is considered ‘high’ by 4/15 respondents, ‘medium’ by 7/15 and ‘low’ by 
4/15 respondents. Influence on Replacement is considered ‘low’ by 11/15 respondents 
and ‘medium’ by 3/15 respondents. One respondent indicated that his/her influence on 
Replacement is ‘high’. 
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Factors inhibiting implementation of 3Rs methods 
Question 4.12. The majority of the respondents (8/15) answered that information on 
3Rs methods is ‘regularly’ missed in an information search. Six respondents think 
that this information is missed ‘often to always’, and one respondent thinks that this 
information is missed ‘sometimes’. Question 4.13. The frequency of not implementing 
potentially suitable 3Rs methods is: ‘sometimes’ according to 4/15 respondents, 
‘regularly’ according to 7 and ‘often’ according to 3 respondents.
Question 4.13. AWOs were asked to elaborate on the possible reasons for missing 
information on 3Rs possibilities. They were not specifically questioned about their own 
role in this matter nor about the role of the researcher or the AEC member. Frequently 
mentioned reasons for missing relevant 3Rs information were: ‘unaware of or unfamiliar 
with the possibilities’, ‘lack of knowledge on how and where to search’, and ‘lack of 
interest or priority’.
Question 4.14. A similar question followed concerning the possible reasons for not 
implementing known 3Rs possibilities. Frequently mentioned reasons were: ‘lack of time, 
resources and knowledge on how and where to search for 3Rs information’, ‘the necessity 
to compare results with earlier findings’, ‘difficulties with “prescriptive legislation” (legally 
required animal testing)’ and/or ‘difficulties with accessibility of 3Rs information’. 
Stimulating factors for 3Rs implementation according to AWOs
Question 4.15. AWOs were asked to elaborate on what they regard as stimulating factors 
for successful implementation of 3Rs methods. Eight of the 15 respondents mentioned 
in their answer ‘the positive attitude/willingness of the researcher towards the 3Rs’ as a 
stimulating factor. Other frequently given answers were: ‘advice from AWOs and AECs’ 
(5/15), ‘good cooperation and preparation’ (4/15) and ‘enthusiastic and motivated 
animal care staff and technicians’ (3/15) . Also ‘support from management’ (2/15) and 
‘sufficient time and experience’ (2/15) were mentioned as stimulating factors.
Question 4.16. Respondents were given the opportunity to give additional comments 
on their personal experience with 3Rs information in practice. Some of the individual 
comments were: ‘Researchers should know the added value of implementing the 3Rs 
principles’, ‘More publicity and exchange of information is needed’, ‘The researcher is 
responsible for the implementation of the 3Rs principles’, ‘There is insufficient knowledge 
about experimental design among researchers, AWOs, AEC members, editors and 
referees; this needs to be improved by training and supervision/quality control’.
Ways to facilitate the optimal use of current knowledge on the 3Rs
Question 5.1, table 6. The four most selected items that were believed to contribute 
to a better implementation of 3Rs methods were: ‘Support at the level of a research 
department’ (10/15), ‘A 3Rs literature search service for your specific research’ (9/15) 
‘Well facilitated 3Rs knowledge exchange among individuals, both within and between 
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organisations’ (8/15), and ‘Better accessible information systems and databases with 
3Rs literature’(5/15). 
Six individual respondents selected the option ‘other’ and added the following comments: 
“Each organisation should appoint an expert on alternatives, at the same regulatory and 
organisational level as an AWO”, “Funding of small projects without bureaucracy”, “The 
first question on the research plan (AEC form) should be: Why an animal experiment? 
What did you do and which sources did you consult to optimally apply the 3Rs in your 
animal experiment?”, “ONE information system, not 17!!”, “One national research centre, 
funded by users, that executes literature studies as well as practical 3Rs research 
and development (data sharing, surveys, common goals and joining forces, advice, 
publications)” and “Information exchange to encourage sharing”.
Data not presented
Answers to questions 3.6, 3.7, 3.11, 4.2, 4.3, 4,5, 4.9 and 4.11 are not presented for one 
or more of the following reasons: the answers to these question were too ambiguous 
for meaningful interpretation, the question did go into too much detail for the scope of 
this manuscript, and /or the question is too specific for the Dutch situation. For these 
reasons, the answers to these questions were considered to be of less relevance for an 
international audience and are therefore not shown and discussed.
Discussion
In this survey, the views and perceived influence of Dutch AWOs on the implementation 
of the 3Rs have been investigated. The AWOs perceive the search for 3Rs information 
as a difficult task and acknowledge that 3Rs possibilities are sometimes missed and, 
as a consequence, not implemented in research. Given that the main task of an AWO 
is to monitor the welfare of the laboratory animals before, during and after experiments 
[9], it is not surprising that nearly all respondents agree that implementing the 3Rs is 
important in their job. In practice, they advise most frequently on Refinement matters 
and also consider their influence on the implementation of Refinement methods to be 
the highest, compared to Reduction and Replacement.
According to the survey by van Luijk et al. (2011), scientific researchers consider AWOs 
and colleague researchers to be the most important sources for obtaining 3Rs information 
[12]. In line with this result, AWOs should acquaint themselves with 3Rsinformation 
sources and advise researchers on where to find relevant 3Rs information. Responding 
AWOs know more online 3Rs information sources than the responding AEC members 
and researchers. On average, AWOs were familiar with 6.9 sources, whereas AEC 
members were familiar with 3.7 sources (unpublished data) and researchers were familiar 
with an average of 3.4 online information sources [12]. Nevertheless, searching these 
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online sources remains a difficult task as there are over 100 different databases and it is 
almost impossible to perform an effective and adequate search in all of these [8]. This 
could imply that specifically searching for 3Rs information is not the most fruitful way for 
accumulating relevant 3Rs information [8, 12]. Strengthening personal communication 
between researchers, AWOs and other experts seems a better way to go, as this is already 
perceived as an important source for 3Rs information. This might be achieved by forming 
3Rsexpert groups, which would include an AWO, a statistician and possibly a Replacement 
expert. However, relying solely on personal communication may introduce the risk of 
information remaining local or becoming outdated. Instead of collecting 3Rs information 
in separate databases or websites, it would be more useful to have this information 
incorporated in scientific papers. We would suggest to not address the 3Rs as a separate 
part per experiment, but incorporate them more as best practice in the broad endeavour 
to find answers to a research question. For example by conducting a comprehensive 
search as seen in the Systematic Review (SR) methodology. A comprehensive search is a 
thorough and transparent way of accumulating and all available relevant publications. De 
Vries et al conducted a comprehensive search in PubMed, EMBASE and 3R databases 
to produce an overview of the possibilities of using tissue-engineered constructs as a 
replacement of laboratory animals. Most relevant information was found in the PubMed 
and EMBASE search (238 primary articles) compared to the 3R databases search where 
6 relevant primary studies were found that did not come up in the PubMed or EMBASE 
search[33]. One should note that the search strategy for 3R databases is more difficult to 
design as these databases usually do not have the option to search for thesaurus terms 
and are often less structured [8].  Collecting and combining all available evidence helps 
to make ethically and scientifically sound choices when designing a new line of animal-
based research e.g. on the choice for the most appropriate animal model [34, 35]. 
Additionally, a more transparent search process can assist AWOs and AEC members 
in advising researchers, as it provides them with better insights into how and where 
researchers have searched for information. According to the answers to question 4.4 of 
this questionnaire, this type of insight is highly desirable, but hardly achievable in current 
practice. The conduct of a comprehensive search requires the participation of a team of 
experts such as a librarian or information specialist, a laboratory animal scientist and an 
expert in the field. The inclusion of these multiple fields of expertise can have a positive 
influence on the personal communication and thus implementation of 3R methods. The 
Systematic Review methodology is common practice in the field of clinical research [36, 
37]. Even though animal studies often form the basis for clinical research, SRs of animal 
experiments are still very scarce [35, 38]. SRs of animal experiments need consideration 
as they have the potential to improve the scientific quality of animal experiments, to make 
decision-making (e.g. choice for animal model and study design) more transparent, to 
lead to reduction by preventing unnecessary duplication of animal experiments and to 
improve animal welfare [34, 39, 40].
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A weakness of this survey is that the main focus was on the 3Rs as a whole instead of 
on each individual R separately. A few respondents commented that they would have 
liked to specify their answers per R. Unfortunately this was sometimes not possible due 
to the design of the questionnaire and formulation of the questions. This may have lead 
to ambiguity in the answers and thus may have weakened the results. On the basis 
of the results of this questionnaire, it can be concluded that future surveys on the 3Rs 
should address Replacement separately from Reduction and Refinement.
AWOs already make an important contribution to the implementation of Refinement 
methods in animal-based research. In order to enhance the quality of animal-
based research and welfare of laboratory animals, other strategies, next to and in 
compliance with the 3Rs principles, need to be developed such as facilitating personal 
communication related to 3R methodologies and compressive search strategies for 
retrieving written 3R information.
Without underestimating the value or the importance of the 3Rs, one could say that a 
specific 3Rs literature search may not be the most effective way to retrieve information 
for 3Rs implementation. Instead, combining multidisciplinary expert collaboration and 
synthesis of scientific evidence may be a more fruitful way forward and should therefore 
be considered and explored.
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Table 1  General view on the 3Rs. 
Question 2.1: To what extent do you agree or disagree with following statements? 
(N=15)
 Fully  
disagree Disagree
 
Neutral
 
Agree
Fully
agree
3Rs implementation is important for animal welfare 0 0 0 1 14
Existing 3Rs possibilities are optimally applied 1 4 6 4 0
3Rs implementation is of benefit to the animal, not to the 
researcher 11 3 0 1 0
Optimal implementation of the 3Rs is important in my job 0 1 0 5 9
3Rs implementation will lead to higher appreciation by 
journals 1 3 6 5 0
3Rs implementation will increase research costs 2 7 4 2 0
3Rs implementation needs to be rejected because of the 
necessity to compare results with earlier findings 9 5 1 0 0
3Rs possibilities often remain unused 1 2 3 9 0
The obligation for 3Rs implementation increases bureau-
cracy 2 3 6 4 0
Better animal welfare leads to better experimental results 0 0 1 3 11
Finding information on 3Rs methods is simple 3 7 5 0 0
3Rs implementation is easy 2 6 7 0 0
Application of the 3Rs slows down innovation 8 4 3 0 0
Figure 1 Bar diagram of the level of perceived influence of AWOs on the implementation of the 3Rs.
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Table 2  Information sources contributed to general 3Rs knowledge.  
Question 3.1: To what extent have the following information sources contributed to 
your general 3Rs knowledge?
NA*
Very  
Little
1 2 3 4
Very 
Much
5
Academic education 0 5 2 0 6 2
Postdoctoral education to become AWO 0 0 3 2 4 6
Own experience as an AWO 0 0 1 1 10 3
Conferences/workshops/symposia 0 0 1 5 7 2
Keep up with 3Rs literature 0 0 2 9 3 1
Own research on the 3Rs 2 3 3 3 1 3
Personal communication with... 
...Researchers 0 1 1 8 4 1
...colleague AWOs 0 0 1 1 10 3
...Animal Ethics Committee members 0 1 4 3 3 4
...Animal technicians and care staff 0 0 3 4 4 4
* Not applicable
Table 3  What sources do you consult to get 3Rs information to help you formulate a specific advice? 
Survey question 3.2: In the following situation: When a researcher or an AEC member 
asks your advice on Replacement, Reduction or Refinement matters, what sources do 
you consult to get this information? Please specify how often you use these sources.
NA*
Very  
Little 
1 2 3 4
Very 
Much
5
Own knowledge and experience 0 0 2 5 5 3
By consulting...
...Researchers 0 0 2 11 2 0
...Other AWOs 0 0 1 2 9 3
...Animal Ethics Committee members 0 3 5 5 2 0
...Animal technicians and care staff 0 0 3 4 7 1
...Other, namely... 7 3 2 1 1 1
By searching in scientific or 3Rs literature databases 0 4 4 5 1 1
By outsourcing a literature search 9 4 2 0 0 0
Consulting within the organisation for Dutch AWOs 0 3 1 2 8 1
Consulting within an organisation, namely... 7 3 3 1 1 0
Consulting within an online forum, namely... 7 4 1 2 1 0
Other, namely... 12 1 1 1 0 0
* Not applicable
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Table 4  AWOs advice on the 3Rs 
Question 4.1: How often do you advise researchers on the following topics:
 Never Seldom Sometimes Often Always
Animal model
The choice whether a research question should be answered 
with an animal model
2 3 5 5 0
Choice for an specific animal model 1 2 6 6 0
Knowledge and information
Applicability of 3Rs methods from similar previously conducted 
research
0 4 7 2 2
Possible search activities to retrieve research-specific 3Rs 
methods 
1 5 8 1 0
Pointing out relevant information sources on 3Rs methods 3 6 3 2 1
The possibility to consult others (specialists) 1 2 6 5 1
Replacement
Whether the use of human material is possible 4 3 7 0 1
Possible use of computer simulations 9 3 3 0 0
Reduction
Optimal use of in vitro techniques prior to an animal experiment 1 3 9 0 2
Optimal use/sharing of the experimental animal (e.g. practice 
chirurgical techniques post mortem) 
0 0 8 7 0
If the correct statistical tests are used 0 1 6 6 2
Refinement
If the correct biotechnical procedures have been applied 0 0 3 6 6
If the correct analgesia / anaesthesia is administered 0 0 2 6 7
Correct use/definition of humane endpoints 0 0 0 7 8
Training of animals for better cooperation in the experiment 0 3 5 4 3
Use of cage enrichment 0 0 4 5 6
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Table 5  Topics on which AWOs would like to advise the AEC more. 
Question 4.4: On which of the following topics of a research application would you like 
to advise the AEC more (desirable), and is this possible in the current practice?
Desirable Possible
Animal model
Substantiation of the choice whether a research question should be answered with a animal 
model
11 11
Substantiation of the choice for a specific animal model 10 12
Knowledge and information
Use of 3Rs methods from similar previously conducted research 11 8
How the search for information on 3Rs methods was conducted 7 5
Demonstrated effort by the researcher to find 3Rs methods 12 4
Which information sources have been consulted 7 5
Which experts have been consulted 8 8
The competences of the personnel carrying out the biotechnical procedures 10 9
Replacement
Whether the use of human material is possible 8 6
Whether the use of computer simulations is possible 7 5
Reduction
Optimal use of in vitro methods prior to animal experiment 8 8
Optimal use/sharing of the experimental animal (e.g. practice chirurgical techniques post 
mortem)
8 9
Optimal and correct use of statistical tests 8 9
Refinement
If the standard biotechnical procedures are applied 11 13
If the correct analgesia and anaesthesia is administered 12 12
Correct use/definition of humane endpoints 11 13
Training of animals for better cooperation in the experiment 11 13
Social housing of the animals 11 13
Use of cage enrichment 12 13
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Table 6  Suggestions and priorities for improving 3Rs use. 
Survey question:In case you could start a new project for gaining a more optimal use 
of existing 3Rs knowledge, what would be of your primary focus? 
(Select a minimum of 1 and a maximum of 4 items) 
Number of  
respondents
Support at a level of a research department (3Rs research and development). 10
A 3Rs literature search service for you specific research. 9
Well-facilitated 3Rs knowledge exchange between individuals within and between organisations. 8
Other * 6
Better and accessible information systems and databases with 3Rs literature. 5
External expert on alternatives that can be consulted, just like a bio-statistician. 4
More openness between organisations about animal experimental practices. 4
Encourage 3Rs assessment before funding applications. 3
Systematic reviews of excising literature 2
Funding – Providing budget for conducting a literature search by the researcher. 2
More focus on 3Rs in education 1
Courses to refresh and update 3Rs knowledge. 1
* comments by individual respondents can be found in the text.
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Abstract 
This article describes the outcome of a workshop that was held to generate new ideas 
to improve the use of the 3R principles in science. The participants of the workshop 
represented researchers, Animal Welfare Officers and members of Animal Ethics 
Committees from various Dutch affiliations, including academia, industry, contract 
research organizations and knowledge centres. The workshop resulted in six diverse 
consensus statements, which are presented and discussed in this article. It may be 
concluded that there is not a straightforward solution to improve the implementation 
of 3R methods in animal-based research. The authors discuss the concept of a 
Systematic Review as a possible solution for several items mentioned in the consensus 
statements and as a method to move beyond the 3Rs.
Introduction
Over the last 50 years, the 3Rs have been the guiding principles in animal-based 
research [1]. Even though they are incorporated in the legislation of many countries, it is 
difficult implement the 3Rs principles in science and also to evaluate the effectiveness 
of implementation [2, 3].
In 2009 a survey was conducted in order to investigate how professionals (scientists, 
Animal Welfare Officers and Animal Ethic Committee members) search for the 3Rs 
methods. The results showed that searching for 3Rs methods is perceived as a difficult 
task [4, 5]. These findings were in compliance with earlier findings of a local survey 
[6]. The majority of the respondents were not familiar with specialized databases and 
websites for animal science and 3Rs , while there are over 100. Also the proper skills to 
search in these databases was limited. Most perceived information on the 3Rs comes 
from direct colleagues and personal communication with other professionals [4, 5]. 
This is an undesirable situation as information remains local and may thus inhibits the 
use of new 3Rs innovations.
For this reason a workshop was organised to investigate potential strategies to 
improve the implementation of the 3Rs principles in science. The workshop resulted 
in six consensus statements which are presented in this article. From the diversity 
of the statements and outcomes of other (inter)national studies [2, 7-14] it can be 
concluded that there is not a straight forward solution to improve implementation of the 
3Rs. Systematic Reviews (SR) of animal studies may be a suitable approach to solve 
several of the issues raised. While SRs are common practice in clinical research, this 
is not the case in animal-based research while similar advantages from this approach 
can be expected. Moreover SRs appear a valuable tool to study the translational value 
of animal studies [15-19]. The potential value of SRs of animal studies for both scientific 
Dutch workshop on 3r improvements
67
and ethical reasons (including the 3Rs principles) will be discussed in this paper as a 
way to move us beyond the 3Rs.
Three Rs Workshop
In 2010 the 3R Research Centre (SYRCLE since February 2012) organized in 
collaboration with Vaart Innovation and Knowledge, a workshop in the framework of a 
project funded by the Netherlands Organisation for Health Research and Development 
(ZonMW) : “Three Rs information in practice - national survey of searching, finding and 
applying the 3Rs” (project number ZonMW 114 000 092). The aim of this study was to 
gain insights into how Researchers, Animal Welfare Officers (AWO) and members of 
Animal Ethic Committees (AEC) incorporate the 3Rs principles [1] in their work. This 
workshop was a follow up of earlier survey studies [4, 5]. The questionnaire results 
showed that there is room for improvement of 3Rs implementation.
Respondents of  the questionnaires were asked if they were willing to participate in 
a follow up study. A total of 36 respondents were approached for participation in the 
workshop of which 18 participated. Together, the participants represented 8 different 
organisations including universities, industry, contract research organizations (CRO) 
and knowledge centres. It was for the first time in the Netherlands that researchers, 
AWOs and AEC members from different organisations were brought together to 
discuss the current state of affairs on the 3Rs principles and how to improve the use 
of these principles in daily practice. The aim of the workshop was to deepen the ideas 
suggested in the surveys, and to formulate and prioritize required actions  for a better 
exchange of 3R knowledge and a more optimal 3R implementation in practice. 
Table 1 shows the affiliations of the 18 participants of the workshop. It should be noted 
that five participants exerted in daily practice two professional roles: some AWOs and 
researchers also being a member of an AEC. To avoid a possible conflict between two 
professional roles, those participants were asked to select one main profession during 
the workshop, e.g. preferably the same one as was taken to fill out the questionnaire. All 
of them indicated to represent their main profession which was either researcher or AWO. 
During the introduction of the workshop, a detailed overview of the survey results was 
presented. Accordingly the workshop participants were asked to comment in plenum. 
Based on this general discussion, the more detailed discussion topics for the afternoon 
session were formulated.
In order to facilitate more in-depth discussions, the participants were divided into two 
groups for the afternoon session. The group composition was based on combining 
various backgrounds and professions, to create two more or less similarly mixed 
groups. Each group was led by one of the professional discussion leaders of Vaart 
Innovation and Knowledge Management. In the concluding plenary session, the two 
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groups presented and discussed their main points, which together were used as the 
basis to formulate mutual consensus statements. Full agreement by participants to 
these consensus statements was given at the end of the workshop, and also to a 
written ZonMW report of the workshop (in Dutch) which was circulated afterwards [20].
Consensus statements
At the end of the workshop the participants had formulated six consensus statements, 
which are described below. Table 2 provides an overview of these consensus 
statements and includes suggested key players for achieving each goal mentioned. 
The key players were both suggested by the workshop participants during the 
workshop and also added later according to feedback received on the workshop report. 
1.  Division of the 3Rs and avoiding the use of the term ‘alternatives’
  In order to address each R appropriately in its own right it is, according to the 
participants, advisable to split the 3Rs into “Replacement” and “Reduction and 
Refinement” (also referred to as ‘best practice’). Replacement requires a different 
approach as compared to the application of Reduction and Refinement methods. 
Replacement methods for instance, require validation and sometimes even 
legislative involvement in order to be accepted on a national or international scale. 
By addressing the 3Rs as a whole, the risk arises that no full justice is done to 
each of the 3Rs. 
  An additional issue raised, was the use of the term ‘alternatives’ in the context of 
the communication within the scientific field, as well as with ‘the outside world’ 
(‘the public at large’). 
  In practice the term ‘3R alternatives’ is frequently used, but often creates the impression 
(especially to the public at large) that these only refer to genuine replacements. In 
practice, Replacement is only a very small - and in some fields even negligible- part 
of the 3Rs. It was suggested to abolish the term ‘alternatives’ altogether. Clearly, 
abolishing the term ‘alternatives’ in the scope of Laboratory Animal Science does not 
seem realistic, since it is a very well established term. However, the image of the ‘3R 
alternatives’ in this respect requires more attention. The utility and need of the 3Rs 
should be expressed better in a more scientific context, alongside with the well-known 
animal welfare arguments. The workshop participants also expressed the feeling that 
the current image of the word ‘3R alternatives’ is often seen as “dusty”. The field of 
laboratory animal science with a focus on 3R alternatives is therefore often seen as a 
service or secondary field of research only. For reasons of promoting proper science 
as well as animal welfare, it is important to create a clearer and better definition of the 
3R’s individually, and the field of laboratory animal science as a whole.
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2.   Awareness for Replacement on a higher level and earlier stage of research, 
appointment of a Replacement expert.
  Optimal implementation of each of the 3Rs requires different expertise. For questions 
related to Refinement and Reduction methods an AWO and/or a biostatistician can 
be approached. However, who to consult for Replacement possibilities is not clear 
according to the results of both surveys [4, 5] and the workshop discussions. The 
workshop participants suggested the appointment of a local Replacement expert, 
in a similar manner as the currently appointed AWOs in the Netherlands. An ideal 
situation appears be a team of 3R consulting experts consisting of a Replacement 
expert, a (bio)statistician and an AWO, in order to address each ‘R’ appropriately.
  According to the participants the timing of addressing each of the 3Rs is crucial. 
Ideally, Replacement should be addressed at an early stage and at a high(er) 
responsibility level in the research chain. The responsibility for Replacement lies 
currently with the researcher. This, however, is not an ideal situation, since the 
development of Replacement possibilities usually does not lie within the domain 
of the individual researcher. In order to implement a full Replacement method in 
toxicology testing – which involves legally obligatory animal testing - the participation 
of multiple institutions and researchers over a longer time period is needed. 
Moreover, Replacement is generally not the first priority of the individual researcher. 
Therefore, this responsibility should be shifted to (teams at) higher hierarchical 
levels, such as project leaders, license holders, government and funding bodies. 
Only then development of Replacement methods can be prioritized and achieved 
by making the necessary resources available.
3.   Bring license holders and funding bodies together for discussing topics on 
transparency and responsibility.
  The debate on openness and transparency in the field of laboratory animal 
science in the Netherlands has been going on for a long time. The lack of 
transparency is counterproductive in science, as it creates difficulties for data 
exchange, and thus problems in coordination and cooperation of research. 
Additionally the lack of transparency also raises many critical questions in 
society and animal right groups. From the questionnaires it became clear that 
there is a need for more data exchange between research institutes [4, 5]. The 
responsibility for more openness lies primarily with the licensees and funding 
bodies (e.g. governmental funding and foundations such as the cancer fund 
and heart and kidney foundation). License holders and funding bodies have 
the possibilities and the power to enforce transparency. They can demand the 
mandatory publication of all results, including the so-called “negative results” 
(or neutral results). Depending on the circumstances, the degree of openness 
can be adapted to particular needs: the information from projects can be made 
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anonymous for reasons of personal safety, and information can be temporarily 
withheld when it concerns a non-competition covenant.
4.   Awareness in education for attitude development and best practice/
experimental design.
  In the FELASA category C compatible courses in the Netherlands the main focus 
lies on the 3R principles. This course is legally compulsory for all researchers and 
PhD students who will be involved in research with animal experiments. Often young 
scientist, prior to starting their scientific careers, attends this course. The workshop 
participants discussed the idea of a more continuous and possibly obligatory form of 
education for those involved in animal experimentation, to keep knowledge up-to-date. 
The survey results [4, 5] showed that ’researcher’s own motivation’ and ‘a good 
study preparation’ are two of the key factors for implementation of the 3Rs. It was 
therefore concluded that continuous professional education should focus on 
building the ‘proper’ attitude and on experimental design, in order to stimulate the 
motivation to implement the 3Rs in practice. 
5.   Accessible knowledge exchange.
  The current lack of transparency limits other needs within (laboratory animal) 
science, such as the exchange of knowledge. When planning a new study, it is 
essential to take all other planned or ongoing studies into account in the same 
field of research by other groups. In order to stimulate collaborations and prevent 
unnecessary duplications, it is evident that this information needs to be shared. 
  During the workshop the idea was suggested to organize (inter)national meetings 
focussed on animal models to share knowledge and experiences. Similar types 
of meetings could also be organised per research field (e.g. disease types) and 
these meetings can easily be organised in combination with already existing (inter)
national meetings and conferences. This also allows for more in-depth discussions 
on the pros and cons of the various animal models used in one specific field of 
research.  A second issue that was addressed during the workshop was the 
necessity of publication of ‘negative’ (neutral) results. Knowledge gained from 
studies that gave ‘negative’ or neutral results is only rarely published, i.e. due to 
journal editorial policies. This information however, is very valuable for scientific 
reasons and necessary in order to prevent unnecessary duplications. Editorial 
boards of scientific journals can play an important role to make publication of these 
results possible and more attractive.
6.  Facilitate and stimulate collaborations (communication)
  According to the workshop participants there seems to be a need for management 
and coordination within the field of laboratory animal science in the Netherlands. 
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Issues such as lack of transparency and competition are currently important 
factors that limit research cooperation and knowledge exchange. The lively and 
passionate debates during the workshop demonstrate that these issues are not 
easily resolved, but that there is certainly much room for improvement of current 
practice. According to the workshop participants, the national coordination and 
communication should e.g. be organised by the NKCA (Netherlands Knowledge 
Centre for Alternatives), in order to define an action plan that identifies, prioritises 
and addresses the topics needed, on a national level. 
Potential value of Systematic Reviews
For both scientific and ethical reasons the design of a new animal experiment should 
encompass all relevant knowledge and information [21]. One way of achieving this so-
called synthesis of evidence is by conducting Systematic Reviews (SRs) of animal studies. 
SRs have the potential to solve several of the issues raised in the consensus statements 
and advance the 3Rs principles in science. A SR can be defined as literature review 
to identify, appraise, select and synthesise all available relevant evidence to a specific 
research question. The conduct of a SR usually includes the following steps: 1. Formulate 
a specific question, 2. Define inclusion and exclusion criteria, 3. Locate studies, 4. Select 
studies, 5. Quality assessment, 6. Data extraction, 7. Analyse (if appropriate a meta-
analysis) and present results, and 8. Interpret results [22]. The approach is systematic, 
thorough and leads to transparency on currently available data and its value.
Since decades, SRs have been a well adopted methodology in the field of evidence-
based medicine. This approach has led to major improvements in the methodology 
and reporting quality of clinical trials [22-24]. Major scientific and ethical improvements 
can be expected in by the introduction of SRs methodology in animal-based research 
too [25-29]. As CAMARADES has already shown the scientific value of SRs of animal 
studies in the field of neurology, it is very likely that the broad use of the SR methodology 
is of similar value in other areas of research involving animal studies [27]. 
From a scientific point of view one could make various arguments to support the conduct 
of SRs of animal studies  [30]. Sir Iain Chalmers has explained some of these scientific 
arguments very well during the First International Symposium on SR in laboratory 
animal science [31]. A literature overview of all available relevant publications can reveal 
scientific gaps, e.g. were more research is needed or the presence of publication bias 
(unpublished studies with often negative or neutral results as mentioned in statement 
5). The value of performing SRs lies in the fact that publication bias is made transparent 
[32]. This type of unpublished data can lead to an overestimation of the effects of a 
treatment, as demonstrated by SRs in the field of Stroke [25, 29]. A SR can include a 
meta-analysis in which data from multiple animal studies are statistically combined. 
This retrospective analysis evaluates both the coherence of the different animal studies 
and the contribution of the individual studies within a bigger research objective.
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There are also prospective reasons to conduct a SR as this literature overview can 
provide scientists with information to make more founded decisions for new experiments 
[23]. Useful information on 3Rs methods for a specific research question are hard to 
find as it is often scattered over various disciplines and different information sources or 
not even  published at all [5, 6]. In this light it is not surprising that some scientist see the 
Thee Rs more as a burden than as a valuable addition to their research (also mentioned 
in consensus statement 1).  As stated above SR seem an useful and scientifically 
consistent methodology to support the incorporation of the 3Rs principles in the 
planning of an animal experiment. Additionally SRs can be published in high impact 
factor journals and thus also contribute satisfactorily to a researcher’s quantitative and 
qualitative output. Which may make the conduct of a SR more appealing. 
From an ethical point of view an animal experiment should only be conducted when 
there is a clear need and necessity for the experiment and the objectives serve a 
greater good for the wellbeing of humans or animals. The experiments should be 
designed in such a way that they yield the most relevant and the most reliable results 
[30]. SRs seem a useful methodology for this purpose. Most relevant and reliable 
results are obtained when a model is selected for its properties  to answer the research 
question, SR can help in this process [33]. How and why choices are made (such as 
the selection of an animal model) is not only valuable information for other researchers 
working in the same line of research. Also other stakeholders can advantage from this 
information. For example scientific committees can make more transparent why and 
how a line of research is selected (statements 3 and 5), funding bodies can use a SR 
as documentation on the current scientific quality to evaluate new research proposal 
and also AECs can use a SR in preparing their advice on approval of animal studies. 
A survey of published animal studies showed that over 80% did not use randomisation 
or blinding which are essential measures to reduce bias [28]. A quality assessment 
is one of the steps of a SR is to assess the methodological and reporting quality of 
the individual studies. In this step individual papers are scored for their internal (the 
extent to which bias is minimised) and external (the applicability of the results in other 
circumstances, translation) validity [22]. The conduct of SR of animal studies have 
there for the potential to improve transparency and thus raise the awareness for the 
need of correct experimental design as mentioned in statement 4. In the field of clinical 
research there is the CONSORT statement, to support the publication of various items 
in order to reduce the amount of bias. The endorsement of these guidelines by journals 
has lead to improvement in the completeness of reporting of clinical trials [24]. Similar 
developments are seen in animal research where recently, the GSPC and ARRIVE 
guidelines for planning and reporting of animal studies have been published [34, 35]. 
In line with the process in clinical research it is recommendable to make the animal-
research guidelines also evolving documents and make them subject to changes as 
new evidence emerges. 
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SRs can also play an important role in the decision making from pre-clinical animal studies 
to clinical trials as described by Pound [36]. With two examples she shows that the safety of 
patients was jeopardized in clinical trials while this could have been prevented by conducting 
a SR of animal studies prior to starting the clinical trials [37, 38]. Individual animal studies 
showed some positive effects, however this effect was no longer found in a retrospective 
overall analysis of the animal studies. One could say that scientist have a moral duty to 
encompass all available data into the planning of a clinical trial. Not only regarding to patient 
safety but also with respect to the utility of results of animal studies. 
Conducting a SR is a multi-disciplinary process and requires involvement and collaboration 
of experts from the various disciplines needed, such as: a librarian, a statistician, a 
laboratory animal scientists and a field (medical) expert (e.g. when writing in oncology, 
a clinician working in the field of cancer should be part of the team). Conducting a SR 
stimulates multi-disciplinary involvement and collaboration as mentioned in statement 
6 which will very likely also have a positive effect on the scientific quality. Education is 
needed to increase awareness of potential value of SRs of animal studies in science and 
to improve the skills needed to perform such a SR. Educational programs have been 
started at our university, both by successfully incorporating SR in the FELASA category 
C courses as well as an one week module on SRs of animal studies in the curriculum 
of biomedical science master students. These courses have branched out to other 
(inter)national universities such as Amsterdam, Lausanne and Bergen. It is a positive 
development that the Netherlands Organisation for Health Research and Development 
(ZonMw) has now issued a proposal to stimulate this type of education for animal 
researchers as continuing professional development [39]. 
Concluding remarks.
As the results of the workshop and other previous studies have shown, there is not 
one single solution to enhance the implementation of the 3Rs principles in science. 
We have argued that many of the items mentioned in the consensus statements may 
be addressed by conducting SRs of animal studies. However incorporating the 3Rs 
principles in sciences is not the only advantage of SRs and implementing these reviews 
will, therefore, enhance science beyond the Three Rs.
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Table 1 Affiliations of the workshop participants
Academia Industry Knowledge 
institute
Contract  
Research 
Organisation
Other Total
Researchers 1 0 3 2 0 6
Animal welfare officers 4 2 2 1 0 9
Animal ethics commites members 0 0 2 0 1   3*
* The total number of AEC members was eight, but only three were solely AEC member, the 
other AEC members were an AEC member as a second profession. Their main profession was 
an AWO or a researcher and they participated in the workshop as such. 
Table 2 The consensus statements formulated during the workhop and suggested key players
Consensus statement Suggested key players
1 Division of the Three Rs and cautious use of 
the term ‘alternatives’. 
All involved in animal based research
2 Awareness for Replacement on a higher level 
and earlier stages of research, additionally 
appointment of a Replacement expert.
License holders, project leaders, Animal Ethics Committees, Scien-
tific committees/boards within license holding organisations. 
3 Bring license holders and funding bodies 
together for discussing the topics ‘transpa-
rency’ and ‘responsibility’.
License holders, funding bodies (e.g. ZonMw and disease related 
funding agencies), government, public.
4 Awareness in education for building the 
‘proper’ attitude and improve implementation 
of ‘best practices’/experimental design.
Dutch association for laboratory animal science (NVP), National 
Coordinators of the courses in laboratory animal science, FELASA.
5 Accessible knowledge exchange.
- (inter)national meetings on animal models
- Publication of ‘negative’ results
Animal care staff and technicians, researchers, AWOs, research 
departments, funding bodies, editorial boards of scientific journals.
6 Facilitate and stimulate collaborations  
(communication)
NKCA (Netherlands Knowledge Centre on Alternatives), govern-
ment, politicians and society.

Jan Rongen
Gerjon Hannink
Tony van Tienen
Judith van Luijk
Carlijn Hooijmans
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The protective effect of meniscus allograft transplantation 
on articular cartilage: a systematic review of animal studies
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Abstract 
Despite widespread reporting on clinical results, the effect of meniscus allograft 
transplantation on the development of osteoarthritis is still unclear. The aim of this 
study was to systematically review all studies on the effect of meniscus allograft 
transplantation on articular cartilage in animals.
Systematic review and meta-analysis. 
Pubmed and Embase were searched for original articles concerning the effect of 
meniscus allograft transplantation on articular cartilage compared with both its 
positive (meniscectomy) and negative (either sham or non-operated) control in 
healthy animals. Outcome measures related to assessment of damage to articular 
cartilage were divided in five principal outcome categories. Standardized mean 
differences (SMD) were calculated and pooled to obtain an overall SMD and 95% 
confidence interval. 
17 articles were identified, representing 14 original animal cohorts with an average timing 
of data collection of 24 weeks [range 4 weeks; 30 months]. Compared to a negative 
control, meniscus allograft transplantation caused gross macroscopic (1.45 [0.95; 
1.95]), histological (3.43 [2.25; 4.61]) damage to articular cartilage, and osteoarthritic 
changes on radiographs (3.12 [1.42; 4.82]). Moreover, results on histomorphometrics 
and cartilage biomechanics are supportive of this detrimental effect on cartilage. On 
the other hand, meniscus allograft transplantation caused significantly less gross 
macroscopic (-1.19 [-1.84; -0.54]) and histological (-1.70 [-2.67; -0.74]) damage to 
articular cartilage when compared to meniscectomy. However, there was no difference 
in osteoarthritic changes on plain radiographs (0.04 [-0.48; 0.57]), and results on 
histomorphometrics and biomechanics did neither show a difference in effect between 
meniscus allograft transplantation and meniscectomy. 
Although meniscus allograft transplantation does not protect articular cartilage from 
damage, it reduces the extent of it when compared with meniscectomy. 
Introduction
The menisci fulfill key biomechanical functions in the knee joint.[1] Unfortunately, 
meniscal injuries are quite common, accompanied by acute clinical symptoms such 
as knee pain, locking, and joint effusions. First documented treatments embraced swift 
and total meniscectomy to ameliorate acute symptoms.[2] However, an increased 
understanding of the osteoarthritic changes that occur after meniscectomy made 
clear that it is beneficial to save as much meniscal tissue as possible.[3-5] Meniscus 
allograft transplantation has been proposed as a promising treatment strategy for total 
meniscectomy already in the mid 1980s.[6] The initial goal of this treatment was to 
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prevent, and possibly even reverse, the development of osteoarthritic changes in the 
knee joint.[6-11] Encouraged by the results of few animal studies clinical implantation 
was experimented upon.[12] However, a limited availability of donor menisci, and 
inconclusive results from meniscus allograft transplantation on development of 
osteoarthritis in humans, shifted its indication to treat localized pain after meniscectomy 
in a pre-selected patient population.[9, 13] Rosso et al. recently published a systematic 
review on the clinical and radiographic outcomes of meniscus allograft transplantation 
and its possible role in preventing osteoarthritis in humans.14 Despite the inclusion 
of 55 articles a meta-analysis could not be performed, mainly because of the lack of 
standardized evaluation methods to evaluate joint changes. The authors concluded 
that any chondroprotective effect in humans is still unclear. This result is not in 
accordance with their expectations based on the single animal study they refer to.[15] 
Although it is not uncommon for animal studies not to correspond (well) to results from 
clinical studies it does raise the question what the actual effect is of meniscus allograft 
transplantation on the articular cartilage in animals.[16] Therefore, we performed a 
systematic review and meta-analysis of all available preclinical studies we identified for 
this review, on the effect of meniscus allograft transplantation on the articular cartilage 
in animals. In addition, we discussed to what extent results from animals in meniscus 
related research can be translated to humans. 
Methods
This systematic review investigates the effect of meniscus allograft transplantation 
on articular cartilage in animals. The inclusion criteria and method of analysis were 
specified in advance and documented in a protocol.[17]
Search strategy and selection of studies 
Pubmed and Embase were searched (last search performed July 29th, 2014) for 
original articles concerning the effect of meniscus allograft transplantation on articular 
cartilage compared with both its positive (meniscectomy) and negative (either sham 
or non-operated) controls in healthy animals. The search strategy, composed of three 
elements (meniscus, allograft, and animals), was developed in collaboration with 
information specialists from the medical library of the Radboud university medical 
center Nijmegen, the Netherlands.[18] To detect all animal studies search filters for 
Pubmed and Embase were used.[19, 20] The detailed search strategy is provided in 
supplementary file 1.
Reference lists of the selected relevant (review-) papers were screened for potentially 
missed papers, and no restrictions (e.g. language or publication date) were imposed. 
Search results were imported in EROS (Early Review Organizing Software, developed 
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by Institute of Clinical Effectiveness and Health Policy, Buenos Aires, Argentina) to 
remove duplicates, and randomly allocate references to two independent reviewers 
responsible for screening and selection (JR, GH). Discrepancies were resolved by 
discussion and if necessary a third reviewer was consulted (CH). 
Initially, during the screening phase, primary studies evaluating meniscus allograft 
transplantation in healthy animals were selected based on their title and abstract only. 
In the event that there was insufficient information to make a valid judgment, the whole 
publication was evaluated
Full-text copies of all publications eligible for inclusion were subsequently assessed and 
included when they met our pre-specified inclusion criteria: 1) a controlled interventional 
design (meniscectomy as a positive control and/or either sham or non-operated as a 
negative control); 2) description of (semi-) quantitative outcome measures related to articular 
cartilage damage (radiographic assessment, gross macroscopic assessment, histological/
histochemical based grading, immunohistochemistry based grading, histomorphometry, 
magnetic resonance imaging (MRI), and/or biomechanical characterization). 
Data extraction
Next to bibliographic details, information was extracted related to: study design; animal 
model; intervention; outcome measures; and information related to exclusion of animals 
from analysis. Outcome measures related to assessment of damage to articular 
cartilage were divided in five principal outcome categories 1) Gross macroscopic 
assessment of damage (Grading or determining the area of articular cartilage with 
gross morphological changes , ICRS scores, Outerbridge scores, either with or without 
staining methods); 2) Medical imaging of changes related to osteoarthritis (plain 
radiographical (Kellgren & Lawrence) and MRI based classifications of morphological 
changes); 3) Histological histochemical grading of changes in articular cartilage 
(Mankin Grading method); 4) Histomorphometrics (any kind of quantitative study on 
microscopic images of articular cartilage); and 5) Biomechanical characterization of 
articular cartilage (tensile and compressive measures of stiffness). Raw data or group 
averages (mean, median), standard deviation (SD), standard error (SE) or ranges 
and number of animals per group (n) were extracted for all (semi-) continuous and 
ordinal outcome measures respectively. Attempts were made to obtain original data 
by contacting authors if results were presented incomplete or graphically only. If not 
otherwise possible, graphically presented data was converted to numerical data using 
digital ruler software (Plot Digitizer, University of South Alabama, USA).[21, 22]
Risk of bias assessment
The internal validity of the included studies was assessed, by two reviewers 
independently (JR, GH), using SYRCLE’s risk of bias tool.[23] This tool is based on the 
Cochrane risk of bias tool [24] and has been adjusted for particular aspects of bias that 
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play a role in animal intervention studies. It contains 10 entries related to 6 types of bias 
(selection, performance, detection, attrition, reporting and ‘other’ bias). The score ‘yes’ 
indicates a low risk of bias, ‘no’ indicates high risk of bias, and ‘?’ indicates an unclear 
risk of bias. We used the provided signaling questions wherever possible.
Reporting of experimental details on animals, methods and materials was expected 
to be poor.[25] To overcome the problem of judging too many items as unclear risk 
of bias two entries were added: 1) reporting of any measure of randomization, and 
2) reporting of any measure of blinding. [23] For these two items, a ‘yes’ indicates 
reported, and a ‘no’ indicates unreported.
Data analysis
A meta-analysis was performed whenever three or more independent comparisons per 
outcome category could be included (provided that outcome measure assessments 
were sufficiently comparable in terms of entity), and standardized mean differences 
(SMD) were calculated (SMD = the mean of the experimental group minus the mean 
of the control group divided by the pooled SDs of the two groups). Despite anticipated 
heterogeneity, the individual effect sizes were subsequently pooled to obtain an overall 
SMD and 95% confidence interval. We used a random effects model26 which takes 
into account the precision of individual studies and the variation between studies 
and weights each study accordingly. Heterogeneity was addressed by I2 which is the 
proportion of total variance explained by heterogeneity. With respect to the different 
time points of data collection across several studies, only results obtained equal or 
later than twelve weeks following index intervention were included in the meta-analysis. 
The latter is based on the assumption that, at least in sheep, damage to the articular 
cartilage is readily observed 3 months after meniscal destabilization procedures.[27] 
If multiple independent experimental groups were compared with the same control 
group within the same meta-analysis the number of animals in the control group 
was corrected by dividing it by the number of comparisons. In the case that more 
than one outcome measure corresponding to the same principal outcome category 
was presented, only one was included in the meta-analysis (continuous outcome 
measures were favored above semi quantitative and ordinal ones). For those outcome 
measures, of which results were presented separately for different anatomic regions in 
the knee joint, the tibia or its central weight bearing zone was used because this area 
is expected to demonstrate the highest degree of damage.[28] If contralateral knees 
were presented as paired non-operated controls, we solely used the paired controls of 
the meniscus allograft transplantation as negative controls. Because several authors 
presented and/or analyzed their ordinal data as continuous, and it was not possible 
to obtain raw data for each data set, results of ordinal scales were meta-analyzed as 
continuous data. In case the SD of the control group was zero, we used the SD of the 
experimental group instead to be able to calculate a SMD.
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Subgroup analyses were performed only if the subgroups contained a minimum of 3 
independent comparisons. Subgroups were pre-specified in our protocol and analyses 
were planned for animal species (large/small), compartment of intervention (medial/
lateral), and time of implantation after meniscectomy (delayed / immediate). Although 
not pre-specified, a subgroup analysis was additionally performed for timing of data 
collection as from meniscectomy (< 6 months (26weeks) / ≥ 6 months (26weeks)). 
Publication bias was addressed by means of a funnel plot, but only if at least ten 
studies could be included. 
In order to assess the robustness of our findings and in an attempt to further explain 
observed study heterogeneity, we performed a sensitivity analysis and investigated the 
effect of study quality and changing the time point of data collection from 3 to at least 
6 months follow-up. 
RESULTS
Study descriptives
The search strategy retrieved 377 unique records; subsequent selection procedure 
resulted in 17 eligible articles, representing 14 original animal cohorts (figure 1).[15, 
29-44] Both Aagaard et al.[36, 37] and Rijk et al.[32-34] confirmed that results of one 
single animal cohort were presented in more than one article. Overall, characteristics 
varied considerably between studies: Sheep (n=7), rabbits (n=7), goat (n=1), dogs 
(n=1), and rats (n=1), either males or females were used as animal models; they were 
operated upon uni- and bilaterally on the medial and lateral tibiofemoral compartment; 
and the follow up times ranged from 4 weeks to 30 months (Table 1).
Risk of bias and quality of reporting
The risk of bias assessment, summarized in Figure 2, shows that many items were 
scored unclear risk of bias which can be regarded as an indicator for poor reporting 
of the included animal studies.[45] For example, 9 of the 17 studies mentioned 
randomization at any level. However, none of these studies mentioned neither their 
methods of randomization nor sufficient details to judge its adequacy, and were 
therefore judged as unclear risk of bias. Twelve of the 17 studies stated that their 
experiment was blinded at any level, in all cases this implied that the outcome assessor 
was blinded. The individual scores of each study are presented in supplementary file 2.
Effect of meniscus allograft on articular cartilage
Out of the 14 original animal cohorts, 20 independent experimental groups could be 
identified which underwent meniscus allograft transplantation and had a follow up longer 
than or equal to 12 weeks. Only Yamasaki et al. provided results prior to 3 months (4 
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or 8 weeks) and was therefore not included in any analysis.[44] Aagaard et al.[36, 37], 
Jiang et al.[40], Rijk et al.[32-34] and McNickle et al.[39] provided additional data by 
request, although the latter two were not able to retrieve all the requested information. 
Gross macroscopic assessment
Results of studies included in the meta-analysis. Nine and 10 comparisons could 
be included in the meta-analysis concerning gross macroscopic damage between 
meniscus allograft transplantation with either meniscectomy or a negative control, 
respectively. The average timing of data collection from meniscectomy was 21.3 
weeks (range [12weeks; 6 months]). Meniscus allograft transplantation demonstrated 
significantly less gross macroscopic damage when compared with meniscectomy 
(effect size -1.19 [-1.84; -0.54], I2 = 63%, figure 3a), but demonstrated more damage 
compared with a negative control (effect size 1.45 [0.95; 1.95], I2 = 42%, figure 3b).
Results of studies not included in the meta-analysis. Elliot et al.[35] analyzed their 
results by using principal component analysis, providing factor loadings instead of 
descriptive results on gross macroscopic damage, and was therefore not included in 
the meta-analysis. Elliot et al.[35] described significant more degenerative changes 
in the morphological appearance of the articular cartilage following meniscal allograft 
transplantation compared with the non-operated control (in line with the meta-analysis), 
but differences between meniscectomy and meniscal allograft transplantation were not 
observed (not in line with the meta-analysis). 
Medical imaging
Results of studies included in the meta-analysis. Four comparisons could be included 
in the meta-analysis concerning osteoarthritic changes on plain radiographs between 
meniscus allograft transplantation with either meniscectomy or a negative control. 
The average timing of data collection from meniscectomy was 55.9 weeks (range 
[6 months; 30 months]). There was no difference in osteoarthritic changes between 
meniscus allograft transplantation and meniscectomy (effect size 0.04 [-0.48; 0.57], I2 
= 0%, figure 4a). Meniscus allograft transplantation demonstrated significantly more 
osteoarthritic changes compared to a negative control (effect size 3.12 [1.42; 4.82], I2 
= 69%, figure 4b).
Results of studies not included in the meta-analysis. Whereas the studies included 
in the meta-analysis assessed osteoarthritic changes on plain radiographs, Kelly et 
al.[15] assessed morphologic changes in cartilage, bone, and bone marrow by using 
MRI. Because MRI and plain radiographs measure different entities of osteoarthritic 
changes the study of Kelly et al. [15] was not included in a meta-analysis. Kelly et 
al.[15] demonstrated less MRI based morphologic degenerative changes for meniscus 
allograft transplantation when compared with meniscectomy (not in line with the meta-
analysis). However, more degenerative changes were observed for meniscus allograft 
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transplantation when compared with the non-operated controls (in line with the meta-
analysis). Spin echo T2 quantitative relaxation maps demonstrated better results for 
the non-operated controls when compared with meniscus allograft transplantation (in 
line with the meta-analysis), but there was no difference between meniscus allograft 
transplantation and meniscectomy (in line with the meta-analysis).
Histological/histochemical grading
Results of studies included in the meta-analysis. 11 comparisons could be included 
in the meta-analysis concerning histological histochemical grading of articular cartilage 
damage between meniscus allograft transplantation with either meniscectomy or a 
negative control. The average timing of data collection from meniscectomy was 26.5 
weeks (range (12 weeks; 12 months)). Notably, the Mankin score was used by all authors, 
but often modified and presented for various anatomical regions. Meniscus allograft 
transplantation demonstrated less histological damage to articular cartilage compared 
with meniscectomy (effect size -1.70 [-2.67; -0.74], I2 = 84%, figure 5a). However, meniscus 
allograft transplantation showed more histological damage to cartilage compared with a 
negative control (effect size 3.43 [2.25; 4.61], I2 = 82%, figure 5b). 
Results of studies not included in the meta-analysis. Elliot et al.[35] analyzed their results 
by using principal component analysis, providing factor loadings instead of descriptive 
results on gross macroscopic damage, and was therefore not included in the meta-
analysis. Elliot et al.[35] described more degenerative changes in the histological 
appearance of the articular cartilage following meniscal allograft transplantation 
compared with the non-operated control (in line with the meta-analysis). Differences in 
degenerative changes between meniscectomy and meniscal allograft transplantation 
were not observed (not in line with the meta-analysis). 
Histomorphometrics
There were five studies that used any kind of quantitative study on microscopic images 
of articular cartilage to assess the effect of meniscus allograft on articular cartilage. 
The nature of these measurements was so divers (e.g. measuring different entities) 
that pooling of the individual effect sizes was not suitable. Results of individual studies 
are summarized in figure 6. Three of the 9 comparisons, of which 2 were independent, 
demonstrated a significant difference in damage to articular cartilage between meniscus 
allograft transplantation and meniscectomy, but in favor of different treatments. The 
remaining 6 comparisons, of which 3 were independent, did not demonstrate any 
significant difference in damage (figure 6a). 
Nine of the 13 comparisons, of which 5 were independent, demonstrated significant 
less damage to articular cartilage in favor for the negative control compared with 
meniscus allograft transplantation. The remaining 4 comparisons, of which 2 were 
independent, did not demonstrate any significant difference (figure 6b).
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Biomechanics
Two studies used biomechanical characterization to address the effect of meniscus 
allograft transplantation on articular cartilage. Compared to meniscectomy, one 
comparison did, and one did not demonstrate a significant difference in stiffness in 
favor of meniscus allograft transplantation (figure 7a). Compared to a negative control, 
two comparisons demonstrated a significant lower stiffness of articular cartilage after 
meniscus allograft transplantation (figure 7b). 
Subgroup analysis
Because of the relative low number of included studies it was not possible to perform 
statistical robust subgroup analyses for all planned subgroups. For those subgroups 
that included more than 3 studies, the effect estimates were described in table 2. None 
of those subgroup analyses showed significant differences between the groups.
Publication bias
Because of the low number of studies that were included in the meta-analyses, a funnel 
plot was not created.
Sensitivity analysis 
Changing the time point for data collection from 3 to at least 6 months follow-up did not 
change the outcome of results. Due to poor reporting of experimental details the results 
from the risk of bias could not be implemented as a screening part in the sensitivity 
analysis.
DISCUSSION
The concept of meniscus allograft transplantation was conceived to prevent 
degeneration of articular cartilage in the meniscectomized knee.[6-11] So far, despite 
widespread reporting on clinical results, the effect of meniscus allograft transplantation 
on the development of osteoarthritis is still unclear.[14] This is not in line with 
expectations from the animal study referred to by the recently published meta-analysis.
[14] We therefore conducted this study to systematically review all studies on the effect 
of meniscus allograft transplantation on articular cartilage in animals.
From this systematic review and meta-analysis, which included studies with an average 
timing of data collection of 28 weeks (range (12 weeks; 30 months)), it becomes 
clear that compared to a negative control, meniscus allograft transplantation causes 
gross macroscopic and histological damage to articular cartilage, and osteoarthritic 
changes on plain radiographs. Moreover, results on histomorphometry and cartilage 
biomechanics support that meniscus allograft transplantation has a detrimental 
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influence on articular cartilage. Although showing damage to articular cartilage, 
meniscus allograft transplantation causes significantly less gross macroscopic 
and histological damage to articular cartilage when compared to meniscectomy. 
However, this difference in favor of meniscus allograft transplantation is not observed 
for osteoarthritic changes on plain radiographs. Results on histomorphometrics and 
biomechanics do neither appear to show a clear difference in damage to articular 
cartilage between meniscus allograft transplantation and meniscectomy. Osteoarthritis 
is characterized by a molecular phase, a pre radiographic phase, and a recalcitrant 
radiographic phase with evident structural joint changes.[46] In this continuum of 
osteoarthritic stages we interpret our results as such that, although both meniscus 
allograft transplantation and meniscectomy cause structural joint changes, damage to 
articular cartilage is less extensive after meniscus allograft transplantation.
Some methodological issues which might hamper the interpretation of the experimental 
animal data and the subsequent translation to the clinical setting have to be discussed.
First, the heterogeneity among the various animal studies was substantial. Unfortunately, 
unraveling this heterogeneity by performing subgroup analyses was not feasible due 
to too low number of independent comparisons within subgroups. The soundness 
of pooling different animal species and models within a single meta-analysis could 
be questioned. However, consistent results across species and models do provide 
some reassurance that the observed effect is reliable. Moreover, subgroup analysis 
did not demonstrate differences in results between large (sheep/goats) and middle 
(dogs/rabbits) animals. In addition, from a biomechanical point of view, the meniscus 
has the same function across different species: load distribution over two incongruent 
moving articular surfaces. Removing it will inflict pathological (peak) stresses causing 
articular cartilage to be damaged. To what extent this damage occurs, at what rate, 
and with what clinical symptoms could well be species specific. For example, it has 
been demonstrated that sheep show changes in kinematics after meniscectomy 
comparable to humans.[27] Rabbits only show little change in knee kinematics[47], 
and rats show only minor changes in static weight-bearing after meniscectomy.[48, 49] 
Unfortunately, due to too few comparisons, assessing differences in extent of damage 
between animal species could not be performed in this review. 
The minimum of twelve weeks as a time point of data collection used in the present 
study was based on the assumption that, at least in sheep, damage to the articular 
cartilage is readily observed 3 months after meniscal destabilization procedures. It is 
possible that adequate duration would be different for different animals/species. 
With the combination of consistent results across species and models, the theoretical 
background, and the results of the subgroup analysis in mind, we have no arguments 
that show that it might be better to only focus on large animals.
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We did not differentiate for time from meniscectomy to meniscus allograft transplantation 
(e.g. delayed transplantation). It could well be that delayed meniscus allograft 
transplantation performs worse in comparison to immediate transplantation, because 
there is a time period in which the cartilage is overloaded. This seems as an important 
question to address, looking to the current clinical situation in which humans receive a 
meniscus allograft a substantial time period after the removal of their meniscus (Rosso 
et al. reported an overall weighted average time between meniscectomy and meniscus 
allograft transplantation of 15.16 years (range, 1.1-35.8 years)[14]). However, a fallacy 
here is that the current the indication of meniscus allograft transplantation is not the 
prevention of osteoarthritis but to treat localized pain post meniscectomy in a selected 
patient population. Not differentiating for time between meniscectomy and allograft 
transplantation theoretically underestimates the protective effect on damage to articular 
cartilage when compared to meniscectomy.
Second, poor reporting of crucial pieces of information in the included articles is 
of serious concern, and limited the application of the SYRCLE’s risk of bias tool. 
Regrettably, this is not uncommon practice in animal studies, limiting the ability to draw 
reliable conclusions. This concern is also shared and addressed by others.[25, 45, 50-
52] It is crucial that the poor reporting in animal studies is addressed and future studies 
should improve on this, allowing others to be able to replicate and build on previously 
published work. Ultimately, with better reporting, systematic reviews of high quality 
will become feasible. In recent years checklists have been developed to improve the 
quality of animal studies.[45, 50] Implementing such initiatives will improve the quality 
of individual scientific papers on animal experimentation. Moreover, as a consequence, 
numbers of animals used would be expected to fall, and will set in motion better 
translation to the clinic and increases patient safety.[16, 45, 53, 54] 
Because of the poor reporting of experimental details it was not possible to assess how 
the results of this review might have been affected if studies with a high risk of bias 
were excluded from the analysis.
Third, results on long term effect of meniscus allograft transplantation on articular 
cartilage are not provided in the current systematic review. Our sensitivity analysis 
showed that results did not change if 6 instead of 3 months was used as a minimum 
time point of data collection. Damage to articular cartilage would be expected to be 
progressively more severe if even longer endpoints would have been used. Since 
both meniscus allograft transplantation and meniscectomy cause damage to articular 
cartilage it is imaginable that both interventions ultimately lead to end stages of 
osteoarthritis. To what extent meniscus allograft transplantation is able to postpone 
disabling end stages compared to meniscectomy, remains unknown. 
Regarding translation from pre clinical animal models to clinical practice, several 
aspects should be addressed. First, consistent results across species and models do 
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provide some reassurance that the observed effect is reliable, and that humans might 
respond similarly. Moreover, the minimal invasive arthroscopic procedures used in 
humans may have less detrimental effect on cartilage compared to the extensive open 
procedures used in animal experiments, which could improve the outcome of meniscal 
allograft transplantation. Finally, whereas graft sizing was only scarcely mentioned in 
animal experiments it is common practice in humans. From a biomechanical point of 
view, proper graft sizing leads to better load distribution, which is an important factor 
for a successful outcome of meniscal transplantation.[55] 
However, some aspects interfere with translation to clinical practice. First, in pre 
clinical animal models the meniscus allograft is transplanted in a “pristine” knee. 
Here, damage of articular cartilage is the result of both the surgical procedure and the 
meniscus allograft only. In contrast, clinically, a meniscus allograft is transplanted in a 
knee that has undergone a trauma large enough to cause considerable damage to the 
meniscus. This trauma may even well have damaged the cartilage directly, limiting the 
theoretical treatment effect of a meniscus allograft. 
Second, we demonstrated that both meniscectomy as well as meniscus allograft 
transplantation will cause degeneration of articular cartilage. This raises the question 
as to what extent the theoretically lesser damage to articular cartilage after meniscus 
allograft transplantation gives rise to a clinical meaningful reduction or delay in clinical 
(disabling) osteoarthritis, and subsequent need for total knee arthroplasty. However it 
should be noted that, not all patients who develop damage to the articular cartilage, 
or even radiographical established osteoarthritis, will end up with clinical disabling 
osteoarthritis.[56-58] Subsequently, a next question would be what the cost per health 
unit gain would be of meniscus allograft transplantation. These questions can only be 
addressed with information obtained from a (randomized) controlled clinical trial. 
Rosso et al. explain their inability to analyze the chondroprotective effect of meniscus 
allograft transplantation because of the lack of standardized evaluation methods 
(e.g. radiographically different grading scores were used to evaluate joint changes). 
However, a more important limitation in human studies is the lack of control groups. 
To be able to demonstrate any positive effect of meniscus allograft transplantation in 
humans, a control group of patients undergoing meniscectomy is imperative. Only 1 
out of the 55 articles on human meniscus allograft transplantation identified by Rosso 
et al. used a control cohort of meniscectomized patients. However, it concerned a 
historical cohort and comparisons were made on subjective assessment rather than 
evaluating the status of articular cartilage.[59] This lack of control groups limits us to 
directly assess to what extent results from animal experiments in meniscus related 
research can be translated to humans. 
In conclusion, this systematic review with an average follow up of included studies 
of 28 weeks (range (12 weeks; 30 months)) demonstrates that, in animals, although 
meniscus allograft transplantation does not protect articular cartilage from damage, it 
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reduces the extent of it when compared with meniscectomy. Consistent results across 
species and models do provide some reassurance that this observed effect is reliable, 
and that humans might respond in a similar manner.
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Supplementary Table 1 Search strategy
Pubmed
Component 1: Meniscus Menisci, Tibial [Mesh] OR (knee [mesh] AND fibrocartilage [mesh]) OR (knee joint 
[mesh] AND fibrocartilage [mesh]) OR meniscal [tiab]  OR meniscected [tiab]  OR 
meniscectomie [tiab]  OR meniscectomies [tiab]  OR meniscectomised [tiab]  OR 
meniscectomisized [tiab]  OR meniscectomized [tiab] OR meniscectomy [tiab]  OR 
menisceotomy [tiab]  OR meniscetomy [tiab]  OR menisci [tiab]  OR meniscial [tiab]  
OR meniscopathies [tiab]  OR meniscopathy [tiab]  OR meniscopexia [tiab]  OR 
meniscopexies [tiab]  OR meniscopexy [tiab]  OR meniscoplasty [tiab]  OR menisco-
tomies [tiab]  OR meniscotomy [tiab] OR meniscus [tiab]  OR meniscusectomy [tiab]  
OR meniscusectomy [tiab]  OR menisectomies [tiab]  OR menisectomized [tiab]  OR 
menisectomy [tiab] OR (knee [tiab] AND fibrocartilage [tiab]) OR (knee [tiab] AND 
fibro-cartilage [tiab]) OR (knee [tiab] AND fibrocartilagenous [tiab]) OR (knee [tiab] 
AND fibro-cartilagenous [tiab]) OR (knee [tiab] AND fibrocartilageous [tiab]) OR 
(knee [tiab] AND fibrocartilages [tiab]) OR (knee [tiab] AND fibro-cartilages [tiab]) 
OR (knee [tiab] AND Semilunar [tiab]) OR (knees [tiab] AND fibrocartilage [tiab]) 
OR (knees [tiab] AND fibro-cartilage [tiab]) OR (knees [tiab] AND fibrocartilagenous 
[tiab]) OR (knees [tiab] AND fibro-cartilagenous [tiab]) OR (knees [tiab] AND fibro-
cartilageous [tiab]) OR (knees [tiab] AND fibrocartilages [tiab]) OR (knees [tiab] AND 
fibro-cartilages [tiab]) OR (knees [tiab] AND semilunar [tiab]) OR (tibiafemoral [tiab] 
AND fibrocartilage [tiab]) OR (tibia-femoral [tiab] AND fibrocartilage [tiab]) OR (tibi-
afemoral [tiab] AND fibro-cartilage [tiab]) OR (tibia-femoral [tiab] AND fibro-cartilage 
[tiab]) OR (tibiafemoral [tiab] AND fibrocartilagenous [tiab]) OR (tibiafemoral [tiab] 
AND fibrocartilagenous [tiab]) OR (tibia-femoral [tiab] AND fibrocartilagenous [tiab]) 
OR (tibiafemoral [tiab] AND fibro-cartilagenous [tiab]) OR (tibiafemoral [tiab] AND 
fibro-cartilagenous [tiab]) OR (tibia-femoral [tiab] AND fibro-cartilagenous [tiab]) OR 
(tibiafemoral [tiab] AND fibrocartilageous [tiab]) OR (tibiafemoral [tiab] AND fibrocar-
tilageous [tiab]) OR (tibia-femoral [tiab] AND fibrocartilageous [tiab]) OR (tibiafemoral 
[tiab] AND fibrocartilages [tiab]) OR (tibia-femoral [tiab] AND fibrocartilages [tiab]) OR 
(tibiafemoral [tiab] AND fibro-cartilages [tiab]) OR (tibiafemoral [tiab] AND fibro-carti-
lages [tiab]) OR (tibia-femoral [tiab] AND fibro-cartilages [tiab]) OR (tibiafemoral [tiab] 
AND semilunar [tiab]) OR (tibia-femoral [tiab] AND semilunar [tiab]) OR (tibiofemoral 
[tiab] AND fibrocartilage [tiab]) OR (tibio-femoral [tiab] AND fibrocartilage [tiab]) OR 
(tibiofemoral [tiab] AND fibro-cartilage [tiab]) OR (tibio-femoral [tiab] AND fibro-car-
tilage [tiab]) OR (tibiofemoral [tiab] AND fibrocartilagenous [tiab]) OR (tibio-femoral 
[tiab] AND fibrocartilagenous [tiab]) OR (tibiofemoral [tiab] AND fibro-cartilagenous 
[tiab]) OR (tibio-femoral [tiab] AND fibro-cartilagenous [tiab]) OR (tibiofemoral [tiab] 
AND fibrocartilageous [tiab]) OR (tibio-femoral [tiab] AND fibrocartilageous [tiab]) 
OR (tibiofemoral [tiab] AND fibrocartilages [tiab]) OR (tibio-femoral [tiab] AND fibro-
cartilages [tiab]) OR (tibiofemoral [tiab] AND fibro-cartilages [tiab]) OR (tibio-femoral 
[tiab] AND fibro-cartilages [tiab]) OR (tibiofemoral [tiab] AND semilunar [tiab]) OR 
(tibio-femoral [tiab] AND semilunar [tiab]) OR Semilunar Cartilage [tiab] OR Semilunar 
Cartilages [tiab] OR Semilunar fibrocartilage [tiab]
Component 2: Allograft Allografts [Mesh] OR Transplantation, Homologous [Mesh] OR Tissue Transplanta-
tion [mesh] OR Allogeneic implant [tiab] OR Allogeneic implants [tiab] OR Allogenic 
implants [tiab] OR Allograft [tiab] OR Allo-graft [tiab] OR Allografted [tiab] OR Al-
lo-grafted [tiab] OR Allografting [tiab] OR Allo-grafting [tiab] OR Allograftings [tiab] 
OR Allografts [tiab] OR Allo-grafts [tiab] OR Alloplastic implant [tiab] OR Alloplastic 
implants [tiab] OR Allotransplant [tiab] OR Allo-transplant [tiab] OR Allotransplantation 
[tiab] OR Allo-transplantation [tiab] OR Allotransplantations [tiab] OR Allo-transplanta-
tions [tiab] OR Allotransplanted [tiab] OR Allo-transplanted [tiab] OR Allotransplanting 
[tiab] OR Allotransplants [tiab] OR Allo-transplants [tiab] OR Graft [tiab] OR Grafted 
[tiab] OR Grafting [tiab] OR Graftings [tiab] OR Grafts [tiab]  OR Homo-graft  [tiab]  
OR Homograft [tiab]  OR Homografted [tiab] OR Homografting [tiab] OR Homo-graft-
ing [tiab] OR Homograftings [tiab] OR Homografts [tiab] OR Homo-grafts [tiab] OR 
Homologous implants [tiab] OR Homotransplant [tiab]  OR Homotransplantation [tiab] 
OR Homo-transplantation [tiab] OR Homotransplantations [tiab] OR Homo-transplan-
tations [tiab] OR Homotransplanted [tiab]  OR Homo-transplanted [tiab]  OR Homo-
transplants [tiab] OR Homo-transplants [tiab] OR Transplant [tiab] OR Transplantation 
[tiab] OR Transplantations [tiab] OR Transplanted [tiab] OR Transplanting [tiab] OR 
Transplants [tiab]
Component 3: Animal Search filter for animal studies [Hooijmans 2010]
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Embase
Component 1: Meniscus (exp knee / AND exp fibrocartilage/) OR (exp knee joint / AND  exp fibrocartilage/) OR 
exp knee meniscus/  OR exp knee meniscus rupture/  OR exp meniscectomy/  OR exp 
meniscal surgery / OR meniscal .ti,ab.  OR meniscected .ti,ab.  OR meniscectomie 
.ti,ab.  OR meniscectomies .ti,ab.  OR meniscectomised .ti,ab.  OR meniscectomis-
ized .ti,ab.  OR meniscectomized .ti,ab. OR meniscectomy .ti,ab.  OR menisceotomy 
.ti,ab.  OR meniscetomy .ti,ab.  OR menisci .ti,ab.  OR meniscial .ti,ab.  OR menis-
copathies .ti,ab.  OR meniscopathy .ti,ab.  OR meniscopexia .ti,ab.  OR meniscopex-
ies .ti,ab.  OR meniscopexy .ti,ab.  OR meniscoplasty .ti,ab.  OR meniscotomies 
.ti,ab.  OR meniscotomy .ti,ab. OR meniscus .ti,ab.  OR meniscusectomy .ti,ab.  OR 
meniscusectomy .ti,ab.  OR menisectomies .ti,ab.  OR menisectomized .ti,ab.  OR 
menisectomy .ti,ab. OR (knee .ti,ab. AND fibrocartilage .ti,ab.) OR (knee .ti,ab. AND 
fibro-cartilage .ti,ab.) OR (knee .ti,ab. AND fibrocartilagenous .ti,ab.) OR (knee .ti,ab. 
AND fibro-cartilagenous .ti,ab.) OR (knee .ti,ab. AND fibrocartilageous .ti,ab.) OR 
(knee .ti,ab. AND fibrocartilages .ti,ab.) OR (knee .ti,ab. AND fibro-cartilages .ti,ab.) 
OR (knee .ti,ab. AND Semilunar .ti,ab.) OR (knees .ti,ab. AND fibrocartilage .ti,ab.) 
OR (knees .ti,ab. AND fibro-cartilage .ti,ab.) OR (knees .ti,ab. AND fibrocartilagenous 
.ti,ab.) OR (knees .ti,ab. AND fibro-cartilagenous .ti,ab.) OR (knees .ti,ab. AND fibro-
cartilageous .ti,ab.) OR (knees .ti,ab. AND fibrocartilages .ti,ab.) OR (knees .ti,ab. AND 
fibro-cartilages .ti,ab.) OR (knees .ti,ab. AND semilunar .ti,ab.) OR (tibiafemoral .ti,ab. 
AND fibrocartilage .ti,ab.) OR (tibia-femoral .ti,ab. AND fibrocartilage .ti,ab.) OR (tibi-
afemoral .ti,ab. AND fibro-cartilage .ti,ab.) OR (tibia-femoral .ti,ab. AND fibro-cartilage 
.ti,ab.) OR (tibiafemoral .ti,ab. AND fibrocartilagenous .ti,ab.) OR (tibiafemoral .ti,ab. 
AND fibrocartilagenous .ti,ab.) OR (tibia-femoral .ti,ab. AND fibrocartilagenous .ti,ab.) 
OR (tibiafemoral .ti,ab. AND fibro-cartilagenous .ti,ab.) OR (tibiafemoral .ti,ab. AND 
fibro-cartilagenous .ti,ab.) OR (tibia-femoral .ti,ab. AND fibro-cartilagenous .ti,ab.) OR 
(tibiafemoral .ti,ab. AND fibrocartilageous .ti,ab.) OR (tibiafemoral .ti,ab. AND fibrocar-
tilageous .ti,ab.) OR (tibia-femoral .ti,ab. AND fibrocartilageous .ti,ab.) OR (tibiafemoral 
.ti,ab. AND fibrocartilages .ti,ab.) OR (tibia-femoral .ti,ab. AND fibrocartilages .ti,ab.) 
OR (tibiafemoral .ti,ab. AND fibro-cartilages .ti,ab.) OR (tibiafemoral .ti,ab. AND 
fibro-cartilages .ti,ab.) OR (tibia-femoral .ti,ab. AND fibro-cartilages .ti,ab.) OR (tibi-
afemoral .ti,ab. AND semilunar .ti,ab.) OR (tibia-femoral .ti,ab. AND semilunar .ti,ab.) 
OR (tibiofemoral .ti,ab. AND fibrocartilage .ti,ab.) OR (tibio-femoral .ti,ab. AND fibro-
cartilage .ti,ab.) OR (tibiofemoral .ti,ab. AND fibro-cartilage .ti,ab.) OR (tibio-femoral 
.ti,ab. AND fibro-cartilage .ti,ab.) OR (tibiofemoral .ti,ab. AND fibrocartilagenous .ti,ab.) 
OR (tibio-femoral .ti,ab. AND fibrocartilagenous .ti,ab.) OR (tibiofemoral .ti,ab. AND 
fibro-cartilagenous .ti,ab.) OR (tibio-femoral .ti,ab. AND fibro-cartilagenous .ti,ab.) OR 
(tibiofemoral .ti,ab. AND fibrocartilageous .ti,ab.) OR (tibio-femoral .ti,ab. AND fibrocar-
tilageous .ti,ab.) OR (tibiofemoral .ti,ab. AND fibrocartilages .ti,ab.) OR (tibio-femoral 
.ti,ab. AND fibrocartilages .ti,ab.) OR (tibiofemoral .ti,ab. AND fibro-cartilages .ti,ab.) 
OR (tibio-femoral .ti,ab. AND fibro-cartilages .ti,ab.) OR (tibiofemoral .ti,ab. AND 
semilunar .ti,ab.) OR (tibio-femoral .ti,ab. AND semilunar .ti,ab.) OR Semilunar Carti-
lage .ti,ab. OR Semilunar Cartilages .ti,ab. OR Semilunar fibrocartilage .ti,ab. OR knee 
disk .ti,ab.
Component 2: Allograft exp meniscal transplantation/  OR exp allograft/  OR exp allotransplantation/  OR exp 
Tissue Transplantation / OR Allogeneic implant .ti,ab. OR Allogeneic implants .ti,ab. 
OR Allogenic implants .ti,ab. OR Allograft .ti,ab. OR Allo-graft .ti,ab. OR Allografted 
.ti,ab. OR Allo-grafted .ti,ab. OR Allografting .ti,ab. OR Allo-grafting .ti,ab. OR Allograft-
ings .ti,ab. OR Allografts .ti,ab. OR Allo-grafts .ti,ab. OR Alloplastic implant .ti,ab. OR 
Alloplastic implants .ti,ab. OR Allotransplant .ti,ab. OR Allo-transplant .ti,ab. OR Allo-
transplantation .ti,ab. OR Allo-transplantation .ti,ab. OR Allotransplantations .ti,ab. OR 
Allo-transplantations .ti,ab. OR Allotransplanted .ti,ab. OR Allo-transplanted .ti,ab. OR 
Allotransplanting .ti,ab. OR Allotransplants .ti,ab. OR Allo-transplants .ti,ab. OR Graft 
.ti,ab. OR Grafted .ti,ab. OR Grafting .ti,ab. OR Graftings .ti,ab. OR Grafts .ti,ab.  OR 
Homo-graft  .ti,ab.  OR Homograft .ti,ab.  OR Homografted .ti,ab. OR Homografting 
.ti,ab. OR Homo-grafting .ti,ab. OR Homograftings .ti,ab. OR Homografts .ti,ab. OR 
Homo-grafts .ti,ab. OR Homologous implants .ti,ab. OR Homotransplant .ti,ab.  OR 
Homotransplantation .ti,ab. OR Homo-transplantation .ti,ab. OR Homotransplantations 
.ti,ab. OR Homo-transplantations .ti,ab. OR Homotransplanted .ti,ab.  OR Homo-trans-
planted .ti,ab.  OR Homotransplants .ti,ab. OR Homo-transplants .ti,ab. OR Transplant 
.ti,ab. OR Transplantation .ti,ab. OR Transplantations .ti,ab. OR Transplanted .ti,ab. OR 
Transplanting .ti,ab. OR Transplants .ti,ab.
Component 3: Animal Search filter for animal studies [de Vries 2011]
Chapter 5
110
S
up
p
le
m
en
ta
ry
 T
ab
le
 2
 In
d
iv
id
ua
l r
is
k 
o
f 
b
ia
s 
sc
o
re
s
M
or
a 
20
03
K
el
ly
 
20
06
S
zo
m
or
 
20
00
Ja
ck
so
n 
19
92
R
ijk
 
20
04
E
lli
ot
 
20
02
A
ag
aa
rd
 
20
03
C
um
m
in
s 
19
97
M
cN
ic
kl
e 
20
09
Ji
an
g 
20
12
Zw
ie
rz
ch
ow
sk
i 
20
12
W
ad
a 
19
97
E
dw
ar
ds
 
19
96
R
ijk
 
20
02
R
ijk
20
06
A
ag
aa
rd
 
19
99
Ya
m
as
ak
i 
20
08
1
se
le
ct
io
n 
bi
as
W
as
 th
e 
al
lo
ca
tio
n 
se
qu
en
ce
 a
de
-
qu
at
el
y 
ge
ne
ra
te
d 
an
d 
ap
pl
ie
d?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
2
S
el
ec
tio
n 
bi
as
W
er
e 
th
e 
gr
ou
ps
 
si
m
ila
r a
t b
as
e-
lin
e 
or
 w
er
e 
th
ey
 
ad
ju
st
ed
 fo
r c
on
-
fo
un
de
rs
 in
 th
e 
an
al
ys
is
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
3
S
el
ec
tio
n 
bi
as
W
as
 th
e 
al
lo
ca
tio
n 
to
 th
e 
di
ffe
re
nt
 
gr
ou
ps
 a
de
qu
at
el
y 
co
nc
ea
le
d?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
4
Pe
rfo
r-
m
an
ce
 
bi
as
W
er
e 
th
e 
an
im
al
s 
ra
nd
om
ly
 h
ou
se
d 
du
rin
g 
th
e 
ex
pe
r-
im
en
t?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
5
Pe
rfo
r-
m
an
ce
 
bi
as
W
er
e 
th
e 
ca
re
gi
v-
er
s 
an
d/
or
 in
ve
s-
tig
at
or
s 
bl
in
de
d 
fro
m
 k
no
w
le
dg
e 
w
hi
ch
 in
te
rv
en
tio
n 
ea
ch
 a
ni
m
al
 re
-
ce
iv
ed
 d
ur
in
g 
th
e 
ex
pe
rim
en
t?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
6
D
et
ec
ti-
on
 b
ia
s
W
er
e 
an
im
al
s 
se
le
ct
ed
 a
t r
an
-
do
m
 fo
r o
ut
co
m
e 
as
se
ss
m
en
t?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
7
D
et
ec
ti-
on
 b
ia
s
W
as
 th
e 
ou
tc
om
e 
as
se
ss
or
 b
lin
de
d?
?
ye
s
ye
s
?
ye
s
ye
s
ye
s
ye
s
?
ye
s
ye
s
?
ye
s
ye
s
ye
s
ye
s
?
a systematic review of animal studies
111
8
A
ttr
iti
on
 
bi
as
W
er
e 
in
co
m
pl
et
e 
ou
tc
om
e 
da
ta
 
ad
eq
ua
te
ly
 a
d-
dr
es
se
d?
 
?
no
ye
s
no
ye
s
ye
s
no
?
ye
s
ye
s
ye
s
ye
s
ye
s
ye
s
ye
s
no
?
9
R
ep
or
-
tin
g 
bi
as
A
re
 re
po
rts
 o
f 
th
e 
st
ud
y 
fre
e 
of
 
se
le
ct
iv
e 
ou
tc
om
e 
re
po
rti
ng
?
ye
s
ye
s
ye
s
?
ye
s
ye
s
ye
s
ye
s
no
ye
s
?
?
ye
s
?
ye
s
ye
s
ye
s
10
O
th
er
W
as
 th
e 
st
ud
y 
ap
pa
re
nt
ly
 fr
ee
 o
f 
ot
he
r p
ro
bl
em
s 
th
at
 c
ou
ld
 re
su
lt 
in
 
hi
gh
 ri
sk
 o
f b
ia
s?
?
no
no
?
no
?
?
?
?
no
?
?
no
?
?
?
?
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
11
A
dd
iti
o-
na
l
W
as
 it
 s
ta
te
d 
th
at
 
th
e 
ex
pe
rim
en
t 
w
as
 ra
nd
om
iz
ed
 
at
 a
ny
 le
ve
l?
ye
s
ye
s
ye
s
no
ye
s
no
ye
s
no
ye
s
ye
s
no
no
ye
s
no
ye
s
no
no
12
A
dd
iti
o-
na
l
W
as
 it
 s
ta
te
d 
th
at
 
th
e 
ex
pe
rim
en
t 
w
as
 b
lin
de
d 
at
 a
ny
 
le
ve
l?
no
ye
s
ye
s
no
ye
s
ye
s
ye
s
ye
s
no
ye
s
ye
s
no
ye
s
ye
s
ye
s
ye
s
no

CHAPTER 6
Systematic reviews of animal studies; missing link in 
translational research?
Judith van Luijk
Brenda Bakker
Maroeska Rovers
Merel Ritskes-Hoitinga
Rob de Vries
Marlies Leenaars
PlosOne 9(3), e89981, 2014
Chapter 6
114
Abstract
The methodological quality of animal studies is an important factor hampering the 
translation of results from animal studies to a clinical setting. Systematic reviews of 
animal studies may provide a suitable method to assess and thereby improve their 
methodological quality.  
The aims of this study were: 1) to evaluate the risk of bias assessment in animal-based 
systematic reviews,  and 2) to study the internal validity of the primary animal studies 
included in these systematic reviews 
We systematically searched Pubmed and Embase for SRs of preclinical animal studies 
published between 2005 and 2012. 
A total of 91 systematic reviews met our inclusion criteria. The risk of bias was assessed in 
48 (52.7%) of these 91 systematic reviews. Thirty-three (36.3%) SRs provided sufficient 
information to evaluate the internal validity of the included studies. Of the evaluated 
primary studies, 24.6% was randomized, 14.6% reported blinding of the investigator/
caretaker, 23.9% blinded the outcome assessment, and 23.1% reported drop-outs.
To improve the translation of animal data to clinical practice, systematic reviews of 
animal studies are worthwhile, but the internal validity of primary animal studies needs 
to be improved. Furthermore, risk of bias should be assessed by systematic reviews of 
animal studies to provide insight into the reliability of the available evidence.
Introduction
The majority of animal experiments is being carried out in the context of preclinical 
research, e.g. to test safety and efficacy of new treatments to improve healthcare. 
However, translating animal data to the human situation has been proven to be very 
challenging. Various factors influence this translation, such as biological differences 
between species, internal validity, differences in experimental design between animal 
studies and clinical trials, insufficient reporting, and publication bias [1]. Systematic 
reviews (SRs) of animal studies have the potential to reduce some of the challenges 
in the translation of animal data to clinical trials, for example by explicitly assessing 
the internal validity. SRs attempt to identify, appraise and synthesize all the empirical 
evidence that meets pre-specified eligibility criteria to answer a given research 
question. SRs of animal studies are still quite rare, but their number appears to be 
slightly increasing [2-4].However, little is known about the extent to which the available 
SRs include a risk of bias assessment, in which the internal validity of the included 
primary animal studies is evaluated.  We therefore performed a systematic review of 
the risk of bias assessment in SRs of animal studies. Subsequently, we studied the 
internal validity of the individual studies included in these SRs. 
SyStematic reviewS of animal StudieS, riSk of BiaS aSSeSSment
115
Materials and methods
Search strategy 
To find all SRs of animal studies published between 2005 and 2012, the following search 
strategy was carried out on 28 January 2013. To identify animal studies, the MEDLINE 
(PubMed platform) and EMBASE (OvidSP platform) databases were searched using 
the ‘Animal’ filter for PubMed by Hooijmans et al., [5] and the filter for EMBASE by De 
Vries et al., [6, 7] respectively. Since we were interested in SRs, we used the clinical 
query for SRs from PubMed, which we have adapted for Embase (see Text S1). 
Study selection 
For the purpose of this study, a review was classified as a SR when at least all of the 
following items were reported: 1) the term Systematic Review 2) database(s) searched 
and 3) search terms. Selection was performed by two independent observers and 
disagreements were resolved  through discussion (JvL, BB, ML). Only SRs aiming to 
inform human healthcare by reviewing a medical drug intervention were included, such 
as vitamin-based supplementations or stem cells treatment. Medical devices, such as 
prosthetics and scaffolds, and other types of interventions such as oxygen or heat were 
excluded. We also excluded SRs that were not written in English or could not be retrieved 
in full text. When supplementary data were available online, these were obtained.
Scoring procedure of SRs
Data on both the characteristics and methods used to assess risk of bias in the SRs 
were extracted by at least two independent reviewers (JvL, BB, ML). In SRs where 
both animal and human studies were included in the SR, only the animal data were 
evaluated. Disagreements between reviewers were resolved through discussion and if 
necessary a third reviewer was consulted. 
Assessment risk of bias items
The methodology of quality assessment differs between SRs of animal studies [8]. 
For the purpose of this study we focused on the internal validity of primary studies. 
Therefore, we defined quality assessment as a risk of bias assessment. To fit this 
definition, the assessment had to include at least one of the following internal validity 
items: 1) randomized study design (selection bias), 2) blinding of investigator/
caretaker (performance bias), 3) blinding of outcome assessment (detection bias) and 
4) mentioning of drop-outs (attrition bias). 
SR characteristics
Additional information on the characteristics of the SRs was extracted: 1) the way in 
which the risk of bias was taken into account in the SR (e.g. conduct of subgroup 
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analyses based on quality, exclusion of studies based on quality or a general comment/
statement related to the study quality), 2) level of reporting detail on internal validity 
(e.g. score per item or a summary for quality per study) and  3) research area of the SR.
Data extraction Primary studies
SRs that provided detailed information on the required internal validity items were 
used to evaluate the internal validity of the included individual studies. Per SR, data 
were extracted on: total number of included studies and number of studies per 
item (randomised study design, blinding investigator/caretaker, blinding outcome 
assessment and drop-outs). 
Results
Literature search and SR selection
We identified 592 potentially eligible articles, of which 91 SRs met our inclusion criteria. 
Figure 1 shows the number of studies identified at each stage of the selection process. 
A complete list of the 91 references can be found elsewhere (see Table S2A).
Characteristics of included Systematic Reviews
The number of published systematic reviews of animal studies increased over the last years 
from 6 in 2005 and 2, 6 and 12 in 2006, 2008 and 2010 to 32 in 2012, respectively (Figure 2). 
The 91 SRs included in this review cover a range of research topics. Most reviews 
(n=38; 41.8%) cover a neurological topic, of which 20 reviews (22.0%) pertained 
to stroke. The second largest group was on endocrinology (n = 11; 12.1%). Other 
topics included cardiovascular diseases, orthopaedics, infectious diseases, oncology, 
pharmacotoxicology, dentistry and gastroenterology. The complete list of topics and 
number of SRs per topic can also be found elsewhere (see Table S2A).
Risk of bias assessment
Risk of bias assessment in systematic reviews
Nearly half of the SRs (n=43; 47.3%) did not assess any of the risk of bias items 
(figure 3). In 48 reviews (52.7%), one or more of our predefined risk of bias items 
were assessed. Thirty-three (36.3%) reviews also provided detailed information on the 
outcome of this assessment per individual study. 
Figure 3 shows that of the 91 SRs only 3 (3.3%) assessed all 4 internal validity items 
in their quality assessment. Twenty-two SRs (24.2%) assessed 3 items, of which 17 
SRs (18.7%) did not assess drop-outs; the other 5 (5.5%) did not score blinding of 
the caretaker. Fourteen SRs (15.4%) assessed two items namely randomisation and 
blinding (of these, 13 SRs assessed blinding of the outcome assessment, in one SR 
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the type of blinding was unclear). Nine SRs (9.9%) assessed only one item, which in all 
cases was randomisation.
Risk of bias use in SRs
Of the 48 SRs that assessed risk of bias of included individual studies, 45 (93.8%) 
referred to the internal validity of the primary studies in the results, discussion or 
conclusion section. This means that three SRs did not discuss the outcome of the risk 
of bias assessment in any way. In most reviews, (n=42; 87.5%) a general comment 
was made on the quality of the primary studies. In 25 SRs (52.1%), the primary study 
quality was used as a factor in the meta-analysis (e.g. subgroup analyses) and in three 
SRs the study quality was used as an exclusion criterion (see Table S2A).
Internal validity of primary studies
Thirty-three SRs that provided detailed information on the risk of bias assessment were 
used to evaluate the internal validity of the included primary studies. These 33 SRs 
included a total of 2280 primary studies (median 18, range: 2 – 1152 primary studies). 
Most of these studies were on the subject of stroke or other neurological topics (see 
Table S2A and S2B).
Figure 4 provides an overview of risk of bias scores of the individual animal studies 
per item (randomisation, blinding of caretaker/investigator, blinding of outcome 
assessment and drop-outs). As not all reviews scored all four items we evaluated (see 
figure 3), the number of primary studies varies per item in figure 4. Of the 2280 included 
primary studies, 562 (24.6%) were randomised. Blinding of the investigator/caretaker 
was scored for 546 (23.9%) primary studies, of which 80 (14.6%) were actually blinded. 
Blinding of the outcome assessment was scored for 2220 (97.4%) primary studies, 
of which 530 (23.9%) were indeed blinded. Drop-outs were scored in only 78 (3.4%) 
primary studies, of which 18 (23.1%) really did reported drop-outs. One study assessed 
blinding, without specifying the type of blinding. Therefore, the data of this study were 
not included in our results (see Table S2A and S2B).
Discussion
Our results show that the assessment of the methodological quality by systematic 
reviews of animal studies is quite poor. Half of the 91 evaluated SRs did not critically 
appraise the risk of bias in the included studies. Furthermore, the thirty-three reviews 
that did assess and report the risk of bias showed that the internal validity of most 
individual animal studies is poor as well. Therefore, there is a real risk that the 
outcomes of both, the individual studies and the subsequent SRs of these studies 
are biased.
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Our findings that the methodological quality of SRs is poor are in line with findings 
by Peters et al., who identified a number of deficiencies in the conduct and reporting 
of SRs and meta-analyses of animal studies. Peters et al. suggest that initiatives to 
improve the conduct and reporting of primary animal studies and of SRs of animal 
studies should go hand-in-hand [2]. Poor internal validity of animal studies has 
previously been demonstrated by Kilkenny et al. Of the 271 publications of animal 
studies they surveyed, only 13% had been randomised and 14% had blinded the 
outcome assessment [9]. We found slightly higher percentages, namely 24.6% 
randomisation and 23.9% for blinding. These higher percentages may be explained 
by two factors. First, our study contains a relative high number of stroke studies. 
Over the last decades, researchers in the field of stroke have been actively working 
on recommendations and guidelines for preclinical research in order to improve 
effective translation [10]. Second, over the last years, general awareness of the need 
for better reporting of animal studies has been steadily increasing.
Although both the methodological quality of animal SRs and the internal validity of 
primary animal studies have been investigated before, they were studied separately 
by different research groups and more recent SRs of animal studies have not yet been 
taken into account. A major strength of our study is, therefore, that by updating and 
combining these evaluations in one study, we were able to gain more in-depth insight 
into the current state and level of available preclinical evidence.
Some potential limitations should also be discussed. First, we have restricted ourselves 
to one type of SR, namely SRs of animal-based drug-intervention studies, which might 
hamper the generalization  of our results to other SRs of animal studies. Although we 
excluded SRs of animal studies that are not directly related to clinical research, we 
consider it likely that  the latter type of SRs are of lower methodological quality, as the SR 
methodology and measures to safeguard internal validity may not be as well established 
as in fields closely related to clinical research. Therefore, our restriction might have 
caused an overestimation of the methodological quality of SRs and the internal validity 
of primary studies in general.  Second, it cannot be ruled out that a small proportion of 
the SRs did not assess certain internal validity items, because the experimental design 
of the included individual studies did not allow a risk of bias assessment (e.g. due to 
a lack of (independent) control groups). Third, some individual studies may have been 
less subject to bias than the SRs estimated due to a lack of (adequate) reporting of 
the randomization and/or blinding methods they actually used. Fourth, we have not 
investigated whether the SRs assessed the adequacy of the method of randomisation 
or blinding. Inadequate randomization and blinding in animal studies can cause 
overestimation of the effect size [11, 12] and thus may falsely inform other preclinical 
research or clinical trials. In principle, this means that even randomised studies could 
be subject to bias, namely when the randomisation method was not adequate for the 
study design. Similarly, some SRs assessed blinding but did not specify the level or 
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type of blinding. As long as the reporting of animal studies remains poor, however, these 
limitations are hardly avoidable.
Adequate internal validity of animal studies has been described as one of the key factors 
for improving the translation of results to human studies [1]. SRs can be a useful method 
to evaluate and analyse (the quality of) available evidence. As previously stated, SRs of 
animal studies could profit from the use of guidelines [2]. Currently, there is no standard 
procedure available for conducting SRs of animal studies [8, 13]. This could be one of 
the reasons why so many animal-based SRs did not assess any of the risk of bias items. 
Valuable lessons can be learned here from the guidelines used in clinical research, 
such as the CONSORT and PRISMA statements. Guidelines for planning, conducting 
and reporting primary animal studies are already available [14, 15]. Even though the 
ARRIVE guidelines are adopted by many journals, the effect on publication standards of 
animal studies is still very minimal. Therefore, effective implementation of endorsement 
of these guidelines requires more attention [16]. As does education on this matter. A 
good education strategy regarding both the internal validity of animal studies and the 
SR methodology can help raise awareness for the current state of potentially biased 
animal data. Authors, as well as reviewers and editors, need to be aware of the potential 
risk of this bias in animal studies and how it can adequately be reduced to eventually 
produce high-quality research with reliable results for human healthcare.
Conclusions
To improve the translation of animal data to clinical practice, systematic reviews of 
animal studies are worthwhile, but the internal validity of the individual animal studies 
needs to be improved. Furthermore, risk of bias should be assessed by SRs of animal 
studies to provide insight into the reliability of available evidence.
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Figure 2  Number (n) of published SRs of intervention animal studies per publication  
year (2005-2012).
Figure 3  Percentages of  SRs per number of internal validity item scored.  
Zero items by 47.3%, one item all randomisation, two items randomisation and one 
level of blinding, three items randomisation, blinding of caretaker/investigator and 
blinding of outcome assessment or randomisation, one level of blinding and drop-
outs) and all four items by 3.3%.
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Figure 4 Percentage of primary animal studies assessed per validity item; yes or no. 
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Appendix chapter 6:
Supplementary file 1 Systematic Review filters
Pubmed (systematic review [ti] OR meta-analysis [pt] OR meta-analysis [ti] OR systematic 
literature review [ti] OR (systematic review [tiab] AND review [pt]) OR consensus 
development conference [pt] OR practice guideline [pt] OR cochrane database syst 
rev [ta] OR acp journal club [ta] OR health technol assess [ta] OR evid rep technol 
assess summ [ta]) OR ((evidence based[ti] OR evidence-based medicine [mh] 
OR best practice* [ti] OR evidence synthesis [tiab])AND (review [pt] OR diseases 
category[mh] OR behavior and behavior mechanisms [mh] OR therapeutics [mh] OR 
evaluation studies[pt] OR validation studies[pt] OR guideline [pt])) OR ((systematic [tw] 
OR systematically [tw] OR critical [tiab] OR (study selection [tw]) OR (predetermined 
[tw] OR inclusion [tw] AND criteri* [tw]) OR exclusion criteri* [tw] OR main outcome 
measures [tw] OR standard of care [tw] OR standards of care [tw]) AND (survey [tiab] 
OR surveys [tiab] OR overview* [tw] OR review [tiab] OR reviews [tiab] OR search* 
[tw] OR handsearch [tw] OR analysis [tiab] OR critique [tiab] OR appraisal [tw] OR 
(reduction [tw]AND (risk [mh] OR risk [tw]) AND (death OR recurrence))) AND (literature 
[tiab] OR articles [tiab] OR publications [tiab] OR publication [tiab] OR bibliography 
[tiab] OR bibliographies [tiab] OR published [tiab] OR unpublished [tw] OR citation 
[tw] OR citations [tw] OR database [tiab] OR internet [tiab] OR textbooks [tiab] OR 
references [tw] OR scales [tw] OR papers [tw] OR datasets [tw] OR trials [tiab] OR 
meta-analy* [tw] OR (clinical [tiab] AND studies [tiab]) OR treatment outcome [mh] OR 
treatment outcome [tw])) NOT (letter [pt] OR newspaper article [pt] OR comment [pt])
Embase (systematic review.ti. OR meta-analysis.pt. OR meta-analysis.ti. OR systematic literature 
review.ti. OR (systematic review.ti,ab. AND review.pt.) OR consensus development 
conference.pt. OR practice guideline.pt. OR cochrane database syst rev.ja. OR acp 
journal club.ja. OR health technol assess.ja. OR evid rep technol assess summ.ja.) OR 
((evidence based.ti. OR evidence-based medicine/ OR best practice*.ti. OR evidence 
synthesis.ti,ab.) AND (review.pt. OR diseases category/ OR exp behavior and behavior 
mechanisms/ OR exp therapeutics/ OR evaluation studies.pt. OR validation studies.pt. 
OR guideline.pt.)) OR ((systematic.tw. OR systematically.tw. OR critical.ti,ab. OR (study 
selection.tw.) OR (predetermined.tw. OR inclusion.tw. AND criteri*.tw.) OR exclusion 
criteri*.tw. OR main outcome measures.tw. OR standard of care.tw. OR standards of 
care.tw.) AND (survey.ti,ab. OR surveys.ti,ab. OR overview*.tw. OR review.ti,ab. OR 
reviews.ti,ab. OR search*.tw. OR handsearch.tw. OR analysis.ti,ab. OR critique.ti,ab. OR 
appraisal.tw. OR (reduction.tw.AND (exp risk/ OR risk.tw.) AND (death OR recurrence))) 
AND (literature.ti,ab. OR articles.ti,ab. OR publications.ti,ab. OR publication.ti,ab. OR 
bibliography.ti,ab. OR bibliographies.ti,ab. OR published.ti,ab. OR unpublished.tw. OR 
citation.tw. OR citations.tw. OR database.ti,ab. OR internet.ti,ab. OR textbooks.ti,ab. 
OR references.tw. OR scales.tw. OR papers.tw. OR datasets.tw. OR trials.ti,ab. OR 
meta-analy*.tw. OR (clinical.ti,ab. AND studies.ti,ab.) OR exp treatment outcome/ OR 
treatment outcome.tw.)) NOT (letter.pt. OR newspaper article.pt. OR comment.pt.)
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Supplementary file 2 Table 1 Characteristics SRs
Assessment of internal validity: 1) Randomisation assessed, 2) Blinding caretaker/investigator 
assessed, 3) Blinding outcome assessment assessed, 4) Dropouts assessed. Use of internal 
validity: 5) General comment, 6) Used in meta-analysis (e.g. subgroup), 7) Exclusion criterion. 
Additional information: 8) Included in analyses of primary studies, 9) Field of research.
Reference 1 2 3 4 5 6 7 8 9
[1] * * * * * Endocrinology
[2] * * * * * Neurology
[3] * * * * * Oncology
[4] Endocrinology
[5] * * * * * * Stroke
[6] * * * * * * * Stroke
[7] * * * * Neurology
[8] Cardiovascular Research
[9] * * * * * Orthopeadics
[10] * * * * * * Stroke
[11] Neurology
[12] * * Pharmacotoxicology
[13] Oncology
[14] Infectious Diseases
[15] * * * * * * Dentistry
[16] * * * * * Stroke
[17] Infectious Diseases
[18] * * Dentistry
[19] Neurology
[20] Pharmacotoxicology
[21] Oncology
[22] * Neurology
[23] * * * * * Stroke
[24] * * * * * Neurology
[25] * * * * * Neurology
[26] * * * * * Stroke
[27] * Stroke
[28] * * Orthopeadics
[29] * * Stroke
[30] Pharmacology
[31] Endocrinology
[32] Endocrinology
[33] Pharmacotoxicology
[34] * * Orthopeadics
[35] * * * * * * * Gastroenterology
[36] * * * * * Neurology
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[37] * * * Infectious Diseases
[38] * * * * * Stroke
[39] Dentistry
[40] * * * * * Neurology
[41] Orthopeadics
[42] * * * Oncology
[43] Oncology
[44] Psychiatry
[45] Neurology
[46] Neurology
[47] * * * * * * Stroke
[48] Endocrinology
[49] Endocrinology
[50] Infectious Diseases
[51] * * * * * * Cardiovascular Research
[52] * * * * Stroke
[53] Neurology
[54] * * * * * Stroke
[55] * * * * * * Stroke
[56] * * * * * * Stroke
[57] * * Cardiovascular Research
[58] Orthopeadics
[59] * * * * * Endocrinology
[60] Orthopeadics
[61] * * Gastroenterology
[62] * * * * Stroke
[63] Ophthalmology
[64] Pharmacotoxicology
[65] Infectious Diseases
[66] * Cardiovascular Research
[67] Surgery
[68] Endocrinology
[69] * * * * * Neurology
[70] Gastroenterology
[71] Endocrinology
[72] * * * * * * Stroke
[73] * * * * * * Stroke
[74] * * * Endocrinology
[75] Neurology
[76] Neurology
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[77] Neurology
[78] Pulmonology
[79] * * * * * Cardiovascular Research
[80] Pharmacotoxicology
[81] * * * * * Neurology
[82] Otolaryngology
[83] Nephrology
[84] * Pulmonology
[85]1 * ? ? * Cardiovascular Research
[86] * * * * * * Stroke
[87] * * * Stroke
[88] * * * * Stroke
[89] Surgery
[90] * * * * * * Endocrinology
[91] * * * * * * Neurology
n= 48 38 20 8 442 25 3 33
Footnotes: 
1 Level of blinding was unclear
2  In two reviews a comment was made about internal validity without a risk of bias 
assessment
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Supplementary file 2 Table 2 Primary animal studies
1) Total number of animals included, 2) Number of animals randomized, 3) Number of animals 
blinded caretaker/investigator, 4) Number of animals blinded outcome assessment, 5) Number 
of animals drop-outs. ? = number unclear, - = not scored
Reference 1 2 3 4 5
[1] 11 5 0 - 1
[2] 62 45 33 - -
[5] 17 1 5 2 -
[6] 18 9 12 8 9
[7] 85 21 21 - -
[9] 6 3 2 - 0
[10] 14 6 7 5 -
[15] 2 2 2 - 2
[16] 19 16 16 - -
[24] 12 2 5 - -
[25] 18 12 7 - -
[26] 27 2 1 - -
[35] 13 10 7 2 4
[36] 17 13 1 - 1
[37] 2 0 - - -
[40] 14 7 4 0 -
[47] 117 54 57 22 -
[51] 20 15 2 1 -
[52] 9 4 4 - -
[54] 25 6 7 0 -
[55] 13 4 4 2 -
[56] 29 6 2 1 -
[59] 4 0 0 0 -
[69] 254 40 38 - -
[72] 105 46 28 16 -
[73] 18 12 13 1 -
[74] 13 12 - - -
[79] 52 38 22 5 -
[81] 1152 108 184 - -
[85]3 45 12 ? ? -
[86] 6 2 1 0 -
[90] 11 11 0 0 1
[91] 70 38 45 15 -
SyStematic reviewS of animal StudieS, riSk of BiaS aSSeSSment
131
Footnotes:
3  Level of blinding unclear (not specified). Of the 45 primary studies: 15 were blinded 
(33.3%), 14 not blinded (31.1%) and in 16 studies blinding was not mentioned (35.6%).
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Abstract
The number of published systematic reviews and meta-analyses of animal studies has 
increased rapidly over the last decade. Still the use of systematic review for animal 
studies is a developing field. For one, there is uncertainty surrounding the added value 
of using multiple bibliographic databases to identify studies and whether there is an 
impact of language restrictions in their selection.
To investigate to what extent database selection and language restriction in the 
search strategy of systematic reviews of animal studies affect the outcome of the 
meta-analysis.
Systematic reviews of which data for meta-analysis are available in the CAMARADES 
database.
There was a large overlap between PubMed and Embase in retrievability of studies 
included in the reviews (>85% overlap in 2/3 of the evaluated reviews). Restricting 
a search to either PubMed or Embase resulted in missing up to 20% and 4% unique 
studies respectively. Restricting study retrieval to English studies only, could result 
in missing up to 13% relevant studies. An effect of these missed studies (both due 
to database selection or language restriction) on the meta-analysis could neither be 
demonstrated nor refuted.
Restriction of a search to a single database or to studies published in English can lead 
to missing relevant studies for systematic reviews of animal studies and may affect 
the outcome of meta-analyses. How the meta-analysis of the review will be affected if 
these studies had been missed, differs per review. The authors discuss some potential 
strategies and recommendations how the issue of database selection and language 
restriction in systematic reviews of animal studies can be addressed.
Introduction
The number of published systematic reviews  of animal studies has increased rapidly 
over the last decade [1]. Their use has been driven largely by a desire to provide 
empirical evidence to inform improvements in the validity of preclinical studies [2]. 
These reviews provide comprehensive and less biased summaries of research findings, 
but as with any research method, are still susceptible to bias. The use of systematic 
review for animal studies is a developing field of research with a number of different 
approaches to its conduct and reporting [1, 3]. 
A fundamental step in the systematic review process is the identification and selection 
of relevant studies. There is uncertainty surrounding the added value of using 
multiple bibliographic databases to identify studies and whether there is an impact 
of language restrictions in their selection. The reliability of the findings of a systematic 
review is critically dependent on its completeness. For systematic reviews of human 
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clinical research, it has been shown that only searching Medline does not identify all 
controlled clinical trials [4]. Furthermore, only searching MEDLINE may bias summary 
estimates in a meta-analysis as primary studies indexed in MEDLINE are associated 
with larger treatment effects [5]. To date, studies that have assessed the effect of 
language restrictions in systematic review report contradictory findings. It has been 
suggested that investigators working in non-English speaking countries are more likely 
to publish positive results of clinical trials in international English-language journals 
whereas neutral or negative findings are published in local journals. There are also 
indications for a correlation between a lower quality score and studies published in 
another language than English [6].
A more recent study found no evidence of systematic bias from the use of language 
restriction in systematic review-based meta-analyses in medicine [7]. However, other 
studies report that language bias can be more prominent in different fields of medicine 
[8], and can depend on the language that is restricted [9]. For systematic reviews 
of animal studies we were unable to identify  empirical evidence to either support or 
oppose the added value of searching multiple databases instead of a single one, and 
on including studies published in any language rather than English alone.
The most frequently searched biomedical databases are PubMed, Embase and Web 
of Science (WoS). PubMed is freely available and commonly used to access MEDLINE. 
Embase is less often available to researchers and is accessed via paid subscription 
through a range of platforms. Since early 2010, records that were previously only 
available in MEDLINE can also be retrieved via Embase. Both PubMed and Embase 
allow for a comprehensive search using a thesaurus structure for indexing: MeSH for 
MEDLINE via PubMed and EMTREE for Embase. PubMed also contains recent studies 
that are yet to be indexed. This feature is not available in Embase. Other databases, 
such as WoS and Scopus, do not use such all-encompassing thesaurus indexing, 
which results in less specificity and substantially more search hits [10]. 
We have assessed the effects of the use of multiple databases and language restrictions 
in systematic reviews of animal studies. We used data from published systematic 
reviews curated on the Collaborative Approach to Meta-Analysis and Review of Animal 
Data in Experimental Studies (CAMARADES) database to investigate the effects of 
methodological choices of primary study identification and selection. Specifically, we 
aimed to gain insight into the number of studies each database contributed to each 
systematic review and to evaluate the effect of limiting the search for primary studies 
to PubMed or Embase and to studies published in English on the results of meta-
analyses. 
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Methods
Study selection
We selected all published systematic reviews up until January 2015 curated in the 
Collaborative Approach to Meta-Analysis and Review of Animal Data in Experimental 
Studies (CAMARADES) database that met the following inclusion criteria: 1) two or 
more online databases were searched, 2) no language restriction was applied in 
the search or selection of primary studies, 3) a minimum of 25 primary studies were 
included in the systematic review to allow for sub-group analyses and 4) the systematic 
review was published in a peer-reviewed journal.
Data collection
To identify whether the included primary studies were available in PubMed, Embase 
and/or WoS, an information specialist (AT) of the Radboud University Medical Library, 
used the original bibliographic management files (Reference Manager or EndNote) of 
the included primary studies for each systematic review to run batch search scripts per 
database.  We also classified each primary study as written in English if published in 
an English-language journal. In cases where a study was published in a non-English or 
bi-lingual journal we checked the language of the full text version of the study stored in 
the CAMARADES database.
Stratified meta-analysis
For each systematic review, we calculated the total number of studies that could be 
retrieved from each database and assessed the overlap in retrieved studies between 
databases and the number of studies that were uniquely found in a single database. 
For each systematic review we identified the predefined primary outcome measure. If 
the primary outcome was not clearly stated we contacted the corresponding author to 
ascertain which outcome was used as the primary outcome. We abstracted the following 
information from each study: publication year, primary outcome measure, animal cohort, 
effect size and standard error. For each independent comparison, we then calculated 
the effect size for the primary outcome as a standardized mean difference (SMD) and 
corresponding 95% confidence interval (CI). We pooled these SMDs using random 
effects meta-analysis, to account for anticipated heterogeneity [11]. 
We then partitioned heterogeneity (based on Cochran’s Q [12]) using stratified meta-
analysis to investigate the impact of the database searched and of language restrictions. 
In stratified meta-analyses, the heterogeneity statistics for each stratum are summed 
and then subtracted from the total heterogeneity. This residual heterogeneity between 
the strata follows a Chi2 distribution. To test whether there was a significant proportion 
of residual heterogeneity we used the Chi2 test  with n-1 degrees of freedom to test for 
a significant difference between the strata. 
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For each of the included systematic reviews we performed 4 analyses where we 
stratified by: (i) retrievable from PubMed (Y/N), (ii) retrievable from Embase (Y/N), (iii) 
retrievable from either PubMed or Embase (Y/N), and (iv) English language publication 
(Y/N). These analyses were performed in the CAMARADES database (Microsoft Office 
Access 2007). To allow for these multiple analyses, we adjusted our significance level 
to P<0.013 using Bonferroni-Holm correction. We did not assess for studies retrievable 
from WoS as this database was not used in all reviews. 
Meta-analysis of meta-analyses
To assess the overall effect of database and language restriction on meta-analysis, 
we combined the results of the stratified meta-analyses in one meta-meta-analysis. 
For example, to study the overall effect of language restriction, we used the SMD of 
English and non-English studies to calculate the difference between SMDs (ΔSMDs) 
and corresponding 99% confidence interval (CI), for each review. These ΔSMDs were 
then pooled using random effects meta-analysis. The same approach was used to 
determine the effect of database restriction, resulting in a total of 4 meta-meta-analyses 
(all performed using Stata/SE 11.2 software).
Results
A total of 15 systematic reviews [13-27] met our selection criteria (Figure 1). The 
number of studies included in these systematic reviews ranged from 25 to 252, with 
a median of 73 (Table 1). The total number of primary studies was 1314. The topics 
varied between reviews, however they were all neuroscience related (stroke, glioma, 
spinal cord injury, bone cancer pain and Parkinson’s disease). 
Effect of database and language restriction on search results
Table 1 shows the characteristics of the reviews we evaluated. All reviews used 
MEDLINE (via PubMed) and Embase to search for primary studies. Ten systematic 
reviews (67%) searched WoS, including one review that used the Web of Knowledge, 
which includes WoS [16]. Five systematic reviews (33%) searched BioSIS and in eight 
reviews (53%) some type of hand searching (e.g. reference lists of included studies) 
was performed. For three reviews, all included studies could have been retrieved either 
from PubMed or Embase (100% overlap). Out of all the 1314 studies, 1131 (86%) could 
have been retrieved from PubMed and 1169 (89%) from Embase. A search in PubMed 
yielded unique studies for five reviews, if PubMed had not been searched this could 
have resulted in missing studies up to 4% per review. The Embase search yielded 
unique studies for nine reviews; without an Embase search up to 20% of the studies 
would have been missed per review. Five reviews did not search WoS, nevertheless we 
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assessed retrievability of the included studies in these reviews for this database. Five 
reviews used a database for which retrievability could not be checked namely Biosis. 
Unique studies from other sources therefore represent studies that could not have 
been retrieved from PubMed, Embase or Web of Sciences and where thus retrieved via 
other databases or via hand searching (See Table 1).
In six reviews, only studies published in English met the authors’ inclusion criteria 
despite there being no language restriction. If a language restriction had been applied 
in the other reviews, up to 13% of the studies would have been missed. (See Table 1).
Effect of database and language restriction on individual  
meta-analyses
In ten reviews, infarct volume (IV) was the primary outcome measure for the meta-
analysis [15, 17-20, 23-27]. In the other five reviews the primary outcome measure 
was neurobehavioral score (NBS) or extent of pain-related behavior [13, 14, 16, 21, 
22]. Table 2 shows details on the number of studies and experimental comparisons 
included in the meta-analysis of each review. For four reviews, no analysis could be 
performed regarding database and language restrictions, since all studies included 
in their meta-analysis were retrievable from both PubMed and Embase and were 
published in English [17, 18, 21, 26]. 
Table 2 lists the reviews and the respective amounts of heterogeneity in each stratum 
for all four analyses. Ten out of the 11 reviews included studies retrievable with PubMed, 
as well as studies that were not [13-16, 19, 20, 22-25]. For five of these reviews the 
extent of heterogeneity differed significantly between the two groups. The same ten 
reviews included studies retrievable from Embase, as well as studies that were not. In 
five of these reviews heterogeneity between the two groups differed significantly. Six 
reviews included studies from PubMed or Embase, as well as additional studies from 
other databases [13, 14, 19, 22-24]. In one of these reviews, the extent of heterogeneity 
differed significantly between the two groups(PubMed or Embase; yes/no). 
Eight reviews had both English and non-English studies included in the meta-analysis 
[13, 14, 16, 19, 20, 22, 24, 27]. In four of these reviews the extent of heterogeneity 
between the two groups differed significantly.
Meta-meta-analyses on the overall effect of database and language 
restriction 
Figures 2-5 show the meta-meta-analysis forest plots of our four analyses. Per review 
the effect size is plotted as ΔSMD with a CI of 99%. 
Figure 2 shows the first subgroup analysis (PubMed; Y/N). Overall and the majority of 
reviews (seven) show no effect of database selection for PubMed.  For three reviews, 
the overall effect size of studies retrievable from PubMed was significantly lower than 
that of other studies. The summary ΔSMD of the ten reviews was -0.59 (99%, CI -1.24 
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to 0.07), and heterogeneity in this analysis was high (I2 = 82%), indicating that the 
effect of restriction to PubMed is variable.
Figure 3 shows the second subgroup analysis (Embase; Y/N). Overall and the majority 
of reviews (seven) show no effect of database selection for Embase.  For three reviews, 
the overall effect size of studies retrievable from Embase was significantly lower than 
that of other studies. The summary ΔSMD of the ten reviews was -0.78 (99%, CI -1.81 
to 0.25), and heterogeneity in this analysis was high (I2 = 88%), indicating that the 
effect of restriction to Embase is variable.
Figure 4 shows the third subgroup analysis (PubMed or Embase Y/N). Overall and the 
majority of reviews (four) show no effect of search restriction to PubMed or Embase. 
For two reviews, the overall effect size of studies retrieved from PubMed or Embase 
was significantly lower than that of studies from other sources. The summary ΔSMD of 
the six reviews was -0.45 (99%, CI -0.99 to 0.10), and heterogeneity in this analysis was 
moderate (I2 = 50%), indicating that the effect of restriction to PubMed and Embase is 
less variable between reviews.
Figure 5 shows the fourth subgroup analysis (English Y/N). The majority of reviews 
(six) show no effect for language restriction.  For two reviews, the overall effect size of 
English studies was higher than of non-English studies. The summary ΔSMD of the 
eight reviews was -0.68 (99%, CI -2.29 to 0.94), and heterogeneity in this analysis was 
high (I2 = 96%), indicating that the effect of language restriction is variable.
Discussion
The aim of this study was to investigate to what extent database selection and language 
restriction in the search strategy of systematic reviews of animal studies may affect the 
outcome of the meta-analysis. We assessed the effect of these restrictions on between 
study variation (heterogeneity) and overall effect size per review. 
Our results show that on average an effect of database choice or language restriction 
on the outcome of the meta-analysis could neither be demonstrated nor refuted. 
However, heterogeneity was present, indicating that the results are dependent on 
characteristics of a specific review. 
This indicates that the research area of the review might be an important factor. In two 
reviews on stem-cell research, restricting the search to either pubmed or Embase resulted 
in considerably smaller effect sizes. A second potential factor might be study quality 
(impact of bias), for example it is possible that the quality of studies found in PubMed differ 
from studies found in Embase. However, study quality was beyond the scope of this study, 
but could be interesting to take into account in future methodology research .
Some potential limitations should be discussed. Firstly, we used reviews available in 
the CAMARADES database, of which most are focused on a neurology related topic. 
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The extent to which database selection or language restriction affects the outcome of 
a systematic review may be different in other research areas.
Secondly, we focused on the effect on meta-analysis, but a systematic review is more 
than a meta-analysis alone. By applying any search restrictions, potentially relevant 
evidence can be missed. Even though search restrictions might not always influence 
the results of a meta-analysis, they might jeopardize the purpose of a systematic 
review, namely to provide a complete and objective overview of all available evidence. 
Additionally, we have only included reviews that had a minimum of 25 primary studies 
in the primary meta-analysis, thus relatively large reviews in terms of animal studies. 
A previous study showed that a minority (36%) of the reviews include >25 primary 
animal studies [1]. 
A third limitation is the potential discrepancy between our retrievability analysis and the 
search strategy used in the original reviews. For our analyses we checked the availability 
of included studies in PubMed, Embase and Web of Science (WoS), irrespective of the 
search strategy and databases that were searched in the original reviews. In other 
words, we did not take the effectiveness of the search strategy that was used in the 
original reviews into account. Therefore there might be a discrepancy between the 
retrievability of a study in a database in our analysis and the original review. Use of 
multiple databases in a search strategy of a systematic review is a way of increasing 
chances to retrieve relevant studies [10]. Additionally five reviews originally did not 
search WoS, but we did check the retrievability of the included studies in WoS. In theory 
it is possible that if WoS had been searched with an appropriate strategy, additional 
relevant studies could have been found in this database. For this reason we did not 
perform specific WoS analysis and instead only provided descriptive data in Table 1.  
Fourthly, retrievability of studies per database can be differ depending on the interface 
used or the subscription type the institution has. To update or re-use a search strategy 
of a systematic review, it is important that this information is reported [10]. 
An effect of database choice and language restriction in the search strategy of 
systematic reviews of animal studies on the primary meta-analysis could neither be 
demonstrated nor refuted. Even though the effect on the meta-analysis is inconclusive, 
it has been shown that  database choice and language restriction can result in missing 
relevant studies which can compromise the completeness of the systematic review 
itself. We therefore suggest a similar strategy for systematic reviews of animal studies 
as for clinical systematic reviews; to increase search accuracy by searching a range of 
databases even though the content of various databases may overlap to a great extent 
[4, 5]. However due to the large overlap between PubMed and Embase, searching 
both of these databases might be considered a waste of time and resources. A more 
fruitful strategy could be to search Embase or PubMed and one or two additional 
databases (e.g. Web of Science or Scopus) whether or not in combination with a hand 
search (e.g. reference lists or relevant conference proceedings). For further fine-tuning 
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of guidelines for the search strategy of systematic reviews of animal studies, it could 
be useful to 1) assess the effect of database choice and language restriction in a wider 
range of high quality systematic reviews of animal studies (in multiple research areas), 
and 2) assess if there is a relationship between study quality and database or language 
they are in. Unfortunately, data and sufficient details to perform such analysis on a larger 
scale are not yet available. Nonetheless, the conduct and publication of systematic 
reviews of animal studies is gradually increasing. Adequate reporting of these reviews 
will enable better methodological research for this developing field. Initiatives such 
as reporting guidelines for primary studies (e.g. the ARRIVE guidelines), reporting 
guidelines for systematic reviews of animal studies (akin to the PRISMA guidelines for 
clinical reviews), publication of review protocols (in the near future in Prospero) and 
adequate education and training  on these matters are therefore of great value.
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Background
Quality, reproducibility, reporting and translatability of animal studies have increasingly 
become topics of debate over the last 5-10 years [1-3]. The aim of this thesis was 
to contribute to responsible use of animals in research by studying strategies to 
improve scientific quality and animal welfare in animal-based research. First the use 
and implementation of the so-called 3Rs (of Replacement, Reduction and Refinement 
[4]) in the Netherlands were evaluated. Effective strategies to optimally implement 
the 3Rs appeared to be lacking, which hampers responsible animal use in research. 
A new strategy was introduced, namely systematic reviews of animal studies. This 
methodology may provide new ways of further improving scientific quality, reducing 
wasteful research, and evaluating the translational value of animal research [5, 6]. 
This final chapter puts the main findings of this thesis in the context of the major 
developments in the field of laboratory animal sciences related to the 3Rs and 
systematic reviews in the recent years. The final part of the discussion contains 
recommendations on how the systematic review methodology can contribute to 
responsible use of animals in research.
Background of the 3R principles
The 3R principles were introduced by Russell and Burch in 1959 and became well 
known in the laboratory animal sciences in the 70’s. The 3Rs stand for Replacement, 
Reduction and Refinement and are defined as follows [7]:
- Replace: avoid or replace the use of (living) animals wherever possible, 
-  Reduce: employ strategies that will result in fewer animals being used and which 
are consistent with sound experimental design
-  Refine: modify husbandry or experimental procedures to minimize pain and 
distress. Later this definition was expanded to also encompass the improvement 
of welfare (e.g. by providing enrichment).
Over the years, the 3Rs have been incorporated in the legislation on animal 
experimentation of many countries, including the Netherlands. The first Dutch legislation 
on animal experimentation dates back from 1977, its most recent update was in 2014. 
In the EU, the Directive 86/609 on animal experimentation was first accepted in 1986 
and updated in 2010 (2010/63/EU). In Directive 2010/63/EU the 3Rs are an important 
basic principle to obtain scientifically and ethically justifiable animal experiments. 
3R practice in the Netherlands
A survey held in 2009 among animal researchers in Nijmegen (the Netherlands) 
identified a gap between legal requirements regarding the 3Rs and the lack of practical 
guidelines on how to implement them [8]. One of the main outcomes of this survey 
was that researchers expressed to have difficulties in searching for -and thus optimal 
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implementation of- available and relevant 3R possibilities. This led to the establishment 
of the 3R Research Centre (3RRC) at the animal facility of the Radboud university 
medical center (Radboudumc), funded by the license holder. The 3RRC was a service 
centre conducting specific 3R literature searches for researchers . The assistance 
by the centre was highly appreciated, as 3R information is scattered over more than 
100 websites and databases, which often require different approaches for an efficient 
search. After 2 years, funding by the license holder was discontinued and researchers 
had to cover the service costs themselves. Even though researchers were satisfied with 
this service, funding seemed to be an issue. As a result, requests for help stagnated 
quickly and eventually came to a halt.
It was hypothesised that the situation in Nijmegen was not unique and that potentially 
more animal-based researchers struggled with 3R search and implementation. 
To gain better insights into how the 3Rs were implemented on a national level, the 
3RRC conducted a national survey among researchers, animal welfare officers and 
animal ethics committee members in the Netherlands to assess their opinion and 
practice regarding 3R implementation. Questionnaires were developed and sent out 
to recipients affiliated with academia, industry and non-governmental organisations 
(NGO’s). The results of these surveys were in line with the previous findings of the 
local survey [8] and of surveys from other countries including Denmark and Canada 
[9, 10]. The findings suggest that there is much room for improvement. For example, 
it is indicated that many potential 3R possibilities are missed as knowledge and skills 
to effectively search them are lacking. Instead, information on 3R methods is generally 
obtained via personal communication, mostly with local professionals (e.g. animal care 
staff, animal welfare officer and other researchers within their own organisation). This 
impairs optimal implementation, as latest developments can easily be missed. Another 
interesting finding was that some respondents find it difficult to address the 3Rs as a 
single concept, as the implementation of a Replacement alternative requires a different 
strategy (e.g. in development and in validation and regulation requirements) compared 
to applying Reduction and Refinement possibilities in a planned animal experiment 
[11, 12]. Apparently, available 3R possibilities are not always optimally searched for 
nor implemented. This is jeopardizing the realisation of their aim, namely increasing 
scientific quality and animal welfare in animal-based research. So the question remains, 
how can responsible use of animals be achieved?
In 2010, a follow-up meeting was organised with the survey respondents to 
explore possibilities to improve animal-based research, with a primary focus on 3R 
implementation. It was the first time in the Netherlands that researchers, animal welfare 
officers and animal ethic committee members from academia, industry and NGO’s 
came together to discuss issues regarding 3R implementation. The main outcomes of 
discussions indicated that there is not one single solution and that other strategies are 
needed to improve animal-based research besides the 3Rs. Main issues that occurred 
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repeatedly during the plenary discussions were: the need for more transparency within 
animal-based research, including sharing of (negative) data and knowledge, as well 
as awareness of good experimental practice and the need for more education in this 
respect [13]. These issues indicates that –besides 3R implementation- additional 
strategies are needed to further improve animal-based research and thereby ensure 
responsible animal use. Systematic reviews of animal studies can be a valuable 
addition, as will be further discussed in the following section.
Systematic reviews of animal studies
A systematic review is a comprehensive and reproducible method to summarize 
and synthesize available evidence regarding a specific question. The methodology 
plays a key role in clinical research in creating transparency regarding the available 
body of evidence, including providing indications of potentially unpublished (neutral/
negative) data (publication bias). The methodology also provides transparency 
regarding methodological quality, which has led to awareness of these issues and 
has provided leads for improvement [14]. In clinical research, systematic reviews have 
been performed for over 20 years and are considered the highest level of evidence 
in the chain of evidence-based medicine [14]. Besides medical research, systematic 
reviews are conducted in a number of other research areas including social sciences, 
economics and environmental sciences. 
Even though the conduct and publication of systematic reviews of animal studies have 
gradually increased in the last decade, the numbers are still extremely low compared 
to clinical systematic reviews. This is surprising as preclinical animal studies form the 
basis for clinical trials. Systematic reviews and meta-analyses of animal studies that 
have been published in the past decade have provided structured overviews and new 
insights in a variety of research areas. They provide valuable insights in the scientific 
quality of animal studies and useful information for the experimental design of future 
research, including 3R information. De Vries et al. [15] used the systematic review 
methodology to summarize tissue-engineered constructs that have the potential to 
be a Replacement for animal use in toxicological testing, drug screening and basic 
physiology. A systematic review by Sena et al. presents a cumulative meta-analysis on 
the effect of tPA on infarct volume in stroke, containing data from 3388 animals from 
studies published between 1989 and 2008 [16]. A stable effect could already have been 
found around 2001 based on data of ‘only’ ~1500 animals. Cumulative meta-analysis 
could therefore be a valuable tool summarizing and evaluating available evidence and 
thus avoiding unnecessary duplication of animal experiments (Reduction). A more 
evidence-based choice of animal models can also help in reducing animal studies with 
less suitable animal models. A systematic review by Sloff et al. provided an overview 
of tissue engineering animal models for urinary diversion and showed that data of 
larger animal models (e.g., pigs/dogs instead of rats/rabbits) appeared to translate 
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better to humans [17]. De Vries et al. [18] summarized animal models used in articular 
cartilage tissue engineering in a systematic review and provided evidence-based 
recommendations on how to reduce the number of animals used based on limitations 
and predictive value for each model. A systematic review by Kleikers et al. revealed 
that most NOX2 studies in stroke were insufficiently powered [19]. Focussing purely 
on Reduction of use of animals -without taking statistical principles into account- can 
lead to underpowered studies. Studies with insufficient power are prone to incorrect 
interpretation, which can contribute to a waste of animals and resources. Many 
systematic reviews of animal studies have revealed shortcomings in the experimental 
design and/or reporting of animal studies and valuable recommendations for future 
(pre-)clinical research have been based on these findings [20-22]. The authors of a 
systematic review on animal studies in intestinal anastomosis research concluded that 
the quality and reporting of animal studies in this field is currently so poor that it is 
impossible to infer any valid conclusions from them [23].
The issue of poor experimental design and reporting of preclinical animal studies 
is observed repeatedly in systematic reviews of animal studies [16, 17, 20-25]. In 
recent years, various reporting guidelines have been developed with the aim to 
improve reporting of animal studies [26-28]. These developments are similar to the 
clinical situation, where systematic reviews contributed to the exposure of inadequate 
reporting of randomized controlled trials (RCTs), which in turn fuelled the development 
of reporting guidelines such as the CONSORT statement and improved adequate 
reporting of RCTs [29]. The most well-known reporting guideline for animal studies is 
the ARRIVE guideline, which by 2014 was already incorporated in the instructions to 
authors by more than 400 journals. Unfortunately, at that time this guideline had not yet 
led to major improvements in reporting quality of animal studies [30]. By conducting 
more systematic reviews of animal studies in a variety of research areas, we gain better 
insights in the magnitude of the issue of poor reporting/methodological quality, which 
is expected to support better use and endorsement of these reporting guidelines.
Milestones in systematic reviews of animal studies
To our knowledge, the first systematic review of animal studies was conducted in 
2001 by Horn et al. [31]. Since then the number of published systematic reviews 
and meta-analyses has gradually increased [24, 32]. In 2006, CAMARADES began 
as the “Collaborative Approach to Meta-Analysis and Review of Animal Data from 
Experimental Stroke” for investigators interested in the translational failures in the field 
of stroke. Over time the ‘S’ of stroke was replaced by the ‘S’ of studies, indicating a 
broader implementation and development of the systematic review and meta-analysis 
methodology [33]. During the FELASA/Scand-Las meeting in 2010 in Helsinki, Prof. 
Dr. Scholten, director of the Dutch Cochrane Centre, addressed the Laboratory animal 
science community by saying: “Do like us. Just start performing systematic reviews 
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and learn as you go”. During the 1st international symposium on systematic reviews of 
animal studies in Nijmegen in 2012, the 3R Research Centre officially changed its focus 
from the 3Rs to systematic reviews and launched their new name: SYRCLE. Since then 
SYRCLE has mainly focused on the development of tools and training programmes 
for the conduct of systematic reviews of animal studies [34]. During the 8th World 
Congress on Alternatives and Animal use in the Life Sciences (WC8) in Montréal, 
Canada, the “Montréal Declaration on the Synthesis of Evidence to Advance the 3Rs 
principles in Science” was adopted [35]. This declaration called for a change in the 
culture of planning, conducting, reporting and reviewing animal studies by improving 
synthesis of available evidence, for example by conducting systematic reviews. 
Internationally, many initiatives have embraced the systematic review methodology for 
animal-based research, for example the NC3Rs, SABRE (a patient driven initiative for 
improved translation), Evidence-based Research Network, Evidence-Based Toxicology 
Collaboration, Evidence Synthesis International, the European Food Safety Authority, 
the National Toxicology Program/OHAT, the Environmental Protection Agency (EPA), 
AUGUST (Aarhus University Group for Understanding Systematic reviews and meta-
analyses in Translational Preclinical Science), evidence-based veterinary sciences 
and many more. Also the Cochrane Collaboration gradually starts to evaluate and 
incorporate evidence of pre-clinical animal studies. For the first time in history, a 
special session on the synergy of systematic reviews of animal and clinical studies was 
organised by SYRCLE during the Cochrane colloquium in 2013 in Quebec Canada, 
which resulted in an editorial in the Cochrane Database[36].
In the Netherlands, the parliament accepted two motions on the topic. The first 
motion, “Make systematic reviews the norm in animal-based research, similar to 
clinical research”, was accepted in 2012. This motion has led to funding of a research 
programme by the government on the  development of guidelines [34], open access 
publication of negative/neutral results [37], SR training programs for professionals 
[37] and implementation research among stakeholders [38]. ZonMw (The Netherlands 
Organisation for Health Research and Development) was the first funding body to 
provide funding specifically for the conduct (methodology development, training 
and coaching) of systematic reviews of animal studies. This funding programme 
was part of their “More knowledge with fewer animals”-programme. A programme 
dedicated to stimulate the increase of scientific knowledge while simultaneously 
stimulating a reduction in the number of animals used [39]. The second motion that 
was passed urged to “make education on systematic reviews an obligatory part of the 
Dutch laboratory animal science courses (EU/2010/63 art.23.2.b)”. This motion was 
accepted in 2013 and has led to the development of an e-learning module (funded 
by the Dutch Ministry of Economic affairs), which was officially launched in October 
2015 by EU commissioner Susanna Louhimies [40]. A recent report published by 
a Dutch think tank on animal-free innovations acknowledges the systematic review 
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methodology as an innovative method to generate new knowledge without using new 
animal experiments [41].
Challenges and recommendations 
The aim of this thesis was to investigate ways to improve scientific quality and responsible 
use of animals in research, with an initial focus on optimal 3R-implementation. It was 
demonstrated that optimal practices on 3R-search and implementation are currently 
lacking and it was suggested that additional strategies are needed to ensure high 
quality research and responsible use of animals. Systematic reviews have shown to be 
a powerful strategy to promote responsible use of animals by providing new evidence-
based input for future research, including relevant 3R information. The final part of this 
chapter will provide recommendations on how the systematic review methodology can 
contribute to improved animal-based research and more translational transparency.
1.  Increase the numbers of systematic reviews in a variety of animal-based 
research areas
  Why  First of all, systematic reviews have a great potential to be of high 
scientific value for animal-based research fields (e.g. medicine, toxicology, 
environmental science and veterinary science) as they provide transparent 
overviews of the available evidence. By reanalysing existing data, new 
insights can be gained without performing new animal studies. Already 
published reviews have showed that the following insights can be gained: 
(1) a more evidence-based choice of animal models, (2) insights in efficacy 
and safety of new therapies from animal studies before planning clinical 
trials, and (3) identification of relevant factors for possible mechanisms 
of disease and therapies. Additionally, gained insights can be used to 
determine ‘if’ and ‘how’ future research should be setup. Secondly, by 
increasing the number of published systematic reviews of animal studies, 
more evidence will be generated to inform best-practices for conducting 
these reviews. This can promote both methodology development and 
efficiency in the conduct of systematic reviews.
  How  Simply by just keep doing it. The research groups SYRCLE and CAMARADES 
started performing systematic reviews of preclinical animal studies, which 
have led to various high-impact papers. Additionally, both groups have 
been very successful in the development of tools and guidelines for the 
systematic review methodology for animal studies. Other research areas 
could follow-up on this by developing systematic review tools tailored 
to their line of research. It is highly recommended to establish research 
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groups specifically devoted to the conduct of systematic reviews including 
methodology development and training programmes (similar to SYRCLE, 
CAMARADES, EBTOX and AUGUST) to speed-up progress worldwide. 
SYRCLE has initiated a worldwide ambassador network, aiming at 
appointing individuals that stimulate teaching and research on systematic 
review in their home countries and institutes.
2. Stimulate better reporting of animal studies.
 Why  Use of animals in research is often justified by their proclaimed scientific 
value. The aim of most preclinical animal studies is to provide useful insights 
for human medicine (e.g. disease development or intervention efficacy). 
It has been argued, however, that the majority of animal studies do not 
translate well to the human situation. In order to identify factors crucial for 
maximising the translational value of animal data, the circumstances under 
which these data were obtained need to be fully transparent. This requires 
the reporting of various details of animal studies regarding study design, 
characteristics and quality measures. Reporting guidelines for animal 
studies such as the ARRIVE guideline can therefore be of great value. Even 
though, the ARRIVE is currently endorsed by more than 600 journals, it 
seems that many authors, reviewers and editors still don’t use them. 
 How  Firstly, more journals should endorse reporting guidelines for animal studies, 
and additionally provide guidance for their peer reviewers. The NC3Rs 
recently published a checklist of the ARRIVE guideline, which can help to 
ease the process for the authors, reviewers and editors. Secondly, adequate 
reporting of animal studies should be part of the training for all researchers 
directly or indirectly involved in animal based-research. Ideally, they should 
be discussed as early as in the bachelor training of future scientists and 
not only in the obligatory laboratory animal sciences course. And thirdly, as 
mentioned under recommendation 1, systematic reviews of animal studies 
can help to gain insight into the magnitude of the issue and create awareness 
for the value of these guidelines and the need for using them. 
3.   Perform a comprehensive search for relevant evidence before designing a 
new animal study.
 Why  A full systematic review is not always feasible and certainly not for each 
new animal experiment. Nevertheless, the first steps of the systematic 
review methodology can always be used to accumulate available relevant 
literature in a structured and comprehensive way. A comprehensive search 
can increase transparency and help reduce the introduction of bias in the 
search process. Objective literature overviews can be used to informing 
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new animal studies, including 3R information. Unfortunately, knowledge on 
how to build a comprehensive search is often lacking. 
 How  A comprehensive search can be performed in one or more online databases 
(e.g. PubMed). Strategies to build a comprehensive search often vary 
between databases, therefore it is highly recommended to make use of 
online tutorials, follow training in comprehensive search techniques, use 
available search filters and/or consult an information specialist. Research 
authorities such as animal ethics committees, animal welfare bodies, 
senior research staff and funding bodies can stimulate this evidence-based 
approach by asking for more details on how evidence was searched and 
selected before approving new animal-based studies. For example, in case 
in the application for a new animal study it is stated that no 3R methods are 
available, the researcher should provide more details on the search process 
(search terms, databases used etc.). And, if necessary, the search strategy 
can be assessed by an information specialist regarding sensitivity and 
specificity (meaning if adequate measures were taken to increase retrieval 
of relevant papers and decrease retrieval of irrelevant papers, respectively). 
4.  Provide and endorse training in comprehensive searching and systematic 
reviews of animal studies.
 Why  The previous recommendations and paragraphs describe the added value 
of (aspects of) systematic reviews of animal studies. However, skills and 
knowledge to use these methodologies often appears to be insufficient 
or lacking. This expresses the need for suitable training programs in both 
comprehensive search techniques and the systematic review methodology. 
 How  To maximize output of systematic reviews and their potential contribution 
to improving animal-based research, it is highly recommended  to provide 
training to all directly or indirectly involved in animal-based research. 
However, some only need to become familiar with the principles of the 
methodology, whereas others need to be able to conduct the full process. 
Institutes involved in animal-based research could provide training to their 
staff on comprehensive searching techniques to promote evidence-based 
experimental design. These programmes could then be tailored to the 
databases and software used at that institute to increase efficiency. Also 
students (bachelor, master and PhD) should be taught and examined on 
their search skills throughout the course of their training. To further promote 
evidence-based design, training in systematic reviews could be provided. 
This is expected to contribute to a major extent to a more responsible use 
of animals in research as described under recommendations 1 and 2. 
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In conclusion
Various examples of systematic reviews and meta-analyses of animal studies have 
shown that the basic principles of clinical systematic reviews methodology can be 
translated to preclinical animal research. Systematic reviews and meta-analyses of 
animal studies can be used to provide an overview of available evidence, reduce 
unnecessary duplications of animal studies, provide new insights, identify knowledge 
gaps, provide useful information for new (pre)clinical research (including 3R information), 
and last but not least provide transparency in quality, validity and predictive value of 
animal studies for humans.
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ENGLISH SUMMARY
English Summary
Everyone will agree that the use of animals in research is controversial. Balancing “if”, 
“when” and “how” animals should be used is a continued topic of debate. The aim of 
this thesis is to inform this debate by  evaluating strategies to improve scientific quality 
and responsible use of animals in research. Chapter one introduces the two evaluated 
strategies namely; 1) the in laboratory animal sciences well established 3R-principles 
of Replacement, Reduction and Refinement of animal research and 2) an upcoming 
methodology in animal-based research, namely systematic reviews of animal studies, as a 
new strategy to improve animal-based research.
To gain insights into the current state of affairs regarding the 3R-implementation in the 
Netherlands, surveys were sent out to three main profession groups namely: scientists 
involved in animal-based research, animal welfare officers and animal ethic committee 
members. The surveys covered four main topics: 1) view on the 3R-principles, 2) information 
sources and search strategies, 3) implementation strategies in daily practice and 4) needs 
for future improvement. Each profession group received an adapted survey with questions 
relevant to their professional tasks and responsibilities. Chapter two describes the outcomes 
of the survey among scientists and Chapter three the outcomes of the surveys among 
animal welfare officers and animal ethics committee members. Respondents represented 
a variety of research disciplines affiliated with different institutional backgrounds. The 3Rs 
are very well known and perceived as an important concept by respondents of all the three 
profession groups. Nevertheless, skills and resources to adequately search for relevant 3R 
information are often lacking, resulting in missing and thus not implementing 3R methods in 
research. Additionally, various respondents expressed to have difficulties with addressing 
the 3R-principles as one concept as implementation of a replacement alternative requires 
a different strategy than Reduction and Refinement.
The answers to part 4 of the survey ‘needs for future improvement’ were discussed in 
more detail during a one day workshop with respondents representing all three profession 
groups. Chapter four describes the six consensus statements that were formulated 
during the workshop as suggestions for improved animal-based research. Regarding the 
3R-principles it was suggested to split the 3Rs in two concepts namely as Replacement 
and best practices (Reduction & Refinement). For optimal implementation of replacement 
alternatives it was suggested that all stakeholders (including legislators and funding bodies) 
should be involved in the development process. Other consensus statements covered 
issues such as experimental design, data sharing, transparency and collaboration. The 
diversity and complexity of issues raised during the workshop suggest that besides the 
well established 3R-principles, other strategies are needed to further improve animal-
based research and ensure responsible use of animals.  
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As introduced in Chapter one, systematic reviews of animal studies might be a powerful 
method to promote responsible use of animals in research, especially because they 
can be used to address some of the issues raised in Chapter four such as: sharing 
of (neutral/negative) data and awareness for optimal experimental study design. 
Nevertheless, systematic reviews of animal studies are a relatively new concept. 
Numbers of published systematic reviews are rapidly increasing, but still low compared 
to clinical systematic reviews of human trials. Despite the fact that many safety and 
efficacy animal studies need to be done for protecting humans.
Chapter five shows an example of such a systematic review of animal studies. The 
aim of this review was to systematically appraise and summarize all available evidence 
on the effect of meniscus allograft transplantation on articular cartilage in animals. 
By providing an overview of the available animal studies, the authors concluded that 
meniscus allograft transplantation does not protect articular cartilage from damage, 
but it reduces the extent of it when compared with meniscectomy. The consistent 
results across species and models might be an indication that a comparable treatment 
of the human knee joint will show similar results. The systematic review also exposed 
the reporting and methodological quality of the included animal studies. Crucial 
information was often not reported, which hampered the evaluation of study quality 
and limiting the ability to draw reliable conclusions. Unfortunately, other systematic 
reviews of animal studies in a variety of research areas show similar concerns when it 
comes to reporting and methodological quality of primary animal studies.     
The step of quality assessment of primary studies in the systematic review methodology 
is very valuable to expose and monitor quality and thus validity of animal studies. 
However as there are no clear guidelines on how systematic reviews of animal studies 
should be conducted, the quality assessment can differ per review. Chapter six 
describes a study in which 91 systematic reviews of animal studies were assessed 
on the used quality assessment. Additionally, the overall quality of the primary studies 
included in these reviews was assessed. Just a little over half (52.7%) of the reviews 
assessed the primary studies on selection bias, performance bias, detection bias 
or attrition bias. Thirty-three systematic reviews provided sufficient information to 
evaluate the internal validity of the included studies. Of the evaluated primary studies, 
24.6% was randomized, 14.6% reported blinding of the investigator/caretaker, 23.9% 
blinded the outcome assessment, and 23.1% reported drop-outs. This indicates that 
there is much room for improved reporting and/or methodological quality of primary 
studies and need for training and guidelines on the conducts of systematic reviews 
of animal studies.
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Perhaps the most vital but also the most time consuming step of the systematic 
review methodology is the search for and screening of papers. There is uncertainty 
surrounding the added value of using multiple bibliographic databases to identify 
studies and whether there is an impact of language restrictions in their selection. 
Chapter seven investigates to what extent database selection and language restriction 
in the search strategy of systematic reviews of animal studies affect the outcome of the 
meta-analysis. There appears to be a large overlap between PubMed and Embase in 
retrievability of studies included in the reviews (>85% overlap in 2/3 of the evaluated 
reviews). Restricting a search to either PubMed or Embase resulted in missing up to 
20% and 4% unique studies respectively. Restricting study retrieval to English studies 
only, could result in missing up to 13% relevant studies. An effect of these missed 
studies (both due to database selection or language restriction) on the meta-analysis 
could be demonstrated nor refuted. Restriction of a search to a single database or 
to studies published in English can lead to missing relevant studies for systematic 
reviews of animal studies and may affect the outcome of meta-analyses. Although how 
the meta-analysis of the review would have been affected if these studies had been 
missed, differs per review. Potential strategies and recommendations on how the issue 
of database selection and language restriction in systematic reviews of animal studies 
can be addressed, are discussed in more detail in this chapter.
The concluding Chapter eight summarises the main outcomes of this thesis and 
describes some key developments in the field of systematic reviews of animal studies. 
The chapter concludes with four recommendations related to the question: How 
can systematic reviews of animal studies contribute to improved scientific quality of 
animal studies; 1) Increase the numbers of systematic reviews in a variety of animal 
based-research areas. 2) Stimulate better reporting of animal studies. 3) Perform a 
comprehensive search for relevant evidence before designing a new animal study. And 
4) Provide and endorse training in comprehensive searching and systematic reviews 
of animal studies.
Use of animals in research is justified by their translational value, however true 
translational value of animal models can only be assessed when animals are used 
responsibly and animal studies comply to the highest standards for animal welfare 
and scientific quality. Insights from systematic reviews of animal studies have shown 
that this type of assessment is currently not optimally feasible. By providing education 
in better reporting, literature search and  systematic reviews, this will lead to quality 
improvements in preclinical science, thereby contributing to the implementation of the 
3Rs and improved patient health care.
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Nederlandse Samenvatting
Iedereen zal het erover eens dat het gebruik van dieren in (bio)medisch onderzoek 
controversieel is. Het balanceren tussen “of”, “wanneer” en “hoe” dieren gebruikt 
mogen worden, blijft onderwerp van discussie. Het doel van dit proefschrift is om een 
bijdrage te leveren aan dit debat. In dit proefschrift zijn twee strategieën geëvalueerd 
die ingezet kunnen worden om de wetenschappelijke kwaliteit van dieronderzoek te 
verbeteren en daarmee verantwoord proefdiergebruik te bewerkstelligen. Hoofdstuk 
een introduceert de twee geëvalueerde strategieën; als eerste het 3V-principe van 
Vervanging, Vermindering en Verfijning. Dit 3V-principe vormt sinds de jaren-70 de 
hoeksteen van de proefdierkunde. De tweede strategie is  een opkomende methode 
binnen de proefdierkunde, namelijk systematic reviews van dierstudies.
Om het effect van het 3V-principe te evalueren is begonnen met het verkrijgen van 
inzicht in 3V-implementatie in Nederland. Hiervoor zijn enquêtes uitgestuurd naar 
drie beroepsgroep: onderzoekers die betrokken zijn bij diergebonden onderzoek, 
proefdierdeskundigen en leden van dierexperimentencommissies (DEC). De 
enquêtes omvatte vier hoofdthema’s: 1) perceptie van de 3V-principes, 2) 3V 
informatiebronnen en zoekstrategieën, 3) implementatie strategieën in de dagelijkse 
praktijk en 4) wensen voor toekomstige verbeteringen. Iedere beroepsgroep ontving 
een aangepaste enquête met specifieke vragen gerelateerd aan hun professionele 
taken en verantwoordelijkheden. Hoofdstuk twee beschrijft de resultaten van de 
enquête onder onderzoekers en Hoofdstuk drie de resultaten van de enquêtes 
onder de proefdierdeskundigen en DEC-leden. De respondenten vertegenwoordigen 
een verscheidenheid aan onderzoeksdisciplines binnen zowel universiteiten als ook 
de (biomedische) industrie. Uit de enquêtes onder alle drie de groepen bleek dat de 
3V’s zeer goed bekend zijn en ook gezien worden als een relevant concept binnen 
proefdiergebonden onderzoek. Vaardigheden en middelen om op adequate wijze te 
zoeken naar relevante 3V-informatie ontbreken vaak, wat resulteert in het missen en 
dus niet toepassen van relevante 3V- methoden in onderzoek.
De antwoorden op deel 4 van het enquêtes (wensen voor toekomstige verbetering) zijn 
gebruikt als startpunt tijdens een verdiepende eendaagse workshop met respondenten 
van alle drie de enquêtes. Hoofdstuk vier beschrijft de zes consensus statements 
die tijdens de workshop als suggesties voor verbetering van diergebonden onderzoek 
zijn geformuleerd. Ten aanzien van de 3V-principes werd voorgesteld om de 3V’s te 
splitsen in twee begrippen namelijk in “Vervanging” en “best practices” (Vermindering 
& Verfijning). Voor een optimale ontwikkeling van vervangingsalternatieven werd 
gesuggereerd dat alle belanghebbenden (inclusief wetgevers en financierders) betrokken 
dienen te worden bij het ontwikkelingsproces. De overige consensusstatements 
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omvatte onder andere belang van goed experimenteel ontwerp, het delen van data 
(inclusief negatieve en neutrale data), en meer transparantie en samenwerking. De 
diversiteit en complexiteit van de geopperde wensen ten aanzien van verbetering van 
proefdiergebonden onderzoek laat zien dat naast de 3V-principes andere strategieën 
nodig zijn om verantwoord diergebruik binnen onderzoek te kunnen waarborgen.
Zoals reeds geïntroduceerd in hoofdstuk een, zouden systematic reviews van 
dierstudies een krachtige methode kunnen zijn om verantwoord diergebruik in 
onderzoek te bevorderen. Vooral ook omdat deze methode ingezet kan worden 
om enkele aandachtspunten zoals beschreven in hoofdstuk vier (bv. het delen van 
data en verantwoord opzetten van nieuwe proefdieronderzoek) aan te pakken. 
Momenteel worden systematic reviews van dierstudies slechts nog incidenteel en niet 
gestandaardiseerd uitgevoerd.  Het aantallen gepubliceerde systematic reviews van 
dierstudies groeit snel, maar is nog steeds relatief laag in vergelijking met systematic 
reviews van humane studies. In de volgende hoofdstukken zal verder op de systematic 
review methodologie voor dierstudies.
Hoofdstuk vijf is een voorbeeld van een systematic review van dierstudies. Het 
doel van dit onderzoek was om op systematische wijze alle beschikbare gegevens te 
zoeken, selecteren en beoordelen op kwaliteit en samen te vatten voor de specifieke 
onderzoeksvraag: “What is the effect of meniscus allograft transplantation on articular 
cartilage in animals?” Door het maken van een dergelijk overzicht kon geconcludeerd 
worden dat meniscus transplantatie kraakbeen schade niet voorkomt, maar dat de 
schade wel kan worden verminderd ten opzichte van meniscectomie. De vergelijkbare 
resultaten die gevonden zijn in verschillende diermodellen en diersoorten kunnen een 
indicatie zijn dat een vergelijkbare behandeling van het menselijke kniegewricht ook 
vergelijkbare resultaten zal laten zien. Daarnaast laat de systematic review ook de 
kwaliteit van de methodologische opzet en rapportage van de geïncludeerde studies 
zien. Zo bleek dat cruciale informatie vaak niet was beschreven. Hoordoor kon de kwaliteit 
van de studie niet altijd kon worden geëvalueerd, wat vervolgens de mogelijkheid om 
betrouwbare conclusies te trekken belemmert. Helaas is dit review hierin niet uniek, 
diverse systematic reviews van dierstudies uit verschillende onderzoeksgebieden 
laten een zorgwekkende situatie zien op gebied van methodologische kwaliteit en/of 
rapportage van primaire dierstudies. Kwaliteitsbeoordeling van primaire studies een 
zeer waardevolle stap in het systematic review proces. Niet alleen voor het transparant 
maken van de huidige stand van zaken, maar ook voor het bewaken van veranderingen 
in kwaliteit over de tijd. 
Systematic reviews van dierstudies worden nog niet gestandaardiseerd uitgevoerd, 
dit komt o.a. doordat er nog geen eenduidige richtlijnen bestaan over hoe systematic 
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reviews van dierstudies optimaal kunnen worden uitgevoerd. Hoofdstuk zes 
beschrijft een review van systematic reviews van dierstudies. Hierin zijn 91 systematic 
reviews beoordeeld op het gebruik van een kwaliteitsbeoordeling voor de primaire 
studies. Daarnaast is er ook gekeken naar de kwaliteit van de primaire studies in deze 
91 systematic reviews. Iets meer dan de helft (52,7%) van de reviews beoordeelde 
de primaire studies op genomen maatregelen om de volgende vormen van bias te 
voorkomen: selectie bias, performance bias, detectie bias of attrition bias. Drieëndertig 
systematic reviews rapporteerde gedetailleerde informatie over de kwaliteitsbeoordeling 
per primaire studie, dit leverde het volgende beeld op: 24,6% van de primaire studies was 
gerandomiseerd (selection bias), 14,6% rapporteerde blindering van de onderzoeker 
/ verzorger (performance bias), 23,9% blindering bij het meten van de uitkomstmaat 
(detection bias), en 23,1% rapporteerde drop-outs (attrition bias). Dit geeft aan dat 
er nog veel ruimte voor verbetering is op gebied van methodologische kwaliteit en/of 
de rapportage daarvan. Dat slechts de helft van de reviews een kwaliteitsbeoordeling 
uitgevoerd had, laat zien dat er behoefte is aan richtlijnen en training op het gebied van 
systematic reviews dierstudies.
De misschien wel de meest vitale, maar ook meest tijdrovende stap in het systematic 
review proces is het zoeken naar en screening van artikelen. Door het ontbreken van 
richtlijnen op het gebied van systematic reviews van dierstudies is er onzekerheid over 
de toegevoegde waarde van het doorzoeken van meerdere bibliografische databases 
is. Daarnaast is ook niet bekend wat het effect van taalbeperkingen (bijvoorbeeld door 
alleen studies in de Engelse taal te includeren) is op de uitkomsten van systematic 
reviews van dierstudies. Hoofdstuk zeven beschrijft een studie waarin is gekeken 
in hoeverre database selectie en taal beperking in de zoekstrategie van systematic 
reviews van dierstudies invloed kan hebben op de uitkomst van de meta-analyse. 
Allereerst blijkt er een grote overlap te zijn tussen PubMed en Embase in vindbaarheid 
van de artikelen (> 85% overlap in 2/3 van de reviews). Het beperken van een 
zoekopdracht tot PubMed ofwel Embase resulteerde in het missen van tot 20% en 4% 
relevante artikelen. Het beperken van studie selectie naar alleen Engelstalige artikelen 
zou kunnen leiden tot het missen van 13% relevante studies. Een significant effect van 
deze gemiste studies (zowel van database selectie als van taal restrictie) op de meta-
analyse kon niet worden aangetoond of weerlegd. Beperken van de zoekstrategie naar 
een enkele database of selectie van enkel Engelstalige artikelen kan leiden tot het 
missen van relevante studies wat wel tot een vertekening van de uitkomsten van de 
systematic review kan leiden. De mate van vertekening kan variëren per vakgebied. 
In de discussie van dit hoofdstuk worden enkele strategieën en aanbevelingen 
beschreven over hoe om gegaan kan worden met database selectie en taal beperking 
in systematic reviews van dierproeven.
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Het afsluitende Hoofdstuk acht geeft een overzicht van de belangrijkste resultaten 
van dit proefschrift en beschrijft een aantal belangrijke ontwikkelingen op het gebied 
van systematic reviews van dierproeven binnen de proefdierkunde en daarbuiten. Het 
hoofdstuk wordt afgesloten met vier aanbevelingen met betrekking tot de vraag: Hoe 
kunnen systematic reviews van dierstudies bijdragen aan een betere wetenschappelijke 
kwaliteit van dierproeven; 1) Uitvoeren van meer systematic reviews in verschillende 
dierproef gebonden onderzoeksgebieden . 2) Het stimuleren van een betere 
rapportage van dierproeven. 3) Het uitvoeren van een zogenaamde comprehensive 
search naar relevante literatuur voor het ontwerpen van nieuwe dierstudies. En 4) 
Aanbieden van onderwijsprogramma’s op gebied van systematic reviews dierstudies 
en comprehensive search strategies.
Het gebruik van dieren in wetenschappelijk onderzoek wordt gerechtvaardigd door 
hun translationele waarde. De translationele waarde van diermodellen kan echter 
alleen worden beoordeeld wanneer de dieren op verantwoorde wijze worden ingezet 
in onderzoek en de dierstudies zelf voldoen aan de hoogste normen voor dierenwelzijn 
en wetenschappelijke kwaliteit. Uit inzichten verkregen uit systematic reviews van 
dierstudies blijkt dit in de praktijk binnen diverse onderzoeksgebieden vaak nog lang 
niet het geval te zijn. Het aanbieden van onderwijs in hoe dierstudies op een adequate 
wijze gerapporteerd kunnen worden, het uitvoeren van gedegen literatuuronderzoek en 
de systematic review methodologie, kan bijdrage aan de nodige kwaliteitsverbetering 
van preklinische dieronderzoek. Op deze wijze kan een hoogwaardig en transparante 
basis gelegd voor de ontwikkelen van nieuwe en veilige therapieën voor de patiënt.
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Merel, jij bood mij de kans om binnen jouw onderzoeksgroep (toen nog het 3R 
Research Center) mijn afstudeerstage door te zetten in een promotie project. Ik ben je 
enorm dankbaar voor je vertrouwen in mij en de ruimte die je me hebt gegeven om te 
ontwikkelen, niet alleen als onderzoeker, maar ook als ‘ICT-nerd’ en PR medewerker, 
en vooral ook als docent. Jouw visie op de proefdierkunde en je lef om soms wat 
onconventioneel te handelen om de boel eens flink wakker te schudden, zijn enorm 
inspirerend. Dank dat je promotor wilde zijn.
Gert-Jan, na de project- en voortgangsgesprekken met jou liep ik altijd de deur uit 
met nieuwe inzichten en diep onder de indruk van jouw scherpe analytische vermogen. 
Wanneer ik het overzicht kwijt was, wist jij het grote kader weer te schetsen. Sinds 1 
januari 2017 zijn we met onze onderzoeksgroep SYRCLE officieel onderdeel geworden 
van ‘jouw’ sectie HTA binnen de Department for Health Evidence. Erg leuk om te 
zien hoe er in zo’n korte tijd  al mooie ideeën ontkiemen op gebied van gezamenlijk 
onderzoek en onderwijs. Dank dat je promotor wilde zijn.
Rob, je bent bij dit project betrokken als directeur van het Dutch Cochrane Centre. 
Naast de inhoudelijke uitdagingen, doorzag jij ook de uitdaging in het proces in dit 
project. Waar normaal een promovendus zo’n 2 á 3 begeleiders heeft, had ik er –
omdat het nog zo’n nieuw onderzoeksterrein is- vijf. Zo nu en dan stuurde je me een 
kort opbeurend mailtje, vaak maar met een paar regels. Een hart onder de riem om mij 
en mijn onderzoek weer op de rit te krijgen. Dank dat je promotor wilde zijn.
Marlies, door jou ben ik bij het 3R Research Center terecht gekomen nadat ik een 
lezing van jou hoorde op de Hogeschool van Utrecht. En jij bent ook degene die me 
het laatste zetje gaf om ja te zeggen tegen dit promotie-onderzoek. Op een boot tijdens 
het FELASA symposium in Helsinki deelde je jouw visie dat dit onderzoek wel eens van 
grote waarde voor de proefdierkunde zou kunnen zijn. In de afgelopen 7 jaar is er 
ontzettend veel gebeurd; samen met vele andere inzichten, heeft ons onderzoek ook 
inzicht gegeven in de vaak lage kwaliteit en vertaalbaarheid van dierstudies, het kwam 
zelfs tot Kamervragen en moties in de Tweede Kamer. Gezien de vele (inter)nationale 
verzoeken voor trainingen, lezingen en symposia die we nu als SYRCLE ontvangen 
durf ik wel te concluderen dat je visie van toen een underestimation was van wat het 
uiteindelijk allemaal teweeg heeft gebracht. Ik ben ontzettend trots dat ik daar met dit 
proefschrift aan heb mogen bijdragen. Dank dat je co-promotor wilde zijn.
Bart, via jou heb ik de onderzoeksgroep CAMARADES leren kennen, hetgeen het 
methodologische onderzoek naar de systematic review methodologie van dierstudies 
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in dit proefschrift heeft mogelijk gemaakt. Je ervaringen als pioneer systematic reviewer 
en clinicus waren van grote waarde. Dank dat je co-promotor wilde zijn.
Dear CAMARADES-crew, after the first systematic review of animal studies by 
Janneke Horn in 2001, you were the pioneers who introduced the systematic review and 
meta-analysis methodology to the pre-clinical stroke research field. The CAMARADES 
database is a goldmine for systematic reviews of systematic reviews. Chapter 7 of this 
thesis would not have been possible without it. Thank you all for all the educational, 
inspiring and fun visits to CAMARADES at the University of Edinburgh in Scotland. 
I see a bright future for CAMARADES, SYRCLE and many more other international 
collaborations to come.
Dank aan ZonMw en Stichting Reinier Post voor het gestelde vertrouwen in 
het werk van SYRCLE. Dankzij deze financiële ondersteuning hebben we de 
geleerde lessen uit dit proefschrift kunnen vertalen naar vele nationale training- en 
begeleidingsprogramma’s, waarmee ook een grote impact op onderwijs en onderzoek 
op nationaal en internationaal niveau is bereikt. 
Alice, ‘onze’ informatie specialist bij de medische bibliotheek. Ik heb ontzettend veel 
van je geleerd op het gebied van grondig literatuur zoeken. Samen hebben we ook 
onderwijs voor literatuur zoeken voor systematic reviews doorontwikkeld en ontelbare 
keren gegeven. Heel veel dank voor al je hulp bij dit proefschrift. 
Het grootste deel van mijn promotie heb ik op het CDL (Centraal Dierenlaboratorium) 
doorgebracht. Dank aan alle collega’s daar voor de leuke dagjes-uit, de gezellige 
(on)zinnige gesprekken tijdens de koffiepauzes. Ook dank aan de voormalig CDL 
bedrijfsleider Kees Hagenaar die slechts met een blik kon zeggen: “Judith leg dat ei en 
maak dat boekje nou eens af”. Kees, het is gelukt!
Carlijn en Kim (CH en KW), lieve collega’s, kamergenoten en methodologische 
toppers van het eerste uur! Ik heb met jullie gelachen (lachen, lachen, lachen), gehuild, 
gegeten (o.a. beschuit met muisjes en veel chocola), gedronken, gevlogen, auto 
gereden, gefietst, gezongen, gepubquized en trampoline gesprongen. Later kwam 
ook Cathalijn (CL) erbij, gelukkig ook al zo’n choc-a-holic. Dank meiden voor al jullie 
input, steun en gezelligheid.
Rob (Ropperdepop of RdV) de collega die ik het meest en het langst achter elkaar 
gezien heb door de vele reizen die we samen hebben mogen maken om systematic 
review trainingen te geven. Ik ben super blij dat jij tijdens de verdediging van mijn 
proefschrift als paranimf naast mij staat. Met jouw rust, wijsheid en (Italic Friday) humor 
186
DANKWOORD
heb je me al door vele moeilijke momenten heen gesleept. Als het allemaal achter de 
rug is drink ik er graag een goede Whisky uit jouw collectie op!
Lieve Eef (Eva) het begon eigenlijk na onze studie pas, samen stappen in Utrecht en 
een prachtige  reis naar Japan, een lang gekoesterde droom van mij. Waar ik soms sta 
te twijfelen, pak jij door en daardoor ben je echt een inspiratie voor mij.  Ik ben daarom 
ook super trots en blij dat je tijdens de verdediging naast me staat als paranimf, ik 
weet dat jij me er met je enthousiasme doorheen sleept. Robert, ik mocht naast Eva 
staan als getuige toen jij haar volmondig het ja-woord gaf. Super om te zien hoe jouw 
vriendschap en die van je (de leuke) vrienden werkt als een soort spons, wie in de 
buurt komt wordt vrijwel direct opgenomen. Dank voor jullie grenzeloze gezelligheid in 
Athene, Utrecht, Maartensdijk, Hilversum, Nijmegen, Tilburg en straks ook Soesterberg.
Lieve Jessica en Anne, mijn dierbare vriendinnetjes van heel vroeg. We zijn samen 
opgegroeid, van jonge naïeve meiden naar stoere, zelfstandige ‘jonge’ vrouwen die 
allemaal grote mensen dingen doen zoals huizen kopen, kinderen krijgen en verre 
reizen maken. En nu dus ook een proefschrift schrijven, ik ben blij dat ik ook dit met 
jullie mag delen, op naar de volgende mijlpalen!
Marije, ouwe CDL-er! Het begon allemaal met een BBQ-tje op mijn dakterras na het 
werk, gewoon lekker in chill-broek alsof we elkaar al jaren kenden. Na jaren samen 
eten, sporten, stappen en delen van lief en leed, heb je het gemoedelijke Nijmegen 
verruild voor de stadse-fratsen van Amsterdam. Dank voor je altijd luisterende oor, 
kritische reflecties, heerlijke sarcasme en verhelderende inzichten.
Mieke en Nathalie, mijn twee ‘culturele’ vriendinnetjes uit Nijmegen die ook naar 
Amsterdam vertrokken. We zien elkaar niet zo vaak, maar ik weet dat jullie er (voor mij) 
zijn en dat is een fijne gedachte.
Miranda, nog zo’n oud CDL-er, eentje van het eerste uur. Samen hebben we veel lol 
gehad op het CDL in de Activiteiten Commissie en daarbuiten. Onze vrijdagmiddag 
borrels/diners bij van Buren met Nathalie en later ook Claudia zijn le-gen-da-risch. 
Wat daar allemaal boven de van Buren-Burgers besproken is… Ik zou er nog een 
boekje mee kunnen vullen. Of wie weet misschien toch ooit nog die eigen smartlap op 
de Dag van het Levenslied? 
Dirk, Barbara, Thomas en Janneke (en Jip), jullie zijn bijna als een tweede familie voor 
mij. Dank voor -zoals jullie het zelf noemen- jullie bijdrage aan de wetenschap, in de vorm 
van een wekelijkse warme maaltijd, sporten, wintersport, zeilen, goede gesprekken, 
nerd-talk en onzin. Opa Leo, het boekje is eindelijk af! Familie Beekwilder, dank dat ik 
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regelmatig op jullie heerlijke huis mocht passen. Verschillende delen van dit proefschrift 
zijn aan jullie eettafel geschreven, onder streng toeziend oog van poes Lotje.
Familie van Bavel, ineens was ik daar in het leven van jullie zoon, broer en vader, 
dank voor jullie oprechte interesse en Brabantse gezelligheid. Jack, bedankt dat je op 
de valreep nog even als kritische ‘leek’ hebt meegelezen.
Lieve Erik, ook jij hebt een lange studieweg doorlopen: van VBO heb jij helemaal 
geploeterd naar WO, dat getuigt van ongelofelijk doorzettingsvermogen (net als het 
uitlopen van de 4-daagse trouwens). Jij legde de lat hoog, waar ik als kleine zus 
natuurlijk niet voor onder wilde doen. En dus ploeterde ik ook door met dit boekje als 
resultaat (maar die 4-daagse ga ik echt nooit lopen en al zeker de 50km niet). Dank 
aan jou en Dorine voor jullie steun, goede gesprekken, scherpe vragen, lieve kaartjes 
en natuurlijk het allergrootste plezier: trotse tante zijn van Sylt!
Lieve pap en mam, het dankwoord aan jullie is het moeilijkste te verwoorden, want die 
dank is het grootst. We praten altijd heel veel, maar dit zeg ik niet zo vaak: dank jullie 
wel voor jullie liefde, vertrouwen, steun en vrijheid om te studeren en te reizen. Welke 
keus ik ook maak, ik voel me door jullie altijd gesteund. Fijn om in drukke tijden bij 
jullie aan te mogen schuiven, lekker mee-eten, samen een spelletje te spelen en bij te 
praten over werk (hoe gaat het met je boekje?) en wat er in Oeffelt is gebeurd. Het voelt 
allemaal zo vanzelfsprekend dat ik soms vergeet hoe bijzonder het is. 
Lieve Matthijs, geheel onverwacht kruisten onze wegen weer en sloeg de vonk over. 
Ik ben heel benieuwd waar de toekomst ons zal brengen, maar laten we beginnen met 
een biertje want mijn boekje is klaar. Xx
Dank aan iedereen die ik onderweg naar dit proefschrift ben tegen gekomen. Je hebt 
je sporen achtergelaten, en mij -op welke manier dan ook- een stap verder geholpen!
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workshop’ FELASA-congress, Helsinki, Finland, 14-16 June 2010.
Posters 
-  Van Luijk J, M. Leenaars, M. Ritskes-Hoitinga. ‘Improving transparency on quality 
and translatability of animal studies using a new science driven approach’ FELASA 
congress, Brussels (Belgium), 13-16 June 2016.
-  Leenaars M, J. Van Luijk, C. Hooijmans, M. Ritskes-Hoitinga, R. de Vries, K. 
Wever. ‘Unique e-learning module on systematic reviews and meta-analysis of 
animal studies; an interactive introduction to the basic principles and power of this 
methodology’ FELASA congress, Brussels (Belgium), 13-16 June 2016
-  van Luijk J, M. Leenaars, R. de Vries, C. Hooijmans, M. Ritskes-Hoitinga. 
‘Systematic Reviews of animal studies: assessing translational value’ NCEBP PhD 
retreat, Wageningen (The Netherlands), 29-30 September 2011.
-  van Luijk J, M. Leenaars, R. de Vries, C. Hooijmans, M. Ritskes-Hoitinga. ‘How the 
3Rs can benefit from Systematic Reviews’ 8th World congress on alternatives and 
animal use in the life sciences, Montréal (Canada), 21-25 Augustus 2011.
-  van Luijk, J, Y. Cuijpers, L. van der Vaart, M. Leenaars, M. Ritskes-Hoitinga. 
‘Enhancing implementation of the 3Rs in daily practice – which way to go?’ 8th 
World congress on alternatives and animal use in the life sciences, Montréal 
(Canada), 21-25 Augustus 2011.
Other
-  Chair ‘laptop session’ Implementing systematic reviews of animal studies – the 
next step, Radboudumc Nijmegen the Netherlands, 16 October 2015.
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-  Organizing committee Symposium 60 year Central animal facility; Changing 
perspective on the impact of animal studies on health care, Nijmegen The 
Netherlands, October 2015.
-  Chair session 3: ‘Exciting new techniques for systematic review and meta-analysis’ 
3rd international symposium on systematic review and meta-analysis of laboratory 
animal studies, The Embassy of Australia, Washington DC, USA, 13-14 November 
2014.
-  Chair ‘laptop session’ Inspiration day on synthesis of evidence, NWO, Den Haag, 
the Netherlands, 2 July 2014.
Trainer 
-  One day workshop: Hands-on training in systematic reviews, Nijmegen, 
Amsterdam, Utrecht (the Netherlands), Geneva, Lausanne, Zurich, Basel 
(Switzerland), Italy (Varese),  Aarhus (Denmark), Voss (Norway),  Stockholm 
(Sweden), Sao Paulo (Brazil). –  Topics: “Comprehensive search strategies”, “Risk 
of bias assessment” and “data extraction and meta-analysis”
-  Laboratory Animal Science course, Radboudumc Nijmegen (the Netherlands), 
AMC and KNAW Amsterdam (the Netherlands), Aarhus University (Denmark)  – 
Topics: “Introduction to the systematic review methodology”, “Comprehensive 
search strategies”, “Reporting and publication bias” 
-  Radboud Summer School, Nijmegen (the Netherlands) – Topics: “Translational 
challenges”, “Risk of bias assessment” and “Randomisation and blinding of 
experimental design”
-  Systematic reviews at EFSA, European Food and Safety Authority, Parma – 
Topics: “Introduction to the systematic review methodology” and “Comprehensive 
search strategies”
-  Master of Science in Laboratory Animal Science, RWTH Aachen University 
(Germany) – Topics: “Experimental design and reporting, 3Rs”, “Systematic 
reviews and searching”, ”Systematic reviews advantages and challenges”
-  Leuk om te leren, Weekendschool Arnhem – Topics: “Dierproeven – waarom en 
hoe doen ze dat?”
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